# title
Healthcare Common Procedure Coding System (HCPCS) level II alphanumeric codes

# publisher
U.S. Centers for Medicare & Medicaid Services (CMS)

# contact[].name
U.S. Centers for Medicare & Medicaid Services (CMS)

# description
The Level II HCPCS codes, which are established by CMS's Alpha-Numeric Editorial Panel, primarily represent items and supplies and non-physician services not covered by the American Medical Association's Current Procedural Terminology-4 (CPT-4) codes; Medicare, Medicaid, and private health insurers use HCPCS procedure and modifier codes for claims processing.  Level II alphanumeric procedure and modifier codes comprise the A to V range.

# concept[].designation[].value
Anesthesia services performed personally by anesthesiologist

# concept[].designation[].value
Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary

# concept[].designation[].value
Medical supervision by a physician: more than four concurrent anesthesia procedures

# concept[].designation[].value
Alternate payment method declined by provider of service

# concept[].designation[].value
Determination of refractive state was not performed in the course of diagnostic ophthalmological examination

# concept[].designation[].value
Physician providing a service in an unlisted health professional shortage area (hpsa)

# concept[].designation[].value
Physician provider services in a physician scarcity area

# concept[].designation[].value
Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery

# concept[].designation[].value
Acute treatment (this modifier should be used when reporting service 98940, 98941, 98942)

# concept[].designation[].value
Item furnished in conjunction with a urological, ostomy, or tracheostomy supply

# concept[].designation[].value
Item furnished in conjunction with a prosthetic device, prosthetic or orthotic

# concept[].designation[].value
Item furnished in conjunction with a surgical dressing

# concept[].designation[].value
Item furnished in conjunction with dialysis services

# concept[].designation[].value
Item or service furnished to an esrd patient that is not for the treatment of esrd

# concept[].designation[].value
Physician providing a service in a dental health professional shortage area for the purpose of an electronic health record incentive payment

# concept[].designation[].value
Item furnished in conjunction with parenteral enteral nutrition (pen) services

# concept[].designation[].value
Special acquisition of blood and blood products

# concept[].designation[].value
Orally administered nutrition, not by feeding tube

# concept[].designation[].value
The beneficiary has been informed of the purchase and rental options and has elected to purchase the item

# concept[].designation[].value
The beneficiary has been informed of the purchase and rental options and has elected to rent the item

# concept[].designation[].value
The beneficiary has been informed of the purchase and rental options and after 30 days has not informed the supplier of his/her decision

# concept[].designation[].value
Procedure payable only in the inpatient setting when performed emergently on an outpatient who expires prior to admission

# concept[].designation[].value
Service ordered by a renal dialysis facility (rdf) physician as part of the esrd beneficiary's dialysis benefit, is not part of the composite rate, and is separately reimbursable

# concept[].designation[].value
Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)

# concept[].designation[].value
Amcc test has been ordered by an esrd facility or mcp physician that is part of the composite rate and is not separately billable

# concept[].designation[].value
Amcc test has been ordered by an esrd facility or mcp physician that is a composite rate test but is beyond the normal frequency covered under the rate and is separately reimbursable based on medical necessity

# concept[].designation[].value
Amcc test has been ordered by an esrd facility or mcp physician that is not part of the composite rate and is separately billable

# concept[].designation[].value
0 percent impaired, limited or restricted

# concept[].designation[].value
At least 1 percent but less than 20 percent impaired, limited or restricted

# concept[].designation[].value
At least 20 percent but less than 40 percent impaired, limited or restricted

# concept[].designation[].value
At least 40 percent but less than 60 percent impaired, limited or restricted

# concept[].designation[].value
At least 60 percent but less than 80 percent impaired, limited or restricted

# concept[].designation[].value
At least 80 percent but less than 100 percent impaired, limited or restricted

# concept[].designation[].value
100 percent impaired, limited or restricted

# concept[].designation[].value
Outpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant

# concept[].designation[].value
Adjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim

# concept[].designation[].value
Outpatient physical therapy services furnished in whole or in part by a physical therapist assistant

# concept[].designation[].value
Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency

# concept[].designation[].value
Computed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standard

# concept[].designation[].value
Oral health assessment by a licensed health professional other than a dentist

# concept[].designation[].value
Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy

# concept[].designation[].value
Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy

# concept[].designation[].value
Erythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy

# concept[].designation[].value
Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle

# concept[].designation[].value
Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle

# concept[].designation[].value
Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab

# concept[].designation[].value
Emergency reserve supply (for esrd benefit only)

# concept[].designation[].value
Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program

# concept[].designation[].value
Items and services furnished by a provider-based, off-campus emergency department

# concept[].designation[].value
No physician or other licensed health care provider order for this item or service

# concept[].designation[].value
Item provided without cost to provider, supplier or practitioner, or full credit received for replaced device (examples, but not limited to, covered under warranty, replaced due to defect, free samples)

# concept[].designation[].value
Partial credit received for replaced device

# concept[].designation[].value
Service provided as part of family planning program

# concept[].designation[].value
The service was furnished using audio-only communication technology

# concept[].designation[].value
The supervising practitioner was present through two-way, audio/video communication technology

# concept[].designation[].value
Split (or shared) evaluation and management visit

# concept[].designation[].value
Unrelated evaluation and management (e/m) visit on the same day as another e/m visit or during a global procedure (preoperative, postoperative period, or on the same day as the procedure, as applicable). (report when an e/m visit is furnished within the global period but is unrelated, or when one or more additional e/m visits furnished on the same day are unrelated)

# concept[].designation[].value
X-ray taken using computed radiography technology/cassette-based imaging

# concept[].designation[].value
Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an acute stroke

# concept[].designation[].value
Most recent urr reading of 75 or greater

# concept[].designation[].value
Esrd patient for whom less than six dialysis sessions have been provided in a month

# concept[].designation[].value
Pregnancy resulted from rape or incest or pregnancy certified by physician as life threatening

# concept[].designation[].value
Monitored anesthesia care (mac) for deep complex, complicated, or markedly invasive surgical procedure

# concept[].designation[].value
Monitored anesthesia care for patient who has history of severe cardio-pulmonary condition

# concept[].designation[].value
Waiver of liability statement issued as required by payer policy, individual case

# concept[].designation[].value
Claim being re-submitted for payment because it is no longer covered under a global payment demonstration

# concept[].designation[].value
This service has been performed in part by a resident under the direction of a teaching physician

# concept[].designation[].value
Units of service exceeds medically unlikely edit value and represents reasonable and necessary services

# concept[].designation[].value
This service has been performed by a resident without the presence of a teaching physician under the primary care exception

# concept[].designation[].value
Non-physician (e.g. nurse practitioner (np), certified registered nurse anesthetist (crna), certified registered nurse (crn), clinical nurse specialist (cns), physician assistant (pa)) services in a critical access hospital

# concept[].designation[].value
Performance and payment of a screening mammogram and diagnostic mammogram on the same patient, same day

# concept[].designation[].value
Diagnostic mammogram converted from screening mammogram on same day

# concept[].designation[].value
"opt out" physician or practitioner emergency or urgent service

# concept[].designation[].value
Reasonable and necessary item/service associated with a ga or gz modifier

# concept[].designation[].value
Medically unnecessary upgrade provided instead of non-upgraded item, no charge, no advance beneficiary notice (abn)

# concept[].designation[].value
Services delivered under an outpatient speech language pathology plan of care

# concept[].designation[].value
Services delivered under an outpatient occupational therapy plan of care

# concept[].designation[].value
Services delivered under an outpatient physical therapy plan of care

# concept[].designation[].value
This service was performed in whole or in part by a resident in a department of veterans affairs medical center or clinic, supervised in accordance with va policy

# concept[].designation[].value
Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level

# concept[].designation[].value
Via interactive audio and video telecommunication systems

# concept[].designation[].value
Waiver of liability statement issued as required by payer policy, routine notice

# concept[].designation[].value
Attending physician not employed or paid under arrangement by the patient's hospice provider

# concept[].designation[].value
Service not related to the hospice patient's terminal condition

# concept[].designation[].value
Notice of liability issued, voluntary under payer policy

# concept[].designation[].value
Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit

# concept[].designation[].value
Item or service expected to be denied as not reasonable and necessary

# concept[].designation[].value
Integrated mental health/substance abuse program

# concept[].designation[].value
Specialized mental health programs for high-risk populations

# concept[].designation[].value
Competitive acquisition program no-pay submission for a prescription number

# concept[].designation[].value
Competitive acquisition program, restocking of emergency drugs after emergency administration

# concept[].designation[].value
Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge

# concept[].designation[].value
Off-the-shelf orthotic subject to dmepos competitive bidding program that is furnished as part of a physical therapist or occupational therapist professional service

# concept[].designation[].value
Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

# concept[].designation[].value
One month supply or less of drug or biological

# concept[].designation[].value
Three month supply of drug or biological

# concept[].designation[].value
Drug amount discarded/not administered to any patient

# concept[].designation[].value
Zero drug amount discarded/not administered to any patient

# concept[].designation[].value
Lower extremity prosthesis functional level 0 - does not have the ability or potential to ambulate or transfer safely with or without assistance and a prosthesis does not enhance their quality of life or mobility.

# concept[].designation[].value
Lower extremity prosthesis functional level 1 - has the ability or potential to use a prosthesis for transfers or ambulation on level surfaces at fixed cadence. typical of the limited and unlimited household ambulator.

# concept[].designation[].value
Lower extremity prosthesis functional level 2 - has the ability or potential for ambulation with the ability to traverse low level environmental barriers such as curbs, stairs or uneven surfaces.  typical of the limited community ambulator.

# concept[].designation[].value
Lower extremity prosthesis functional level 3 - has the ability or potential for ambulation with variable cadence.  typical of the community ambulator who has the ability to transverse most environmental barriers and may have vocational, therapeutic, or exercise activity that demands prosthetic utilization beyond simple locomotion.

# concept[].designation[].value
Lower extremity prosthesis functional level 4 - has the ability or potential for prosthetic ambulation that exceeds the basic ambulation skills, exhibiting high impact, stress, or energy levels, typical of the prosthetic demands of the child, active adult, or athlete.

# concept[].designation[].value
Beneficiary requested upgrade for abn, more than 4 modifiers identified on claim

# concept[].designation[].value
Replacement of special power wheelchair interface

# concept[].designation[].value
Bid under round one of the dmepos competitive bidding program for use with non-competitive bid base equipment

# concept[].designation[].value
Item designated by fda as class iii device

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program number 1

# concept[].designation[].value
Dmepos item, initial claim, purchase or first month rental

# concept[].designation[].value
Dmepos item, second or third month rental

# concept[].designation[].value
Dmepos item, parenteral enteral nutrition (pen) pump or capped rental, months four to fifteen

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program number 2

# concept[].designation[].value
Replacement of facial prosthesis including new impression/moulage

# concept[].designation[].value
Replacement of facial prosthesis using previous master model

# concept[].designation[].value
First drug of a multiple drug unit dose formulation

# concept[].designation[].value
Second or subsequent drug of a multiple drug unit dose formulation

# concept[].designation[].value
Glucose monitor supply for diabetic beneficiary not treated with insulin

# concept[].designation[].value
Beneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid item

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program number 3

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program number 4

# concept[].designation[].value
Requirements specified in the medical policy have been met

# concept[].designation[].value
Dmepos item subject to dmepos competitive bidding program number 5

# concept[].designation[].value
New coverage not implemented by managed care

# concept[].designation[].value
Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps

# concept[].designation[].value
Left anterior descending coronary artery

# concept[].designation[].value
Lease/rental (use the 'll' modifier when dme equipment rental is to be applied against the purchase price)

# concept[].designation[].value
Left side (used to identify procedures performed on the left side of the body)

# concept[].designation[].value
Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition

# concept[].designation[].value
Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of insufficient internet access

# concept[].designation[].value
Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of electronic health record or clinical decision support mechanism vendor issues

# concept[].designation[].value
Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of extreme and uncontrollable circumstances

# concept[].designation[].value
The order for this service adheres to appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional

# concept[].designation[].value
The order for this service does not adhere to the appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional

# concept[].designation[].value
The order for this service does not have applicable appropriate use criteria in the qualified clinical decision support mechanism consulted by the ordering professional

# concept[].designation[].value
Unknown if ordering professional consulted a clinical decision support mechanism for this service, related information was not provided to the furnishing professional or provider

# concept[].designation[].value
Six month maintenance and servicing fee for reasonable and necessary parts and labor which are not covered under any manufacturer or supplier warranty

# concept[].designation[].value
Nebulizer system, any type, fda-cleared for use with specific drug

# concept[].designation[].value
New when rented (use the 'nr' modifier when dme which was new at the time of rental is subsequently purchased)

# concept[].designation[].value
A patient with severe systemic disease that is a constant threat to life

# concept[].designation[].value
A moribund patient who is not expected to survive without the operation

# concept[].designation[].value
A declared brain-dead patient whose organs are being removed for donor purposes

# concept[].designation[].value
Surgical or other invasive procedure on wrong body part

# concept[].designation[].value
Surgical or other invasive procedure on wrong patient

# concept[].designation[].value
Wrong surgery or other invasive procedure on patient

# concept[].designation[].value
Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days

# concept[].designation[].value
Positron emission tomography (pet) or pet/computed tomography (ct) to inform the initial treatment strategy of tumors that are biopsy proven or strongly suspected of being cancerous based on other diagnostic testing

# concept[].designation[].value
Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital

# concept[].designation[].value
Excepted service provided at an off-campus, outpatient, provider-based department of a hospital

# concept[].designation[].value
Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary's treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy

# concept[].designation[].value
Colorectal cancer screening test; converted to diagnostic test or other procedure

# concept[].designation[].value
Investigational clinical service provided in a clinical research study that is in an approved clinical research study

# concept[].designation[].value
Routine clinical service provided in a clinical research study that is in an approved clinical research study

# concept[].designation[].value
Live kidney donor surgery and related services

# concept[].designation[].value
Service for ordering/referring physician qualifies as a service exemption

# concept[].designation[].value
Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area

# concept[].designation[].value
Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area

# concept[].designation[].value
Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm)

# concept[].designation[].value
Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts exceeds 4 liters per minute (lpm) and portable oxygen is prescribed

# concept[].designation[].value
Recording and storage in solid state memory by a digital recorder

# concept[].designation[].value
Prescribed amount of stationary oxygen while at rest is less than 1 liter per minute (lpm)

# concept[].designation[].value
Prescribed amount of stationary oxygen while at rest exceeds 4 liters per minute (lpm) and portable oxygen is prescribed

# concept[].designation[].value
Prescribed amount of stationary oxygen while at rest is greater than 4 liters per minute (lpm)

# concept[].designation[].value
Oxygen conserving device is being used with an oxygen delivery system

# concept[].designation[].value
Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)

# concept[].designation[].value
Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals

# concept[].designation[].value
Patient pronounced dead after ambulance called

# concept[].designation[].value
Ambulance service provided under arrangement by a provider of services

# concept[].designation[].value
Ambulance service furnished directly by a provider of services

# concept[].designation[].value
Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060.

# concept[].designation[].value
Ordering professional consulted a qualified clinical decision support mechanism for this service and the related data was provided to the furnishing professional

# concept[].designation[].value
Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is greater than 4 liters per minute (lpm)

# concept[].designation[].value
Recording and storage on tape by an analog tape recorder

# concept[].designation[].value
Crna service: with medical direction by a physician

# concept[].designation[].value
Medical direction of one certified registered nurse anesthetist (crna) by an anesthesiologist

# concept[].designation[].value
Crna service: without medical direction by a physician

# concept[].designation[].value
Replacement of a dme, orthotic or prosthetic item

# concept[].designation[].value
Replacement of a part of a dme, orthotic or prosthetic item furnished as part of a repair

# concept[].designation[].value
Drug provided to beneficiary, but not administered "incident-to"

# concept[].designation[].value
Furnished in full compliance with fda-mandated risk evaluation and mitigation strategy (rems)

# concept[].designation[].value
Rental (use the 'rr' modifier when dme is to be rented)

# concept[].designation[].value
Right side (used to identify procedures performed on the right side of the body)

# concept[].designation[].value
Nurse practitioner rendering service in collaboration with a physician

# concept[].designation[].value
Services provided by registered nurse with specialized, highly technical home infusion training

# concept[].designation[].value
Second opinion ordered by a professional review organization (pro) per section 9401, p.l. 99-272 (100% reimbursement - no medicare deductible or coinsurance)

# concept[].designation[].value
Ambulatory surgical center (asc) facility service

# concept[].designation[].value
Third or more concurrently administered infusion therapy

# concept[].designation[].value
Member of high risk population (use only with codes for immunization)

# concept[].designation[].value
Home infusion services provided in the infusion suite of the iv therapy provider

# concept[].designation[].value
Procedure performed in physician's office (to denote use of facility and equipment)

# concept[].designation[].value
Pharmaceuticals delivered to patient's home but not utilized

# concept[].designation[].value
Services provided by a certified diabetic educator

# concept[].designation[].value
Persons who are in close contact with member of high-risk population (use only with codes for immunization)

# concept[].designation[].value
Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

# concept[].designation[].value
Technical component; under certain circumstances, a charge may be made for the technical component alone;  under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles

# concept[].designation[].value
Extra patient or passenger, non-ambulance

# concept[].designation[].value
Early intervention/individualized family service plan (ifsp)

# concept[].designation[].value
Rural/outside providers' customary service area

# concept[].designation[].value
Basic life support transport by a volunteer ambulance provider

# concept[].designation[].value
School-based individualized education program (iep) services provided outside the public school district responsible for the student

# concept[].designation[].value
Individualized service provided to more than one patient in same setting

# concept[].designation[].value
Medicaid level of care 1, as defined by each state

# concept[].designation[].value
Medicaid level of care 2, as defined by each state

# concept[].designation[].value
Medicaid level of care 3, as defined by each state

# concept[].designation[].value
Medicaid level of care 4, as defined by each state

# concept[].designation[].value
Medicaid level of care 5, as defined by each state

# concept[].designation[].value
Medicaid level of care 6, as defined by each state

# concept[].designation[].value
Medicaid level of care 7, as defined by each state

# concept[].designation[].value
Medicaid level of care 8, as defined by each state

# concept[].designation[].value
Medicaid level of care 9, as defined by each state

# concept[].designation[].value
Medicaid level of care 10, as defined by each state

# concept[].designation[].value
Medicaid level of care 11, as defined by each state

# concept[].designation[].value
Medicaid level of care 12, as defined by each state

# concept[].designation[].value
Medicaid level of care 13, as defined by each state

# concept[].designation[].value
Services provided on behalf of the client to someone other than the client (collateral relationship)

# concept[].designation[].value
Vascular catheter (alone or with any other vascular access)

# concept[].designation[].value
Arteriovenous graft (or other vascular access not including a vascular catheter)

# concept[].designation[].value
Arteriovenous fistula only (in use with two needles)

# concept[].designation[].value
Medicare diabetes prevention program (mdpp) virtual make-up session

# concept[].designation[].value
Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care

# concept[].designation[].value
Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services

# concept[].designation[].value
Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital

# concept[].designation[].value
Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period

# concept[].designation[].value
Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician

# concept[].designation[].value
Separate encounter, a service that is distinct because it occurred during a separate encounter

# concept[].designation[].value
Separate practitioner, a service that is distinct because it was performed by a different practitioner

# concept[].designation[].value
Separate structure, a service that is distinct because it was performed on a separate organ/structure

# concept[].designation[].value
Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service

# concept[].designation[].value
Ambulance service, outside state per mile, transport (medicaid only)

# concept[].designation[].value
Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest

# concept[].designation[].value
Non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest

# concept[].designation[].value
Non-emergency transportation and bus, intra or inter state carrier

# concept[].designation[].value
Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems

# concept[].designation[].value
Non-emergency transportation and air travel (private or commercial) intra or inter state

# concept[].designation[].value
Non-emergency transportation: per mile - case worker or social worker

# concept[].designation[].value
Transportation ancillary: parking fees, tolls, other

# concept[].designation[].value
Ambulance service, neonatal transport, base rate, emergency transport, one way

# concept[].designation[].value
Bls specialized service disposable supplies; defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances)

# concept[].designation[].value
Als specialized service disposable supplies; defibrillation (to be used only in jurisdictions where defibrillation cannot be performed in bls ambulances)

# concept[].designation[].value
Als specialized service disposable supplies; iv drug therapy

# concept[].designation[].value
Als specialized service disposable supplies; esophageal intubation

# concept[].designation[].value
Ambulance waiting time (als or bls), one half (1/2) hour increments

# concept[].designation[].value
Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation

# concept[].designation[].value
Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)

# concept[].designation[].value
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)

# concept[].designation[].value
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)

# concept[].designation[].value
Ambulance service, basic life support, non-emergency transport, (bls)

# concept[].designation[].value
Ambulance service, basic life support, emergency transport (bls-emergency)

# concept[].designation[].value
Ambulance service, conventional air services, transport, one way (fixed wing)

# concept[].designation[].value
Ambulance service, conventional air services, transport, one way (rotary wing)

# concept[].designation[].value
Paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers

# concept[].designation[].value
Fixed wing air mileage, per statute mile

# concept[].designation[].value
Rotary wing air mileage, per statute mile

# concept[].designation[].value
Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)

# concept[].designation[].value
Ambulance response and treatment, no transport

# concept[].designation[].value
Mirragen advanced wound matrix, per square centimeter

# concept[].designation[].value
Novosorb synpath dermal matrix, per square centimeter

# concept[].designation[].value
Phoenix wound matrix, per square centimeter

# concept[].designation[].value
Kerecis omega3 marigen shield, per square centimeter

# concept[].designation[].value
Innovaburn or innovamatrix xl, per square centimeter

# concept[].designation[].value
Resolve matrix or xenopatch, per square centimeter

# concept[].designation[].value
Mirotract wound matrix sheet, per cubic centimeter

# concept[].designation[].value
Skin substitute, fda cleared as a device, not otherwise specified

# concept[].designation[].value
Syringe with needle, sterile, 1 cc or less, each

# concept[].designation[].value
Syringe with needle, sterile 5 cc or greater, each

# concept[].designation[].value
Non-coring needle or stylet with or without catheter

# concept[].designation[].value
Syringe, sterile, 20 cc or greater, each

# concept[].designation[].value
Sterile water, saline and/or dextrose, diluent/flush, 10 ml

# concept[].designation[].value
Sterile saline or water, metered dose dispenser, 10 ml

# concept[].designation[].value
Refill kit for implantable infusion pump

# concept[].designation[].value
Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs  separately)

# concept[].designation[].value
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)

# concept[].designation[].value
Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)

# concept[].designation[].value
Supplies for maintenance of insulin infusion catheter, per week

# concept[].designation[].value
Supplies for external insulin infusion pump, syringe type cartridge, sterile, each

# concept[].designation[].value
Supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week

# concept[].designation[].value
Infusion set for external insulin pump, non needle cannula type

# concept[].designation[].value
Infusion set for external insulin pump, needle type

# concept[].designation[].value
Syringe with needle for external insulin pump, sterile, 3 cc

# concept[].designation[].value
Replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each

# concept[].designation[].value
Replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each

# concept[].designation[].value
Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each

# concept[].designation[].value
Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each

# concept[].designation[].value
Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service

# concept[].designation[].value
Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service

# concept[].designation[].value
Chlorhexidine containing antiseptic, 1 ml

# concept[].designation[].value
Urine test or reagent strips or tablets (100 tablets or strips)

# concept[].designation[].value
Blood ketone test or reagent strip, each

# concept[].designation[].value
Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips

# concept[].designation[].value
Platforms for home blood glucose monitor, 50 per box

# concept[].designation[].value
Normal, low and high calibrator solution / chips

# concept[].designation[].value
Replacement lens shield cartridge for use with laser skin piercing device, each

# concept[].designation[].value
Temporary, absorbable lacrimal duct implant, each

# concept[].designation[].value
Permanent, long term, non-dissolvable lacrimal duct implant, each

# concept[].designation[].value
Permanent implantable contraceptive intratubal occlusion device(s) and delivery system

# concept[].designation[].value
Contraceptive supply, condom, male, each

# concept[].designation[].value
Contraceptive supply, condom, female, each

# concept[].designation[].value
Contraceptive supply, spermicide (e.g., foam, gel), each

# concept[].designation[].value
Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per 50 tests

# concept[].designation[].value
Adhesive skin support attachment for use with external breast prosthesis, each

# concept[].designation[].value
Breast shield and splash protector for use with breast pump, replacement

# concept[].designation[].value
Polycarbonate bottle for use with breast pump, replacement

# concept[].designation[].value
Locking ring for breast pump, replacement

# concept[].designation[].value
Disposable collection and storage bag for breast milk, any size, any type, each

# concept[].designation[].value
Sacral nerve stimulation test lead, each

# concept[].designation[].value
Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access

# concept[].designation[].value
Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.)

# concept[].designation[].value
Disposable drug delivery system, flow rate of 50 ml or greater per hour

# concept[].designation[].value
Disposable drug delivery system, flow rate of less than 50 ml per hour

# concept[].designation[].value
Insertion tray without drainage bag and without catheter (accessories only)

# concept[].designation[].value
Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)

# concept[].designation[].value
Insertion tray without drainage bag with indwelling catheter, foley type, two-way, all silicone

# concept[].designation[].value
Insertion tray without drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation

# concept[].designation[].value
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)

# concept[].designation[].value
Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone

# concept[].designation[].value
Insertion tray with drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation

# concept[].designation[].value
Irrigation tray with bulb or piston syringe, any purpose

# concept[].designation[].value
Therapeutic agent for urinary catheter irrigation

# concept[].designation[].value
Irrigation syringe, bulb or piston, each

# concept[].designation[].value
Male external catheter with integral collection chamber, any type, each

# concept[].designation[].value
Female external urinary collection device; meatal cup, each

# concept[].designation[].value
Female external urinary collection device; pouch, each

# concept[].designation[].value
Perianal fecal collection pouch with adhesive, each

# concept[].designation[].value
Extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each

# concept[].designation[].value
Lubricant, individual sterile packet, each

# concept[].designation[].value
Urinary catheter anchoring device, adhesive skin attachment, each

# concept[].designation[].value
Urinary catheter anchoring device, leg strap, each

# concept[].designation[].value
Incontinence supply, urethral insert, any type, each

# concept[].designation[].value
Incontinence supply, rectal insert, any type, each

# concept[].designation[].value
Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each

# concept[].designation[].value
Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each

# concept[].designation[].value
Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each

# concept[].designation[].value
Accessories for patient inserted indwelling intraurethral drainage device with valve, replacement only, each

# concept[].designation[].value
Indwelling catheter, foley type, two-way, all silicone or polyurethane, each

# concept[].designation[].value
Indwelling catheter; foley type, three way for continuous irrigation, each

# concept[].designation[].value
Male external catheter, with or without adhesive, disposable, each

# concept[].designation[].value
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each

# concept[].designation[].value
Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each

# concept[].designation[].value
Intermittent urinary catheter, with insertion supplies

# concept[].designation[].value
Insertion tray with drainage bag but without catheter

# concept[].designation[].value
Irrigation tubing set for continuous bladder irrigation through a three-way indwelling foley catheter, each

# concept[].designation[].value
External urethral clamp or compression device (not to be used for catheter clamp), each

# concept[].designation[].value
Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each

# concept[].designation[].value
Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each

# concept[].designation[].value
Disposable external urethral clamp or compression device, with pad and/or pouch, each

# concept[].designation[].value
Skin barrier; solid, 4 x 4 or equivalent; each

# concept[].designation[].value
Ostomy clamp, any type, replacement only, each

# concept[].designation[].value
Adhesive, liquid or equal, any type, per oz

# concept[].designation[].value
Ostomy skin barrier, liquid (spray, brush, etc.), per oz

# concept[].designation[].value
Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each

# concept[].designation[].value
Ostomy pouch, drainable, with faceplate attached, plastic, each

# concept[].designation[].value
Ostomy pouch, drainable, with faceplate attached, rubber, each

# concept[].designation[].value
Ostomy pouch, drainable, for use on faceplate, plastic, each

# concept[].designation[].value
Ostomy pouch, drainable, for use on faceplate, rubber, each

# concept[].designation[].value
Ostomy pouch, urinary, with faceplate attached, plastic, each

# concept[].designation[].value
Ostomy pouch, urinary, with faceplate attached, rubber, each

# concept[].designation[].value
Ostomy pouch, urinary, for use on faceplate, plastic, each

# concept[].designation[].value
Ostomy pouch, urinary, for use on faceplate, heavy plastic, each

# concept[].designation[].value
Ostomy pouch, urinary, for use on faceplate, rubber, each

# concept[].designation[].value
Ostomy faceplate equivalent, silicone ring, each

# concept[].designation[].value
Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each

# concept[].designation[].value
Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each

# concept[].designation[].value
Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce

# concept[].designation[].value
Ostomy deodorant for use in ostomy pouch, solid, per tablet

# concept[].designation[].value
Ostomy belt with peristomal hernia support

# concept[].designation[].value
Ostomy irrigation supply; cone/catheter, with or without brush

# concept[].designation[].value
Ostomy skin barrier, non-pectin based, paste, per ounce

# concept[].designation[].value
Ostomy skin barrier, pectin-based, paste, per ounce

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, with built-in convexity, larger than 4 x 4 inches, each

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each

# concept[].designation[].value
Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each

# concept[].designation[].value
Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each

# concept[].designation[].value
Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), with filter, each

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each

# concept[].designation[].value
Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, larger than 4 x 4 inches, each

# concept[].designation[].value
Ostomy pouch, closed, with barrier attached, with filter (1 piece), each

# concept[].designation[].value
Ostomy pouch, closed, with barrier attached, with built-in convexity, with filter (1 piece), each

# concept[].designation[].value
Ostomy pouch, closed; without barrier attached, with filter (1 piece), each

# concept[].designation[].value
Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each

# concept[].designation[].value
Ostomy pouch, closed; for use on barrier with locking flange (2 piece), each

# concept[].designation[].value
Ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to thicken liquid stomal output, each

# concept[].designation[].value
Ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each

# concept[].designation[].value
Ostomy pouch, drainable; for use on barrier with locking flange (2 piece system), each

# concept[].designation[].value
Ostomy pouch, drainable; for use on barrier with locking flange, with filter (2 piece system), each

# concept[].designation[].value
Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each

# concept[].designation[].value
Ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each

# concept[].designation[].value
Ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type tap with valve (2 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each

# concept[].designation[].value
Irrigation supply; sleeve, reusable, per month

# concept[].designation[].value
Irrigation supply; sleeve, disposable, per month

# concept[].designation[].value
Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each

# concept[].designation[].value
Tape, non-waterproof, per 18 square inches

# concept[].designation[].value
Rectal catheter for use with the manual pump-operated enema system, replacement only

# concept[].designation[].value
Adhesive remover or solvent (for tape, cement or other adhesive), per ounce

# concept[].designation[].value
Enema tube, with or without adapter, any type, replacement only, each

# concept[].designation[].value
Manual pump-operated enema system, includes balloon, catheter and all accessories, reusable, any type

# concept[].designation[].value
Surgical dressing holder, non-reusable, each

# concept[].designation[].value
Surgical dressing holder, reusable, each

# concept[].designation[].value
Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each

# concept[].designation[].value
Belt, strap, sleeve, garment, or covering, any type

# concept[].designation[].value
Exsufflation belt, includes all supplies and accessories

# concept[].designation[].value
Tracheostoma filter, any type, any size, each

# concept[].designation[].value
Moisture exchanger, disposable, for use with invasive mechanical ventilation

# concept[].designation[].value
Surgical stockings above knee length, each

# concept[].designation[].value
Surgical stockings below knee length, each

# concept[].designation[].value
Incontinence garment, any type, (e.g., brief, diaper), each

# concept[].designation[].value
Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm

# concept[].designation[].value
Monthly supplies for use of device coded at e0733

# concept[].designation[].value
Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist

# concept[].designation[].value
Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month

# concept[].designation[].value
Electrode for external lower extremity nerve stimulator for restless legs syndrome

# concept[].designation[].value
Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month

# concept[].designation[].value
Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only

# concept[].designation[].value
Electrodes, (e.g., apnea monitor), per pair

# concept[].designation[].value
Lead wires, (e.g., apnea monitor), per pair

# concept[].designation[].value
Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz

# concept[].designation[].value
Coupling gel or paste, for use with ultrasound device, per oz

# concept[].designation[].value
Neuromuscular electrical stimulator (nmes), disposable, replacement only

# concept[].designation[].value
Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each

# concept[].designation[].value
Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Topical hyperbaric oxygen chamber, disposable

# concept[].designation[].value
Special casting material (e.g., fiberglass)

# concept[].designation[].value
Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, controller

# concept[].designation[].value
Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each

# concept[].designation[].value
Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)

# concept[].designation[].value
Cranial electrotherapy stimulation (ces) system supplies and accessories, per month

# concept[].designation[].value
Sleeve for intermittent limb compression device, replacement only, each

# concept[].designation[].value
Lithium ion battery, rechargeable, for non-prosthetic use, replacement

# concept[].designation[].value
Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each

# concept[].designation[].value
Tubing with integrated heating element for use with positive airway pressure device

# concept[].designation[].value
Tracheal suction catheter, closed system, each

# concept[].designation[].value
Oxygen probe for use with oximeter device, replacement

# concept[].designation[].value
Battery, heavy duty; replacement for patient owned ventilator

# concept[].designation[].value
Battery cables; replacement for patient-owned ventilator

# concept[].designation[].value
Battery charger; replacement for patient-owned ventilator

# concept[].designation[].value
Peak expiratory flow rate meter, hand held

# concept[].designation[].value
Tracheal suction catheter, any type other than closed system, each

# concept[].designation[].value
Tracheostomy care kit for new tracheostomy

# concept[].designation[].value
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler

# concept[].designation[].value
Oral and/or oropharyngeal suction catheter, each

# concept[].designation[].value
Tracheostomy care kit for established tracheostomy

# concept[].designation[].value
Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient

# concept[].designation[].value
Replacement bulb/lamp for ultraviolet light therapy system, each

# concept[].designation[].value
Replacement bulb for therapeutic light box, tabletop model

# concept[].designation[].value
Replacement, handgrip, cane, crutch, or walker, each

# concept[].designation[].value
Replacement, tip, cane, crutch, walker, each.

# concept[].designation[].value
Replacement battery for patient-owned ear pulse generator, each

# concept[].designation[].value
Replacement pad for infrared heating pad system, each

# concept[].designation[].value
Replacement pad for use with medically necessary alternating pressure pad owned by patient

# concept[].designation[].value
Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries

# concept[].designation[].value
Tissue marker, implantable, any type, each

# concept[].designation[].value
Peritoneal dialysis catheter anchoring device, belt, each

# concept[].designation[].value
Sphygmomanometer/blood pressure apparatus with cuff and stethoscope

# concept[].designation[].value
Disposable cycler set used with cycler dialysis machine, each

# concept[].designation[].value
Drainage extension line, sterile, for dialysis, each

# concept[].designation[].value
Extension line with easy lock connectors, used with dialysis

# concept[].designation[].value
Chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per 8 oz

# concept[].designation[].value
Activated carbon filter for hemodialysis, each

# concept[].designation[].value
Dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each

# concept[].designation[].value
Bicarbonate concentrate, solution, for hemodialysis, per gallon

# concept[].designation[].value
Bicarbonate concentrate, powder, for hemodialysis, per packet

# concept[].designation[].value
Acetate concentrate solution, for hemodialysis, per gallon

# concept[].designation[].value
Acid concentrate, solution, for hemodialysis, per gallon

# concept[].designation[].value
Treated water (deionized, distilled, or reverse osmosis) for peritoneal dialysis, per gallon

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 249 cc, but less than or equal to 999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 999 cc but less than or equal to 1999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 1999 cc but less than or equal to 2999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 2999 cc but less than or equal to 3999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 3999 cc but less than or equal to 4999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 4999 cc but less than or equal to 5999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, any concentration of dextrose, fluid volume greater than 5999 cc, for peritoneal dialysis

# concept[].designation[].value
Dialysate solution, non-dextrose containing, 500 ml

# concept[].designation[].value
Fistula cannulation set for hemodialysis, each

# concept[].designation[].value
Topical anesthetic, for dialysis, per gram

# concept[].designation[].value
Injectable anesthetic, for dialysis, per 10 ml

# concept[].designation[].value
Shunt accessory, for hemodialysis, any type, each

# concept[].designation[].value
Blood tubing, arterial or venous, for hemodialysis, each

# concept[].designation[].value
Blood tubing, arterial and venous combined, for hemodialysis, each

# concept[].designation[].value
Dialysate solution test kit, for peritoneal dialysis, any type, each

# concept[].designation[].value
Dialysate concentrate, powder, additive for peritoneal dialysis, per packet

# concept[].designation[].value
Dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml

# concept[].designation[].value
Blood collection tube, vacuum, for dialysis, per 50

# concept[].designation[].value
Serum clotting time tube, for dialysis, per 50

# concept[].designation[].value
Blood glucose test strips, for dialysis, per 50

# concept[].designation[].value
Occult blood test strips, for dialysis, per 50

# concept[].designation[].value
Ammonia test strips, for dialysis, per 50

# concept[].designation[].value
Protamine sulfate, for hemodialysis, per 50 mg

# concept[].designation[].value
Disposable catheter tips for peritoneal dialysis, per 10

# concept[].designation[].value
Plumbing and/or electrical work for home hemodialysis equipment

# concept[].designation[].value
Contracts, repair and maintenance, for hemodialysis equipment

# concept[].designation[].value
Miscellaneous dialysis supplies, not otherwise specified

# concept[].designation[].value
Venous pressure clamp, for hemodialysis, each

# concept[].designation[].value
Oral thermometer, reusable, any type, each

# concept[].designation[].value
Rectal thermometer, reusable, any type, each

# concept[].designation[].value
Ostomy pouch, closed; with barrier attached (1 piece), each

# concept[].designation[].value
Ostomy pouch, closed; without barrier attached (1 piece), each

# concept[].designation[].value
Ostomy pouch, closed; for use on faceplate, each

# concept[].designation[].value
Ostomy pouch, closed; for use on barrier with flange (2 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable; with barrier attached, (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable; without barrier attached (1 piece), each

# concept[].designation[].value
Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each

# concept[].designation[].value
Ostomy pouch, urinary; with barrier attached (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary; without barrier attached (1 piece), each

# concept[].designation[].value
Ostomy pouch, urinary; for use on barrier with flange (2 piece), each

# concept[].designation[].value
Continent device; catheter for continent stoma

# concept[].designation[].value
Continent device, stoma absorptive cover for continent stoma

# concept[].designation[].value
Bedside drainage bottle with or without tubing, rigid or expandable, each

# concept[].designation[].value
Urinary suspensory with leg bag, with or without tube, each

# concept[].designation[].value
Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each

# concept[].designation[].value
Leg strap; latex, replacement only, per set

# concept[].designation[].value
Leg strap; foam or fabric, replacement only, per set

# concept[].designation[].value
Skin barrier; solid, 6 x 6 or equivalent, each

# concept[].designation[].value
Skin barrier; solid, 8 x 8 or equivalent, each

# concept[].designation[].value
Adhesive or non-adhesive; disk or foam pad

# concept[].designation[].value
Appliance cleaner, incontinence and ostomy appliances, per 16 oz.

# concept[].designation[].value
Percutaneous catheter/tube anchoring device, adhesive skin attachment

# concept[].designation[].value
For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe

# concept[].designation[].value
For diabetics only, fitting (including follow-up), custom preparation and supply of shoe molded from cast(s) of patient's foot (custom molded shoe), per shoe

# concept[].designation[].value
For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per shoe

# concept[].designation[].value
For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with wedge(s), per shoe

# concept[].designation[].value
For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe

# concept[].designation[].value
For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe

# concept[].designation[].value
For diabetics only, not otherwise specified modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe

# concept[].designation[].value
For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe

# concept[].designation[].value
For diabetics only, direct formed, compression molded to patient's foot without external heat source, multiple-density insert(s) prefabricated, per shoe

# concept[].designation[].value
For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each

# concept[].designation[].value
For diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each

# concept[].designation[].value
For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each

# concept[].designation[].value
Non-contact wound warming wound cover for use with the non-contact wound warming device and warming card

# concept[].designation[].value
Collagen based wound filler, dry form, sterile, per gram of collagen

# concept[].designation[].value
Collagen based wound filler, gel/paste, per gram of collagen

# concept[].designation[].value
Collagen dressing, sterile, size 16 sq. in. or less, each

# concept[].designation[].value
Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each

# concept[].designation[].value
Collagen dressing, sterile, size more than 48 sq. in., each

# concept[].designation[].value
Collagen dressing wound filler, sterile, per 6 inches

# concept[].designation[].value
Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each

# concept[].designation[].value
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing

# concept[].designation[].value
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing

# concept[].designation[].value
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing

# concept[].designation[].value
Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches

# concept[].designation[].value
Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing

# concept[].designation[].value
Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Composite dressing, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Contact layer, sterile, 16 sq. in. or less, each dressing

# concept[].designation[].value
Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing

# concept[].designation[].value
Contact layer, sterile, more than 48 sq. in., each dressing

# concept[].designation[].value
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing

# concept[].designation[].value
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Foam dressing, wound filler, sterile, per gram

# concept[].designation[].value
Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing

# concept[].designation[].value
Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing

# concept[].designation[].value
Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Hydrocolloid dressing, wound filler, paste, sterile, per ounce

# concept[].designation[].value
Hydrocolloid dressing, wound filler, dry form, sterile, per gram

# concept[].designation[].value
Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing

# concept[].designation[].value
Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Hydrogel dressing, wound filler, gel, per fluid ounce

# concept[].designation[].value
Skin sealants, protectants, moisturizers, ointments, any type, any size

# concept[].designation[].value
Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing

# concept[].designation[].value
Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing

# concept[].designation[].value
Transparent film, sterile, 16 sq. in. or less, each dressing

# concept[].designation[].value
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing

# concept[].designation[].value
Transparent film, sterile, more than 48 sq. in., each dressing

# concept[].designation[].value
Wound filler, gel/paste, per fluid ounce, not otherwise specified

# concept[].designation[].value
Wound filler, dry form, per gram, not otherwise specified

# concept[].designation[].value
Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard

# concept[].designation[].value
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Packing strips, non-impregnated, sterile, up to 2 inches in width, per linear yard

# concept[].designation[].value
Adhesive bandage, first-aid type, any size, each

# concept[].designation[].value
Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Conforming bandage, non-elastic, knitted/woven, non-sterile, width less than three inches, per yard

# concept[].designation[].value
Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to 5 inches, per yard

# concept[].designation[].value
Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard

# concept[].designation[].value
Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to five inches, per yard

# concept[].designation[].value
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard

# concept[].designation[].value
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard

# concept[].designation[].value
Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard

# concept[].designation[].value
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard

# concept[].designation[].value
Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard

# concept[].designation[].value
Tubular dressing with or without elastic, any width, per linear yard

# concept[].designation[].value
Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing

# concept[].designation[].value
Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing

# concept[].designation[].value
Compression burn garment, bodysuit (head to foot), custom fabricated

# concept[].designation[].value
Compression burn garment, chin strap, custom fabricated

# concept[].designation[].value
Compression burn garment, facial hood, custom fabricated

# concept[].designation[].value
Compression burn garment, glove to wrist, custom fabricated

# concept[].designation[].value
Compression burn garment, glove to elbow, custom fabricated

# concept[].designation[].value
Compression burn garment, glove to axilla, custom fabricated

# concept[].designation[].value
Compression burn garment, foot to knee length, custom fabricated

# concept[].designation[].value
Compression burn garment, foot to thigh length, custom fabricated

# concept[].designation[].value
Compression burn garment, upper trunk to waist including arm openings (vest), custom fabricated

# concept[].designation[].value
Compression burn garment, trunk, including arms down to leg openings (leotard), custom fabricated

# concept[].designation[].value
Compression burn garment, lower trunk including leg openings (panty), custom fabricated

# concept[].designation[].value
Compression burn garment, not otherwise classified

# concept[].designation[].value
Compression burn mask, face and/or neck, plastic or equal, custom fabricated

# concept[].designation[].value
Gradient compression garment, glove, padded, for nighttime use, each

# concept[].designation[].value
Gradient compression garment, glove, padded, for nighttime use, custom, each

# concept[].designation[].value
Gradient compression garment, arm, padded, for nighttime use, each

# concept[].designation[].value
Gradient compression garment, arm, padded, for nighttime use, custom, each

# concept[].designation[].value
Gradient compression garment, lower leg and foot, padded, for nighttime use, each

# concept[].designation[].value
Gradient compression garment, lower leg and foot, padded, for nighttime use, custom, each

# concept[].designation[].value
Gradient compression garment, full leg and foot, padded, for nighttime use, each

# concept[].designation[].value
Gradient compression garment, full leg and foot, padded, for nighttime use, custom, each

# concept[].designation[].value
Gradient compression garment, bra, for nighttime use, each

# concept[].designation[].value
Gradient compression garment, bra, for nighttime use, custom, each

# concept[].designation[].value
Gradient compression stocking, below knee, 18-30 mmhg, each

# concept[].designation[].value
Gradient compression stocking, below knee, 30-40 mmhg, used as a surgical dressing, each

# concept[].designation[].value
Gradient compression stocking, below knee, 40-50 mmhg, used as a surgical dressing, each

# concept[].designation[].value
Gradient compression stocking, thigh length, 18-30 mmhg, each

# concept[].designation[].value
Gradient compression stocking, thigh length, 30-40 mmhg, each

# concept[].designation[].value
Gradient compression stocking, thigh length, 40 mmhg or greater, each

# concept[].designation[].value
Gradient compression stocking, full length/chap style, 18-30 mmhg, each

# concept[].designation[].value
Gradient compression stocking, full length/chap style, 30-40 mmhg, each

# concept[].designation[].value
Gradient compression stocking, full length/chap style, 40 mmhg or greater, each

# concept[].designation[].value
Gradient compression stocking, waist length, 18-30 mmhg, each

# concept[].designation[].value
Gradient compression stocking, waist length, 30-40 mmhg, each

# concept[].designation[].value
Gradient compression stocking, waist length, 40 mmhg or greater, each

# concept[].designation[].value
Gradient compression stocking, garter belt

# concept[].designation[].value
Gradient compression wrap, non-elastic, below knee, 30-50 mmhg, used as a surgical dressing, each

# concept[].designation[].value
Gradient compression garment, not otherwise specified

# concept[].designation[].value
Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories

# concept[].designation[].value
Gradient compression stocking, below knee, 30-40 mmhg, each

# concept[].designation[].value
Gradient compression stocking, below knee, 30-40 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, below knee, 40 mmhg or greater, each

# concept[].designation[].value
Gradient compression stocking, below knee, 40 mmhg or greater, custom, each

# concept[].designation[].value
Gradient compression stocking, thigh length, 18-30 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, thigh length, 30-40 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, thigh length, 40 mmhg or greater, custom, each

# concept[].designation[].value
Gradient compression stocking, full length/chap style, 18-30 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, full length/chap style, 30-40 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, full length/chap style, 40 mmhg or greater, custom, each

# concept[].designation[].value
Gradient compression stocking, waist length, 18-30 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, waist length, 30-40 mmhg, custom, each

# concept[].designation[].value
Gradient compression stocking, waist length, 40 mmhg or greater, custom, each

# concept[].designation[].value
Gradient compression gauntlet, custom, each

# concept[].designation[].value
Gradient compression garment, neck/head, each

# concept[].designation[].value
Gradient compression garment, neck/head, custom, each

# concept[].designation[].value
Gradient compression garment, torso and shoulder, each

# concept[].designation[].value
Gradient compression garment, torso/shoulder, custom, each

# concept[].designation[].value
Gradient compression garment, genital region, each

# concept[].designation[].value
Gradient compression garment, genital region, custom, each

# concept[].designation[].value
Gradient compression garment, toe caps, each

# concept[].designation[].value
Gradient compression garment, toe caps, custom, each

# concept[].designation[].value
Gradient compression arm sleeve and glove combination, custom, each

# concept[].designation[].value
Gradient  compression arm sleeve and glove combination, each

# concept[].designation[].value
Gradient  compression arm sleeve, custom, medium weight, each

# concept[].designation[].value
Gradient  compression arm sleeve, custom, heavy weight, each

# concept[].designation[].value
Gradient compression glove, custom, medium weight, each

# concept[].designation[].value
Gradient  compression glove, custom, heavy weight, each

# concept[].designation[].value
Gradient compression wrap with adjustable straps, below knee, 30-50 mmhg, each

# concept[].designation[].value
Gradient compression wrap with adjustable straps, not otherwise specified

# concept[].designation[].value
Gradient pressure wrap with adjustable straps, above knee, each

# concept[].designation[].value
Gradient pressure wrap with adjustable straps, full leg, each

# concept[].designation[].value
Gradient pressure wrap with adjustable straps, foot, each

# concept[].designation[].value
Gradient pressure wrap with adjustable straps, arm, each

# concept[].designation[].value
Gradient pressure wrap with adjustable straps, bra, each

# concept[].designation[].value
External urinary catheters; disposable, with wicking material, for use with suction pump, per month

# concept[].designation[].value
External urinary catheter; non-disposable, for use with suction pump, per month

# concept[].designation[].value
Accessory for gradient compression garment or wrap with adjustable straps, not-otherwise specified

# concept[].designation[].value
Gradient compression bandaging supply, bandage liner, lower extremity, any size or length, each

# concept[].designation[].value
Gradient compression bandaging supply, bandage liner, upper extremity, any size or length, each

# concept[].designation[].value
Gradient compression bandaging supply, conforming gauze, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandage roll, elastic long stretch, linear yard, any width, each

# concept[].designation[].value
Gradient compression bandage roll, elastic medium stretch, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandage roll, inelastic short stretch, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandaging supply, high density foam sheet, per 250 square centimeters, each

# concept[].designation[].value
Gradient compression bandaging supply, high density foam pad, any size or shape, each

# concept[].designation[].value
Gradient compression bandaging supply, high density foam roll for bandage, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandaging supply, low density channel foam sheet, per 250 square centimeters, each

# concept[].designation[].value
Gradient compression bandaging supply, low density flat foam sheet, per 250 square centimeters, each

# concept[].designation[].value
Gradient compression bandaging supply, padded foam, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandaging supply, padded textile, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandaging supply, tubular protective absorption layer, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandaging supply, tubular protective absorption padded layer, per linear yard, any width, each

# concept[].designation[].value
Gradient compression bandaging supply, not otherwise specified

# concept[].designation[].value
Gradient compression stocking, below knee, 18-30 mmhg, custom, each

# concept[].designation[].value
Canister, disposable, used with suction pump, each

# concept[].designation[].value
Canister, non-disposable, used with suction pump, each

# concept[].designation[].value
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable

# concept[].designation[].value
Small volume nonfiltered pneumatic nebulizer, disposable

# concept[].designation[].value
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable

# concept[].designation[].value
Administration set, with small volume filtered pneumatic nebulizer

# concept[].designation[].value
Large volume nebulizer, disposable, unfilled, used with aerosol compressor

# concept[].designation[].value
Large volume nebulizer, disposable, prefilled, used with aerosol compressor

# concept[].designation[].value
Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer

# concept[].designation[].value
Corrugated tubing, disposable, used with large volume nebulizer, 100 feet

# concept[].designation[].value
Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet

# concept[].designation[].value
Water collection device, used with large volume nebulizer

# concept[].designation[].value
Filter, disposable, used with aerosol compressor or ultrasonic generator

# concept[].designation[].value
Filter, nondisposable, used with aerosol compressor or ultrasonic generator

# concept[].designation[].value
Dome and mouthpiece, used with small volume ultrasonic nebulizer

# concept[].designation[].value
Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen

# concept[].designation[].value
Water, distilled, used with large volume nebulizer, 1000 ml

# concept[].designation[].value
Interface for cough stimulating device, includes all components, replacement only

# concept[].designation[].value
Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter)

# concept[].designation[].value
Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical

# concept[].designation[].value
High frequency chest wall oscillation system vest, replacement for use with patient owned equipment, each

# concept[].designation[].value
High frequency chest wall oscillation system hose, replacement for use with patient owned equipment, each

# concept[].designation[].value
Combination oral/nasal mask, used with continuous positive airway pressure device, each

# concept[].designation[].value
Oral cushion for combination oral/nasal mask, replacement only, each

# concept[].designation[].value
Nasal pillows for combination oral/nasal mask, replacement only, pair

# concept[].designation[].value
Full face mask used with positive airway pressure device, each

# concept[].designation[].value
Face mask interface, replacement for full face mask, each

# concept[].designation[].value
Cushion for use on nasal mask interface, replacement only, each

# concept[].designation[].value
Pillow for use on nasal cannula type interface, replacement only, pair

# concept[].designation[].value
Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap

# concept[].designation[].value
Headgear used with positive airway pressure device

# concept[].designation[].value
Chinstrap used with positive airway pressure device

# concept[].designation[].value
Tubing used with positive airway pressure device

# concept[].designation[].value
Filter, disposable, used with positive airway pressure device

# concept[].designation[].value
Filter, non disposable, used with positive airway pressure device

# concept[].designation[].value
Water seal drainage container and tubing for use with implanted chest tube

# concept[].designation[].value
Vacuum drainage bottle and tubing for use with implanted catheter

# concept[].designation[].value
Oral interface used with positive airway pressure device, each

# concept[].designation[].value
Exhalation port with or without swivel used with accessories for positive airway devices, replacement only

# concept[].designation[].value
Water chamber for humidifier, used with positive airway pressure device, replacement, each

# concept[].designation[].value
Oral interface used with respiratory suction pump, each

# concept[].designation[].value
Vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each

# concept[].designation[].value
Expiratory positive airway pressure intranasal resistance valve

# concept[].designation[].value
Tracheostoma valve, including diaphragm, each

# concept[].designation[].value
Replacement diaphragm/faceplate for tracheostoma valve, each

# concept[].designation[].value
Filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each

# concept[].designation[].value
Filter for use in a tracheostoma heat and moisture exchange system, each

# concept[].designation[].value
Housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each

# concept[].designation[].value
Adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each

# concept[].designation[].value
Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each

# concept[].designation[].value
Housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each

# concept[].designation[].value
Filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each

# concept[].designation[].value
Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each

# concept[].designation[].value
Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each

# concept[].designation[].value
Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and reusable), each

# concept[].designation[].value
Helmet, protective, soft, prefabricated, includes all components and accessories

# concept[].designation[].value
Helmet, protective, hard, prefabricated, includes all components and accessories

# concept[].designation[].value
Helmet, protective, soft, custom fabricated, includes all components and accessories

# concept[].designation[].value
Helmet, protective, hard, custom fabricated, includes all components and accessories

# concept[].designation[].value
Soft interface for helmet, replacement only

# concept[].designation[].value
Single vitamin/mineral/trace element, oral, per dose, not otherwise specified

# concept[].designation[].value
Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified

# concept[].designation[].value
Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml

# concept[].designation[].value
Pediculosis (lice infestation) treatment, topical, for administration by patient/caretaker

# concept[].designation[].value
Programmer for transient, orally ingested capsule

# concept[].designation[].value
Programable, transient, orally ingested capsule, for use with external programmer, per month

# concept[].designation[].value
Wound suction, disposable, includes dressing, all accessories and components, any type, each

# concept[].designation[].value
Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type

# concept[].designation[].value
External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories

# concept[].designation[].value
Home glucose disposable monitor, includes test strips

# concept[].designation[].value
Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply

# concept[].designation[].value
Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system

# concept[].designation[].value
Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system

# concept[].designation[].value
Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified

# concept[].designation[].value
Alert or alarm device, not otherwise classified

# concept[].designation[].value
Reaching/grabbing device, any type, any length, each

# concept[].designation[].value
Foot pressure off loading/supportive device, any type, each

# concept[].designation[].value
Hygienic item or device, disposable or non-disposable, any type, each

# concept[].designation[].value
Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment

# concept[].designation[].value
Prescription digital visual therapy, software-only, fda cleared, per course of treatment

# concept[].designation[].value
Fertility cycle (contraception & conception) tracking software application, fda cleared, per month, includes accessories (e.g., thermometer)

# concept[].designation[].value
Technetium tc-99m sestamibi, diagnostic, per study dose

# concept[].designation[].value
Technetium tc-99m teboroxime, diagnostic, per study dose

# concept[].designation[].value
Technetium tc-99m tetrofosmin, diagnostic, per study dose

# concept[].designation[].value
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries

# concept[].designation[].value
Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries

# concept[].designation[].value
Thallium tl-201 thallous chloride, diagnostic, per millicurie

# concept[].designation[].value
Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible

# concept[].designation[].value
Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries

# concept[].designation[].value
Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie

# concept[].designation[].value
Iodine i-123 sodium iodide, diagnostic, per millicurie

# concept[].designation[].value
Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries

# concept[].designation[].value
Technetium tc-99m pertechnetate, diagnostic, per millicurie

# concept[].designation[].value
Lutetium lu 177, dotatate, therapeutic, 1 millicurie

# concept[].designation[].value
Choline c-11, diagnostic, per study dose up to 20 millicuries

# concept[].designation[].value
Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries

# concept[].designation[].value
Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie

# concept[].designation[].value
Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries

# concept[].designation[].value
Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries

# concept[].designation[].value
Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries

# concept[].designation[].value
Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries

# concept[].designation[].value
Iodine i-125, sodium iodide solution, therapeutic, per millicurie

# concept[].designation[].value
Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie

# concept[].designation[].value
Iodine i-131 sodium iodide solution, diagnostic, per millicurie

# concept[].designation[].value
Iodine i-131 sodium iodide solution, therapeutic, per millicurie

# concept[].designation[].value
Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)

# concept[].designation[].value
Iodine i-125 serum albumin, diagnostic, per 5 microcuries

# concept[].designation[].value
Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries

# concept[].designation[].value
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries

# concept[].designation[].value
Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries

# concept[].designation[].value
Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries

# concept[].designation[].value
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries

# concept[].designation[].value
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries

# concept[].designation[].value
Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries

# concept[].designation[].value
Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries

# concept[].designation[].value
Iodine i-131 tositumomab, diagnostic, per study dose

# concept[].designation[].value
Iodine i-131 tositumomab, therapeutic, per treatment dose

# concept[].designation[].value
Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie

# concept[].designation[].value
Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie

# concept[].designation[].value
Indium in-111 pentetate, diagnostic, per 0.5 millicurie

# concept[].designation[].value
Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie

# concept[].designation[].value
Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries

# concept[].designation[].value
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

# concept[].designation[].value
Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries

# concept[].designation[].value
Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries

# concept[].designation[].value
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries

# concept[].designation[].value
Gallium ga-67 citrate, diagnostic, per millicurie

# concept[].designation[].value
Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries

# concept[].designation[].value
Xenon xe-133 gas, diagnostic, per 10 millicuries

# concept[].designation[].value
Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie

# concept[].designation[].value
Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries

# concept[].designation[].value
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries

# concept[].designation[].value
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries

# concept[].designation[].value
Sodium phosphate p-32, therapeutic, per millicurie

# concept[].designation[].value
Chromic phosphate p-32 suspension, therapeutic, per millicurie

# concept[].designation[].value
Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries

# concept[].designation[].value
Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries

# concept[].designation[].value
Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries

# concept[].designation[].value
Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose

# concept[].designation[].value
Indium in-111 labeled autologous white blood cells, diagnostic, per study dose

# concept[].designation[].value
Indium in-111 labeled autologous platelets, diagnostic, per study dose

# concept[].designation[].value
Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries

# concept[].designation[].value
Injection, gadoteridol, (prohance multipack), per ml

# concept[].designation[].value
Injection, gadobenate dimeglumine (multihance), per ml

# concept[].designation[].value
Injection, gadobenate dimeglumine (multihance multipack), per ml

# concept[].designation[].value
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml

# concept[].designation[].value
Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries

# concept[].designation[].value
Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries

# concept[].designation[].value
Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries

# concept[].designation[].value
Florbetapir f18, diagnostic, per study dose, up to 10 millicuries

# concept[].designation[].value
Gallium ga-68, dotatate, diagnostic, 0.1 millicurie

# concept[].designation[].value
Fluciclovine f-18, diagnostic, 1 millicurie

# concept[].designation[].value
Fluoroestradiol f 18, diagnostic, 1 millicurie

# concept[].designation[].value
Copper cu-64, dotatate, diagnostic, 1 millicurie

# concept[].designation[].value
Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie

# concept[].designation[].value
Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie

# concept[].designation[].value
Piflufolastat f-18, diagnostic, 1 millicurie

# concept[].designation[].value
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie

# concept[].designation[].value
Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified

# concept[].designation[].value
Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified

# concept[].designation[].value
Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified

# concept[].designation[].value
Strontium sr-89 chloride, therapeutic, per millicurie

# concept[].designation[].value
Flortaucipir f 18 injection, diagnostic, 1 millicurie

# concept[].designation[].value
Fluorodopa f-18, diagnostic, per millicurie

# concept[].designation[].value
Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries

# concept[].designation[].value
Radium ra-223 dichloride, therapeutic, per microcurie

# concept[].designation[].value
Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie

# concept[].designation[].value
Flotufolastat f 18, diagnostic, 1 millicurie

# concept[].designation[].value
Fludeoxyglucose f18 up to 15 millicuries

# concept[].designation[].value
Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

# concept[].designation[].value
Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose

# concept[].designation[].value
Non-radioactive contrast imaging material, not otherwise classified, per study

# concept[].designation[].value
Supply of injectable contrast material for use in echocardiography, per study

# concept[].designation[].value
Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie

# concept[].designation[].value
Miscellaneous dme supply, accessory, and/or service component of another hcpcs code

# concept[].designation[].value
Dme delivery, set up, and/or dispensing service component of another hcpcs code

# concept[].designation[].value
Miscellaneous dme supply or accessory, not otherwise specified

# concept[].designation[].value
Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape

# concept[].designation[].value
Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape

# concept[].designation[].value
Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape

# concept[].designation[].value
Gastrostomy/jejunostomy tube, standard, any material, any type, each

# concept[].designation[].value
Gastrostomy/jejunostomy tube, low-profile, any material, any type, each

# concept[].designation[].value
Food thickener, administered orally, per ounce

# concept[].designation[].value
Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit

# concept[].designation[].value
Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit

# concept[].designation[].value
Additive for enteral formula (e.g., fiber)

# concept[].designation[].value
In-line cartridge containing digestive enzyme(s) for enteral feeding, each

# concept[].designation[].value
Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape

# concept[].designation[].value
Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, nutritionally complete, for special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, for pediatrics, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, for pediatrics, nutritionally complete soy based with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Enteral formula, for pediatrics, special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit

# concept[].designation[].value
Parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml = 1 unit) - home mix

# concept[].designation[].value
Parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix

# concept[].designation[].value
Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) - home mix

# concept[].designation[].value
Parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) - home mix

# concept[].designation[].value
Parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit) - home mix

# concept[].designation[].value
Parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500 ml = 1 unit) - home mix

# concept[].designation[].value
Parenteral nutrition solution, not otherwise specified, 10 grams lipids

# concept[].designation[].value
Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix

# concept[].designation[].value
Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix

# concept[].designation[].value
Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix

# concept[].designation[].value
Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix

# concept[].designation[].value
Parenteral nutrition; additives (vitamins, trace elements, heparin, electrolytes), home mix, per day

# concept[].designation[].value
Parenteral nutrition supply kit; premix, per day

# concept[].designation[].value
Parenteral nutrition supply kit; home mix, per day

# concept[].designation[].value
Parenteral nutrition administration kit, per day

# concept[].designation[].value
Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, renal-aminosyn-rf, nephramine, renamine-premix

# concept[].designation[].value
Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, hepatic, hepatamine-premix

# concept[].designation[].value
Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, stress-branch chain amino acids-freamine-hbc-premix

# concept[].designation[].value
Enteral nutrition infusion pump - without alarm

# concept[].designation[].value
Enteral nutrition infusion pump, any type

# concept[].designation[].value
Parenteral nutrition infusion pump, portable

# concept[].designation[].value
Parenteral nutrition infusion pump, stationary

# concept[].designation[].value
Intravertebral body fracture augmentation with implant (e.g., metal, polymer)

# concept[].designation[].value
Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval

# concept[].designation[].value
Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable)

# concept[].designation[].value
Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter)

# concept[].designation[].value
Graft, transmural transvenous arterial bypass (implantable), with all delivery system components

# concept[].designation[].value
Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation

# concept[].designation[].value
Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper gastrointestinal endoscope

# concept[].designation[].value
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)

# concept[].designation[].value
Brachytherapy source, non-stranded, gold-198, per source

# concept[].designation[].value
Brachytherapy source, non-stranded, high dose rate iridium-192, per source

# concept[].designation[].value
Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source

# concept[].designation[].value
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)

# concept[].designation[].value
Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)

# concept[].designation[].value
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping

# concept[].designation[].value
Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip

# concept[].designation[].value
Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)

# concept[].designation[].value
Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system components

# concept[].designation[].value
Catheter(s), intravascular for renal denervation, ultrasound, including all single use system components

# concept[].designation[].value
Joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable)

# concept[].designation[].value
Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy device

# concept[].designation[].value
Tissue marker, imaging and non-imaging device (implantable)

# concept[].designation[].value
Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)

# concept[].designation[].value
Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)

# concept[].designation[].value
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)

# concept[].designation[].value
Connective tissue, human (includes fascia lata)

# concept[].designation[].value
Imaging coil, magnetic resonance (insertable)

# concept[].designation[].value
Repair device, urinary, incontinence, with sling graft

# concept[].designation[].value
Retrieval device, insertable (used to retrieve fractured medical devices)

# concept[].designation[].value
Lead, pacemaker, transvenous vdd single pass

# concept[].designation[].value
Ocular implant, aqueous drainage assist device

# concept[].designation[].value
Ocular device, intraoperative, detached retina

# concept[].designation[].value
Septal defect implant system, intracardiac

# concept[].designation[].value
Surgical tissue localization and excision device (implantable)

# concept[].designation[].value
Generator, neurostimulator (implantable), with rechargeable battery and charging system

# concept[].designation[].value
Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system

# concept[].designation[].value
Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads

# concept[].designation[].value
Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system

# concept[].designation[].value
Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller

# concept[].designation[].value
Interbody cage, anterior, lateral or posterior, personalized (implantable)

# concept[].designation[].value
Autograft suspension, including cell processing and application, and all system components

# concept[].designation[].value
Monitor, cardiac, including intracardiac lead and all system components (implantable)

# concept[].designation[].value
Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application

# concept[].designation[].value
Retinal prosthesis, includes all internal and external components

# concept[].designation[].value
Retinal prosthesis, includes all internal and external components; add-on to c1841

# concept[].designation[].value
Skin substitute, synthetic, resorbable, per square centimeter

# concept[].designation[].value
Stent, coated/covered, with delivery system

# concept[].designation[].value
Stent, coated/covered, without delivery system

# concept[].designation[].value
Material for vocal cord medialization, synthetic (implantable)

# concept[].designation[].value
Cardioverter-defibrillator, other than single or dual chamber (implantable)

# concept[].designation[].value
Adapter/extension, pacing lead or neurostimulator lead (implantable)

# concept[].designation[].value
Catheter, extravascular tissue ablation, any modality (insertable)

# concept[].designation[].value
No implantable/insertable device used with device-intensive procedures

# concept[].designation[].value
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser

# concept[].designation[].value
Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)

# concept[].designation[].value
Lead, neurostimulator test kit (implantable)

# concept[].designation[].value
Lead, pacemaker, other than transvenous vdd single pass

# concept[].designation[].value
Lead, left ventricular coronary venous system

# concept[].designation[].value
Probe, image-guided, robotic, waterjet ablation

# concept[].designation[].value
Brachytherapy source, non-stranded, yttrium-90, per source

# concept[].designation[].value
Stent, non-coronary, temporary, without delivery system

# concept[].designation[].value
Pacemaker, dual chamber, non rate-responsive (implantable)

# concept[].designation[].value
Pacemaker, single chamber, non rate-responsive (implantable)

# concept[].designation[].value
Pacemaker, other than single or dual chamber (implantable)

# concept[].designation[].value
Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components

# concept[].designation[].value
Stent, non-coronary, temporary, with delivery system

# concept[].designation[].value
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser

# concept[].designation[].value
Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip

# concept[].designation[].value
Repair device, urinary, incontinence, without sling graft

# concept[].designation[].value
Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source

# concept[].designation[].value
Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source

# concept[].designation[].value
Brachytherapy linear source, non-stranded, palladium-103, per 1 mm

# concept[].designation[].value
Brachytherapy source, stranded, iodine-125, per source

# concept[].designation[].value
Brachytherapy source, non-stranded, iodine-125, per source

# concept[].designation[].value
Brachytherapy source, stranded, palladium-103, per source

# concept[].designation[].value
Brachytherapy source, stranded, cesium-131, per source

# concept[].designation[].value
Brachytherapy source, non-stranded, cesium-131, per source

# concept[].designation[].value
Brachytherapy source, cesium-131 chloride solution, per millicurie

# concept[].designation[].value
Brachytherapy planar source, palladium-103, per square millimeter

# concept[].designation[].value
Brachytherapy source, stranded, not otherwise specified, per source

# concept[].designation[].value
Brachytherapy source, non-stranded, not otherwise specified, per source

# concept[].designation[].value
Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area

# concept[].designation[].value
Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)

# concept[].designation[].value
Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children

# concept[].designation[].value
Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

# concept[].designation[].value
Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area

# concept[].designation[].value
Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)

# concept[].designation[].value
Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children

# concept[].designation[].value
Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

# concept[].designation[].value
Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (e.g., subfacial) drug-delivery device(s)

# concept[].designation[].value
Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)

# concept[].designation[].value
Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)

# concept[].designation[].value
Open biopsy or excision of deep cervical node(s) with intraoperative identification (e.g., mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed

# concept[].designation[].value
Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance

# concept[].designation[].value
Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance

# concept[].designation[].value
Arthrodesis, interphalangeal joints, with or without internal fixation

# concept[].designation[].value
Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance

# concept[].designation[].value
Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance

# concept[].designation[].value
Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed

# concept[].designation[].value
Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed

# concept[].designation[].value
Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed

# concept[].designation[].value
Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed

# concept[].designation[].value
Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report

# concept[].designation[].value
Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report

# concept[].designation[].value
Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

# concept[].designation[].value
Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

# concept[].designation[].value
Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

# concept[].designation[].value
Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

# concept[].designation[].value
Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

# concept[].designation[].value
Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)

# concept[].designation[].value
Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)

# concept[].designation[].value
Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)

# concept[].designation[].value
Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)

# concept[].designation[].value
Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

# concept[].designation[].value
Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

# concept[].designation[].value
Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

# concept[].designation[].value
Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

# concept[].designation[].value
Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation

# concept[].designation[].value
Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation

# concept[].designation[].value
Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

# concept[].designation[].value
Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

# concept[].designation[].value
Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

# concept[].designation[].value
Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with fluorescent imaging agent

# concept[].designation[].value
Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed

# concept[].designation[].value
Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent

# concept[].designation[].value
Thyroidectomy, total or complete with parathyroid autotransplantation

# concept[].designation[].value
Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed

# concept[].designation[].value
Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s)

# concept[].designation[].value
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention

# concept[].designation[].value
Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the  angioplasty within the same artery, initial artery and all additional arteries

# concept[].designation[].value
Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance with intravascular ultrasound (noncoronary vessel(s)) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

# concept[].designation[].value
Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (i.e., open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s) less than 3 cm, reducible with removal of total or near total non-infected mesh or other prosthesis at the time of initial or recurrent anterior abdominal hernia repair or parastomal hernia repair

# concept[].designation[].value
Service for diagnosis, evaluation, or treatment of a mental health  or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

# concept[].designation[].value
Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

# concept[].designation[].value
Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)

# concept[].designation[].value
Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

# concept[].designation[].value
Support device, extravascular, for arteriovenous fistula (implantable)

# concept[].designation[].value
3d anatomical segmentation imaging for preoperative planning, data preparation and transmission, obtained from previous diagnostic computed tomographic or magnetic resonance examination of the same anatomy

# concept[].designation[].value
Preparation of skin cell suspension autograft, automated, including all enzymatic processing and device components (do not report with manual suspension preparation)

# concept[].designation[].value
Implantation of medial knee extraarticular implantable shock absorber spanning the knee joint from distal femur to proximal tibia, open, includes measurements, positioning and adjustments, with imaging guidance (e.g., fluoroscopy)

# concept[].designation[].value
Magnetic resonance angiography with contrast, abdomen

# concept[].designation[].value
Magnetic resonance angiography without contrast, abdomen

# concept[].designation[].value
Magnetic resonance angiography without contrast followed by with contrast, abdomen

# concept[].designation[].value
Magnetic resonance imaging with contrast, breast; unilateral

# concept[].designation[].value
Magnetic resonance imaging without contrast, breast; unilateral

# concept[].designation[].value
Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral

# concept[].designation[].value
Magnetic resonance imaging with contrast, breast; bilateral

# concept[].designation[].value
Magnetic resonance imaging without contrast, breast; bilateral

# concept[].designation[].value
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral

# concept[].designation[].value
Magnetic resonance angiography with contrast, chest (excluding myocardium)

# concept[].designation[].value
Magnetic resonance angiography without contrast, chest (excluding myocardium)

# concept[].designation[].value
Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)

# concept[].designation[].value
Magnetic resonance angiography with contrast, lower extremity

# concept[].designation[].value
Magnetic resonance angiography without contrast, lower extremity

# concept[].designation[].value
Magnetic resonance angiography without contrast followed by with contrast, lower extremity

# concept[].designation[].value
Magnetic resonance angiography with contrast, pelvis

# concept[].designation[].value
Magnetic resonance angiography without contrast, pelvis

# concept[].designation[].value
Magnetic resonance angiography without contrast followed by with contrast, pelvis

# concept[].designation[].value
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete

# concept[].designation[].value
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study

# concept[].designation[].value
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography

# concept[].designation[].value
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study

# concept[].designation[].value
Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report

# concept[].designation[].value
Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report

# concept[].designation[].value
Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis

# concept[].designation[].value
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report

# concept[].designation[].value
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography

# concept[].designation[].value
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision

# concept[].designation[].value
Magnetic resonance angiography with contrast, spinal canal and contents

# concept[].designation[].value
Magnetic resonance angiography without contrast, spinal canal and contents

# concept[].designation[].value
Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents

# concept[].designation[].value
Magnetic resonance angiography with contrast, upper extremity

# concept[].designation[].value
Magnetic resonance angiography without contrast, upper extremity

# concept[].designation[].value
Magnetic resonance angiography without contrast followed by with contrast, upper extremity

# concept[].designation[].value
Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)

# concept[].designation[].value
Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump

# concept[].designation[].value
Injection, c-1 esterase inhibitor (human), haegarda, 10 units

# concept[].designation[].value
Injection, triptorelin extended release, 3.75 mg

# concept[].designation[].value
Injection, testosterone undecanoate, 1 mg

# concept[].designation[].value
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

# concept[].designation[].value
Injection, inotuzumab ozogamicin, 0.1 mg

# concept[].designation[].value
Lutetium lu 177, dotatate, therapeutic, 1 mci

# concept[].designation[].value
Injection, voretigene neparvovec-rzyl, 1 billion vector genome

# concept[].designation[].value
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

# concept[].designation[].value
Injection, dexamethasone 9%, intraocular, 1 mcg

# concept[].designation[].value
Injection, aripiprazole lauroxil (aristada initio), 1 mg

# concept[].designation[].value
Injection, risperidone (perseris), 0.5 mg

# concept[].designation[].value
Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg

# concept[].designation[].value
Injection, bendamustine hcl (belrapzo), 1 mg

# concept[].designation[].value
Injection, moxetumomab pasudotox-tdfk, 0.01 mg

# concept[].designation[].value
Cocaine hydrochloride nasal solution (goprelto), 1 mg

# concept[].designation[].value
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg

# concept[].designation[].value
Injection, cetirizine hydrochloride, 1 mg

# concept[].designation[].value
Injection, daratumumab 10 mg and hyaluronidase-fihj

# concept[].designation[].value
Mitomycin pyelocalyceal instillation, 1 mg

# concept[].designation[].value
Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg

# concept[].designation[].value
Injection, sacituzumab govitecan-hziy, 2.5 mg

# concept[].designation[].value
Gallium ga-68, dotatoc, diagnostic, 0.01 mci

# concept[].designation[].value
Copper cu-64, dotatate, diagnostic, 1 millicurie

# concept[].designation[].value
Injection, belantamab mafodontin-blmf, 0.5 mg

# concept[].designation[].value
Injection, immune globulin (asceniv), 500 mg

# concept[].designation[].value
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Injection, cabotegravir and rilpivirine, 2mg/3mg

# concept[].designation[].value
Injection, melphalan flufenamide hydrochloride, 1 mg

# concept[].designation[].value
Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Injection, loncastuximab tesirine-lpyl, 0.1 mg

# concept[].designation[].value
Injection, avalglucosidase alfa-ngpt, 4 mg

# concept[].designation[].value
Injection, cyclophosphamide, (auromedics), 10 mg

# concept[].designation[].value
Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg

# concept[].designation[].value
Bupivacaine, collagen-matrix implant, 1 mg

# concept[].designation[].value
Injection, plasminogen, human-tvmh, 1 mg

# concept[].designation[].value
Injection, sirolimus protein-bound particles, 1 mg

# concept[].designation[].value
Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg

# concept[].designation[].value
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

# concept[].designation[].value
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Injection, pantoprazole sodium, per vial

# concept[].designation[].value
Mometasone furoate sinus implant, 10 micrograms (sinuva)

# concept[].designation[].value
Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

# concept[].designation[].value
Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.

# concept[].designation[].value
Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.

# concept[].designation[].value
Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.

# concept[].designation[].value
Injection, factor viii, fc fusion protein, (recombinant), per i.u.

# concept[].designation[].value
Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.

# concept[].designation[].value
Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.

# concept[].designation[].value
Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.

# concept[].designation[].value
Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

# concept[].designation[].value
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

# concept[].designation[].value
Cocaine hydrochloride nasal solution (numbrino), 1 mg

# concept[].designation[].value
Injection, mirvetuximab soravtansine-gynx, 1 mg

# concept[].designation[].value
Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

# concept[].designation[].value
Injection, aripiprazole, (abilify asimtufii), 1 mg

# concept[].designation[].value
Injection, buprenorphine extended-release (brixadi), 1 mg

# concept[].designation[].value
Flotufolastat f 18, diagnostic, 1 millicurie

# concept[].designation[].value
Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity

# concept[].designation[].value
Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)

# concept[].designation[].value
Injection, secukinumab, intravenous, 1 mg

# concept[].designation[].value
Injection, adamts13, recombinant-krhn, 10 iu

# concept[].designation[].value
Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram

# concept[].designation[].value
Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram

# concept[].designation[].value
Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml

# concept[].designation[].value
Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose

# concept[].designation[].value
Lidocaine 70 mg/tetracaine 70 mg, per patch

# concept[].designation[].value
Puraply, and puraply antimicrobial, any type, per square centimeter

# concept[].designation[].value
Microporous collagen implantable tube (neuragen nerve guide), per centimeter length

# concept[].designation[].value
Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length

# concept[].designation[].value
Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter

# concept[].designation[].value
Collagen nerve cuff (neuromatrix), per 0.5 centimeter length

# concept[].designation[].value
Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter

# concept[].designation[].value
Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters

# concept[].designation[].value
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc

# concept[].designation[].value
Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters

# concept[].designation[].value
Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length

# concept[].designation[].value
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc

# concept[].designation[].value
Skin substitute, integra meshed bilayer wound matrix, per square centimeter

# concept[].designation[].value
Porcine implant, permacol, per square centimeter

# concept[].designation[].value
Iodine i-131 iobenguane, diagnostic, 1 millicurie

# concept[].designation[].value
Iodine i-131 iobenguane, therapeutic, 1 millicurie

# concept[].designation[].value
Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units

# concept[].designation[].value
Injection, phenylephrine and ketorolac, 4 ml vial

# concept[].designation[].value
Netupitant 300 mg and palonosetron 0.5 mg, oral

# concept[].designation[].value
Injection, fluocinolone acetonide intravitreal implant, 0.01 mg

# concept[].designation[].value
Injection, ceftolozane 50 mg and tazobactam 25 mg

# concept[].designation[].value
Injection, pasireotide long acting, 1 mg

# concept[].designation[].value
Injection, isavuconazonium sulfate, 1 mg

# concept[].designation[].value
Injection, sulfur hexafluoride lipid microsphere, per ml

# concept[].designation[].value
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

# concept[].designation[].value
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries

# concept[].designation[].value
Choline c 11, diagnostic, per study dose

# concept[].designation[].value
Hyaluronan or derivative, durolane, for intra-articular injection, per dose

# concept[].designation[].value
Injection, rituximab and hyaluronidase, 10 mg

# concept[].designation[].value
Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.

# concept[].designation[].value
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg

# concept[].designation[].value
Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)

# concept[].designation[].value
Instillation, ciprofloxacin otic suspension, 6 mg

# concept[].designation[].value
Injection, granisetron extended release, 0.1 mg

# concept[].designation[].value
Ustekinumab, for intravenous injection, 1 mg

# concept[].designation[].value
Injection, conivaptan hydrochloride, 1 mg

# concept[].designation[].value
Plasma, high titer covid-19 convalescent, each unit

# concept[].designation[].value
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch

# concept[].designation[].value
Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

# concept[].designation[].value
Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch

# concept[].designation[].value
Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

# concept[].designation[].value
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel

# concept[].designation[].value
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)

# concept[].designation[].value
Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel

# concept[].designation[].value
Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel

# concept[].designation[].value
Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)

# concept[].designation[].value
Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable)

# concept[].designation[].value
Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy

# concept[].designation[].value
Placement of endorectal intracavitary applicator for high intensity brachytherapy

# concept[].designation[].value
Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure

# concept[].designation[].value
Insertion of implants into the soft palate; minimum of three implants

# concept[].designation[].value
Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple

# concept[].designation[].value
Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance

# concept[].designation[].value
Anoscopy; with directed submucosal injection(s), any substance

# concept[].designation[].value
Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)

# concept[].designation[].value
Adjunctive blue light cystoscopy with fluorescent imaging agent  (list separately in addition to code for primary procedure)

# concept[].designation[].value
Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants

# concept[].designation[].value
Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants

# concept[].designation[].value
Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report

# concept[].designation[].value
Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed

# concept[].designation[].value
Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)

# concept[].designation[].value
Nasal endoscopy, surgical; balloon dilation of eustachian tube

# concept[].designation[].value
Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed

# concept[].designation[].value
Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance

# concept[].designation[].value
Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy

# concept[].designation[].value
Repair of nasal vestibular lateral wall stenosis with implant(s)

# concept[].designation[].value
Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)

# concept[].designation[].value
Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including  fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)

# concept[].designation[].value
Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum

# concept[].designation[].value
Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)

# concept[].designation[].value
Creation of arteriovenous fistula,  percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)

# concept[].designation[].value
Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed

# concept[].designation[].value
Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)

# concept[].designation[].value
Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect  measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar

# concept[].designation[].value
Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study

# concept[].designation[].value
Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed

# concept[].designation[].value
Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study

# concept[].designation[].value
Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter)

# concept[].designation[].value
Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging

# concept[].designation[].value
Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed

# concept[].designation[].value
Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure)

# concept[].designation[].value
Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts

# concept[].designation[].value
Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent

# concept[].designation[].value
Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous,  tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty  within the same vessel(s), when performed

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed

# concept[].designation[].value
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed

# concept[].designation[].value
Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)

# concept[].designation[].value
Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy

# concept[].designation[].value
Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed

# concept[].designation[].value
Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance

# concept[].designation[].value
Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed

# concept[].designation[].value
Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study

# concept[].designation[].value
Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study

# concept[].designation[].value
Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components

# concept[].designation[].value
Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components

# concept[].designation[].value
Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report

# concept[].designation[].value
Gastric electrophysiology mapping with simultaneous patient symptom profiling

# concept[].designation[].value
Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination

# concept[].designation[].value
Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed

# concept[].designation[].value
Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance

# concept[].designation[].value
Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent

# concept[].designation[].value
Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)

# concept[].designation[].value
3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography with report

# concept[].designation[].value
Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)

# concept[].designation[].value
Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions

# concept[].designation[].value
Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis])

# concept[].designation[].value
Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction

# concept[].designation[].value
Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies

# concept[].designation[].value
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

# concept[].designation[].value
Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)

# concept[].designation[].value
Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)

# concept[].designation[].value
Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve stimulation system), including electrode and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)

# concept[].designation[].value
Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice cryosphere, cryoice cryo2), including probe and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)

# concept[].designation[].value
Cryoablation needle (e.g., iovera system), including needle/tip and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)

# concept[].designation[].value
Radiolabeled product provided during a hospital inpatient stay

# concept[].designation[].value
Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage

# concept[].designation[].value
Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components

# concept[].designation[].value
Cane, includes canes of all materials, adjustable or fixed, with tip

# concept[].designation[].value
Cane, quad or three prong, includes canes of all materials, adjustable or fixed, with tips

# concept[].designation[].value
Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips

# concept[].designation[].value
Crutch forearm, includes crutches of various materials, adjustable or fixed, each, with tip and handgrips

# concept[].designation[].value
Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips

# concept[].designation[].value
Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip

# concept[].designation[].value
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips

# concept[].designation[].value
Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each

# concept[].designation[].value
Crutch, underarm, articulating, spring assisted, each

# concept[].designation[].value
Crutch substitute, lower leg platform, with or without wheels, each

# concept[].designation[].value
Walker, rigid (pickup), adjustable or fixed height

# concept[].designation[].value
Walker, folding (pickup), adjustable or fixed height

# concept[].designation[].value
Walker, with trunk support, adjustable or fixed height, any type

# concept[].designation[].value
Walker, rigid, wheeled, adjustable or fixed height

# concept[].designation[].value
Walker, folding, wheeled, adjustable or fixed height

# concept[].designation[].value
Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat

# concept[].designation[].value
Walker, heavy duty, multiple braking system, variable wheel resistance

# concept[].designation[].value
Walker, heavy duty, without wheels, rigid or folding, any type, each

# concept[].designation[].value
Walker, heavy duty, wheeled, rigid or folding, any type

# concept[].designation[].value
Walker, battery powered, wheeled, folding, adjustable or fixed height

# concept[].designation[].value
Platform attachment, forearm crutch, each

# concept[].designation[].value
Wheel attachment, rigid pick-up walker, per pair

# concept[].designation[].value
Leg extensions for walker, per set of four (4)

# concept[].designation[].value
Brake attachment for wheeled walker, replacement, each

# concept[].designation[].value
Sitz type bath or equipment, portable, used with or without commode

# concept[].designation[].value
Sitz type bath or equipment, portable, used with or without commode, with faucet attachment/s

# concept[].designation[].value
Commode chair, mobile or stationary, with fixed arms

# concept[].designation[].value
Commode chair, mobile or stationary, with detachable arms

# concept[].designation[].value
Pail or pan for use with commode chair, replacement only

# concept[].designation[].value
Commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each

# concept[].designation[].value
Commode chair with integrated seat lift mechanism, electric, any type

# concept[].designation[].value
Commode chair with integrated seat lift mechanism, non-electric, any type

# concept[].designation[].value
Seat lift mechanism placed over or on top of toilet, any type

# concept[].designation[].value
Foot rest, for use with commode chair, each

# concept[].designation[].value
Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty

# concept[].designation[].value
Pump for alternating pressure pad, for replacement only

# concept[].designation[].value
Powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty

# concept[].designation[].value
Gel or gel-like pressure pad for mattress, standard mattress length and width

# concept[].designation[].value
Positioning cushion/pillow/wedge, any shape or size, includes all components and accessories

# concept[].designation[].value
Powered air flotation bed (low air loss therapy)

# concept[].designation[].value
Air pressure pad for mattress, standard mattress length and width

# concept[].designation[].value
Water pressure pad for mattress, standard mattress length and width

# concept[].designation[].value
Dry pressure pad for mattress, standard mattress length and width

# concept[].designation[].value
Heat lamp, without stand (table model), includes bulb, or infrared element

# concept[].designation[].value
Phototherapy (bilirubin) light with photometer

# concept[].designation[].value
Therapeutic lightbox, minimum 10,000 lux, table top model

# concept[].designation[].value
Heat lamp, with stand, includes bulb, or infrared element

# concept[].designation[].value
Fluid circulating cold pad with pump, any type

# concept[].designation[].value
Non-contact wound warming device (temperature control unit, ac adapter and power cord) for use with warming card and wound cover

# concept[].designation[].value
Warming card for use with the non contact wound warming device and non contact wound warming wound cover

# concept[].designation[].value
Paraffin bath unit, portable (see medical supply code a4265 for paraffin)

# concept[].designation[].value
Bath/shower chair, with or without wheels, any size

# concept[].designation[].value
Transfer bench for tub or toilet with or without commode opening

# concept[].designation[].value
Transfer bench, heavy duty, for tub or toilet with or without commode opening

# concept[].designation[].value
Pad for water circulating heat unit, for replacement only

# concept[].designation[].value
Hospital bed, fixed height, with any type side rails, with mattress

# concept[].designation[].value
Hospital bed, fixed height, with any type side rails, without mattress

# concept[].designation[].value
Hospital bed, variable height, hi-lo, with any type side rails, with mattress

# concept[].designation[].value
Hospital bed, variable height, hi-lo, with any type side rails, without mattress

# concept[].designation[].value
Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress

# concept[].designation[].value
Hospital bed, semi-electric (head and foot adjustment), with any type side rails, without mattress

# concept[].designation[].value
Hospital bed, total electric (head, foot and height adjustments), with any type side rails, with mattress

# concept[].designation[].value
Hospital bed, total electric (head, foot and height adjustments), with any type side rails, without mattress

# concept[].designation[].value
Hospital bed, institutional type includes: oscillating, circulating and stryker frame, with mattress

# concept[].designation[].value
Hospital bed, fixed height, without side rails, with mattress

# concept[].designation[].value
Hospital bed, fixed height, without side rails, without mattress

# concept[].designation[].value
Hospital bed, variable height, hi-lo, without side rails, with mattress

# concept[].designation[].value
Hospital bed, variable height, hi-lo, without side rails, without mattress

# concept[].designation[].value
Hospital bed, semi-electric (head and foot adjustment), without side rails, with mattress

# concept[].designation[].value
Hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress

# concept[].designation[].value
Hospital bed, total electric (head, foot and height adjustments), without side rails, with mattress

# concept[].designation[].value
Hospital bed, total electric (head, foot and height adjustments), without side rails, without mattress

# concept[].designation[].value
Pediatric crib, hospital grade, fully enclosed, with or without top enclosure

# concept[].designation[].value
Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, without mattress

# concept[].designation[].value
Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, without mattress

# concept[].designation[].value
Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress

# concept[].designation[].value
Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, with mattress

# concept[].designation[].value
Bed accessory: board, table, or support device, any type

# concept[].designation[].value
Safety enclosure frame/canopy for use with hospital bed, any type

# concept[].designation[].value
Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress

# concept[].designation[].value
Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress

# concept[].designation[].value
Control unit for electronic bowel irrigation/evacuation system

# concept[].designation[].value
Disposable pack (water reservoir bag, speculum, valving mechanism and collection bag/box) for use with the electronic bowel irrigation/evacuation system

# concept[].designation[].value
Nonpowered advanced pressure reducing overlay for mattress, standard mattress length and width

# concept[].designation[].value
Powered air overlay for mattress, standard mattress length and width

# concept[].designation[].value
Nonpowered advanced pressure reducing mattress

# concept[].designation[].value
Stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing

# concept[].designation[].value
Stationary compressed gas system, purchase; includes regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing

# concept[].designation[].value
Portable gaseous oxygen system, purchase; includes regulator, flowmeter, humidifier, cannula or mask, and tubing

# concept[].designation[].value
Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing

# concept[].designation[].value
Portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge

# concept[].designation[].value
Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing

# concept[].designation[].value
Portable liquid oxygen system, purchase; includes portable container, supply reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and refill adaptor

# concept[].designation[].value
Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing

# concept[].designation[].value
Stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing

# concept[].designation[].value
Stationary oxygen contents, gaseous, 1 month's supply = 1 unit

# concept[].designation[].value
Stationary oxygen contents, liquid, 1 month's supply = 1 unit

# concept[].designation[].value
Portable oxygen contents, gaseous, 1 month's supply = 1 unit

# concept[].designation[].value
Portable oxygen contents, liquid, 1 month's supply = 1 unit

# concept[].designation[].value
Oximeter device for measuring blood oxygen levels non-invasively

# concept[].designation[].value
Topical oxygen delivery system, not otherwise specified, includes all supplies and accessories

# concept[].designation[].value
Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)

# concept[].designation[].value
Volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)

# concept[].designation[].value
Oxygen tent, excluding croup or pediatric tents

# concept[].designation[].value
Negative pressure ventilator; portable or stationary

# concept[].designation[].value
Volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)

# concept[].designation[].value
Pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)

# concept[].designation[].value
Pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask)

# concept[].designation[].value
Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)

# concept[].designation[].value
Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)

# concept[].designation[].value
Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions

# concept[].designation[].value
Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions

# concept[].designation[].value
Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device

# concept[].designation[].value
Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)

# concept[].designation[].value
Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)

# concept[].designation[].value
Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)

# concept[].designation[].value
Percussor, electric or pneumatic, home model

# concept[].designation[].value
Intrapulmonary percussive ventilation system and related accessories

# concept[].designation[].value
Cough stimulating device, alternating positive and negative airway pressure

# concept[].designation[].value
High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each

# concept[].designation[].value
Oscillatory positive expiratory pressure device, non-electric, any type, each

# concept[].designation[].value
Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Spirometer, electronic, includes all accessories

# concept[].designation[].value
Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote

# concept[].designation[].value
Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply

# concept[].designation[].value
Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application

# concept[].designation[].value
Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply

# concept[].designation[].value
Ippb machine, all types, with built-in nebulization; manual or automatic valves; internal or external power source

# concept[].designation[].value
Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type

# concept[].designation[].value
Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery

# concept[].designation[].value
Humidifier, durable, glass or autoclavable plastic bottle type, for use with regulator or flowmeter

# concept[].designation[].value
Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery

# concept[].designation[].value
Humidifier, non-heated, used with positive airway pressure device

# concept[].designation[].value
Humidifier, heated, used with positive airway pressure device

# concept[].designation[].value
Compressor, air power source for equipment which is not self-contained or cylinder driven

# concept[].designation[].value
Aerosol compressor, adjustable pressure, light duty for intermittent use

# concept[].designation[].value
Ultrasonic/electronic aerosol generator with small volume nebulizer

# concept[].designation[].value
Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter

# concept[].designation[].value
Respiratory suction pump, home model, portable or stationary, electric

# concept[].designation[].value
Continuous positive airway pressure (cpap) device

# concept[].designation[].value
Breast pump, electric (ac and/or dc), any type

# concept[].designation[].value
Breast pump, hospital grade, electric (ac and / or dc), any type

# concept[].designation[].value
Pacemaker monitor, self-contained, (checks battery depletion, includes audible and visible check systems)

# concept[].designation[].value
Pacemaker monitor, self contained, checks battery depletion and other pacemaker components, includes digital/visible check systems

# concept[].designation[].value
Implantable cardiac event recorder with memory, activator and programmer

# concept[].designation[].value
Apnea monitor, without recording feature

# concept[].designation[].value
Skin piercing device for collection of capillary blood, laser, each

# concept[].designation[].value
Sling or seat, patient lift, canvas or nylon

# concept[].designation[].value
Patient lift, bathroom or toilet, not otherwise classified

# concept[].designation[].value
Separate seat lift mechanism for use with patient owned furniture-electric

# concept[].designation[].value
Seat lift mechanism, non-electric, any type

# concept[].designation[].value
Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)

# concept[].designation[].value
Patient lift, electric with seat or sling

# concept[].designation[].value
Multipositional patient support system, with integrated lift, patient accessible controls

# concept[].designation[].value
Combination sit to stand frame/table system, any size including pediatric, with seat lift feature, with or without wheels

# concept[].designation[].value
Standing frame/table system, one position (e.g., upright, supine or prone stander), any size including pediatric, with or without wheels

# concept[].designation[].value
Patient lift, moveable from room to room with disassembly and reassembly, includes all components/accessories

# concept[].designation[].value
Patient lift, fixed system, includes all components/accessories

# concept[].designation[].value
Standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels

# concept[].designation[].value
Standing frame/table system, mobile (dynamic stander), any size including pediatric

# concept[].designation[].value
Pneumatic compressor, non-segmental home model

# concept[].designation[].value
Pneumatic compressor, segmental home model without calibrated gradient pressure

# concept[].designation[].value
Pneumatic compressor, segmental home model with calibrated gradient pressure

# concept[].designation[].value
Non-segmental pneumatic appliance for use with pneumatic compressor, half arm

# concept[].designation[].value
Segmental pneumatic appliance for use with pneumatic compressor, trunk

# concept[].designation[].value
Segmental pneumatic appliance for use with pneumatic compressor, chest

# concept[].designation[].value
Non-segmental pneumatic appliance for use with pneumatic compressor, full leg

# concept[].designation[].value
Non-segmental pneumatic appliance for use with pneumatic compressor, full arm

# concept[].designation[].value
Non-segmental pneumatic appliance for use with pneumatic compressor, half leg

# concept[].designation[].value
Segmental pneumatic appliance for use with pneumatic compressor, full leg

# concept[].designation[].value
Segmental pneumatic appliance for use with pneumatic compressor, full arm

# concept[].designation[].value
Segmental pneumatic appliance for use with pneumatic compressor, half leg

# concept[].designation[].value
Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk

# concept[].designation[].value
Segmental gradient pressure pneumatic appliance, full leg

# concept[].designation[].value
Segmental gradient pressure pneumatic appliance, full arm

# concept[].designation[].value
Segmental gradient pressure pneumatic appliance, half leg

# concept[].designation[].value
Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)

# concept[].designation[].value
Intermittent limb compression device (includes all accessories), not otherwise specified

# concept[].designation[].value
Non-pneumatic sequential compression garment, full leg

# concept[].designation[].value
Non-pneumatic sequential compression garment, half leg

# concept[].designation[].value
Non-pneumatic compression controller with sequential calibrated gradient pressure

# concept[].designation[].value
Non-pneumatic sequential compression garment, full arm

# concept[].designation[].value
Ultraviolet light therapy system, includes bulbs/lamps, timer and eye protection; treatment area 2 square feet or less

# concept[].designation[].value
Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 4 foot panel

# concept[].designation[].value
Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 6 foot panel

# concept[].designation[].value
Ultraviolet multidirectional light therapy system in 6 foot cabinet, includes bulbs/lamps, timer and eye protection

# concept[].designation[].value
Safety equipment, device or accessory, any type

# concept[].designation[].value
Restraints, any type (body, chest, wrist or ankle)

# concept[].designation[].value
Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion

# concept[].designation[].value
Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises

# concept[].designation[].value
Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises

# concept[].designation[].value
Transcutaneous electrical nerve stimulation (tens) device, two lead, localized stimulation

# concept[].designation[].value
Transcutaneous electrical nerve stimulator for nerves in the auricular region

# concept[].designation[].value
Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation

# concept[].designation[].value
Form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient's skin by layers of fabric)

# concept[].designation[].value
Cranial electrotherapy stimulation (ces) system, any type

# concept[].designation[].value
Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve

# concept[].designation[].value
External upper limb tremor stimulator of the peripheral nerves of the wrist

# concept[].designation[].value
Transcutaneous tibial nerve stimulator, controlled by phone application

# concept[].designation[].value
Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories

# concept[].designation[].value
Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors

# concept[].designation[].value
Non-implanted pelvic floor electrical stimulator, complete system

# concept[].designation[].value
External lower extremity nerve stimulator for restless legs syndrome, each

# concept[].designation[].value
Neuromuscular stimulator, electronic shock unit

# concept[].designation[].value
Osteogenesis stimulator, electrical, non-invasive, other than spinal applications

# concept[].designation[].value
Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device

# concept[].designation[].value
Transcutaneous electrical joint stimulation device system, includes all accessories

# concept[].designation[].value
Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program

# concept[].designation[].value
Fda approved nerve stimulator, with replaceable batteries, for treatment of nausea and vomiting

# concept[].designation[].value
Electrical stimulation device used for cancer treatment, includes all accessories, any type

# concept[].designation[].value
Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories

# concept[].designation[].value
Electrical stimulation or electromagnetic wound treatment device, not otherwise classified

# concept[].designation[].value
Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified

# concept[].designation[].value
Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater

# concept[].designation[].value
Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours

# concept[].designation[].value
Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient

# concept[].designation[].value
Infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.)

# concept[].designation[].value
Infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.)

# concept[].designation[].value
External ambulatory infusion pump, insulin

# concept[].designation[].value
Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement

# concept[].designation[].value
Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)

# concept[].designation[].value
External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing

# concept[].designation[].value
Parenteral infusion pump, stationary, single or multi-channel

# concept[].designation[].value
Ambulatory traction device, all types, each

# concept[].designation[].value
Traction frame, attached to headboard, cervical traction

# concept[].designation[].value
Traction equipment, cervical, free-standing stand/frame, pneumatic, applying traction force to other than mandible

# concept[].designation[].value
Traction stand, free standing, cervical traction

# concept[].designation[].value
Cervical traction equipment not requiring additional stand or frame

# concept[].designation[].value
Cervical traction device, with inflatable air bladder(s)

# concept[].designation[].value
Traction frame, attached to footboard, extremity traction, (e.g., buck's)

# concept[].designation[].value
Traction stand, free standing, extremity traction

# concept[].designation[].value
Traction frame, attached to footboard, pelvic traction

# concept[].designation[].value
Traction stand, free standing, pelvic traction, (e.g., buck's)

# concept[].designation[].value
Trapeze bars, a/k/a patient helper, attached to bed, with grab bar

# concept[].designation[].value
Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar

# concept[].designation[].value
Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar

# concept[].designation[].value
Fracture frame, attached to bed, includes weights

# concept[].designation[].value
Fracture frame, free standing, includes weights

# concept[].designation[].value
Continuous passive motion exercise device for use on knee only

# concept[].designation[].value
Continuous passive motion exercise device for use other than knee

# concept[].designation[].value
Trapeze bar, free standing, complete with grab bar

# concept[].designation[].value
Gravity assisted traction device, any type

# concept[].designation[].value
Fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster)

# concept[].designation[].value
Fracture frame, attachments for complex pelvic traction

# concept[].designation[].value
Fracture frame, attachments for complex cervical traction

# concept[].designation[].value
Heel loop/holder, any type, with or without ankle strap, each

# concept[].designation[].value
Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each

# concept[].designation[].value
Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot

# concept[].designation[].value
Wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each

# concept[].designation[].value
Wheelchair accessory, lateral trunk or hip support, any type, including fixed mounting hardware, each

# concept[].designation[].value
Wheelchair accessory, medial thigh support, any type, including fixed mounting hardware, each

# concept[].designation[].value
Manual wheelchair accessory, one-arm drive attachment, each

# concept[].designation[].value
Manual wheelchair accessory, adapter for amputee, each

# concept[].designation[].value
Wheelchair accessory, shoulder harness/straps or chest strap, including any type mounting hardware

# concept[].designation[].value
Manual wheelchair accessory, wheel lock brake extension (handle), each

# concept[].designation[].value
Manual wheelchair accessory, headrest extension, each

# concept[].designation[].value
Manual wheelchair accessory, hand rim with projections, any type, replacement only, each

# concept[].designation[].value
No. 2 footplates, except for elevating leg rest

# concept[].designation[].value
Manual wheelchair accessory, anti-tipping device, each

# concept[].designation[].value
Wheelchair accessory, adjustable height, detachable armrest, complete assembly, each

# concept[].designation[].value
Manual wheelchair accessory, anti-rollback device, each

# concept[].designation[].value
Wheelchair accessory, positioning belt/safety belt/pelvic strap, each

# concept[].designation[].value
Wheelchair accessory, seat upholstery, replacement only, each

# concept[].designation[].value
Wheelchair accessory, back upholstery, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, joystick control

# concept[].designation[].value
Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, tiller control

# concept[].designation[].value
Wheelchair accessory, seat lift mechanism

# concept[].designation[].value
Manual wheelchair accessory, push-rim activated power assist system

# concept[].designation[].value
Manual wheelchair accessory, lever-activated, wheel drive, pair

# concept[].designation[].value
Wheelchair accessory, elevating leg rest, complete assembly, each

# concept[].designation[].value
Manual wheelchair accessory, solid seat insert

# concept[].designation[].value
Wheelchair accessory, calf rest/pad, replacement only, each

# concept[].designation[].value
Wheelchair accessory, power seating system, tilt only

# concept[].designation[].value
Wheelchair accessory, power seating system, recline only, without shear reduction

# concept[].designation[].value
Wheelchair accessory, power seating system, recline only, with mechanical shear reduction

# concept[].designation[].value
Wheelchair accessory, power seating system, recline only, with power shear reduction

# concept[].designation[].value
Wheelchair accessory, power seating system, combination tilt and recline, without shear reduction

# concept[].designation[].value
Wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction

# concept[].designation[].value
Wheelchair accessory, power seating system, combination tilt and recline, with power shear reduction

# concept[].designation[].value
Wheelchair accessory, addition to power seating system, mechanically linked leg elevation system, including pushrod and leg rest, each

# concept[].designation[].value
Wheelchair accessory, addition to power seating system, power leg elevation system, including leg rest, pair

# concept[].designation[].value
Modification to pediatric size wheelchair, width adjustment package (not to be dispensed with initial chair)

# concept[].designation[].value
Wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each

# concept[].designation[].value
Reclining back, addition to pediatric size wheelchair

# concept[].designation[].value
Shock absorber for manual wheelchair, each

# concept[].designation[].value
Shock absorber for power wheelchair, each

# concept[].designation[].value
Heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair, each

# concept[].designation[].value
Heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair, each

# concept[].designation[].value
Residual limb support system for wheelchair, any type

# concept[].designation[].value
Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for joystick, other control interface or positioning accessory

# concept[].designation[].value
Wheelchair accessory, ventilator tray, fixed

# concept[].designation[].value
Wheelchair accessory, ventilator tray, gimbaled

# concept[].designation[].value
Rollabout chair, any and all types with casters 5" or greater

# concept[].designation[].value
Multi-positional patient transfer system, with integrated seat, operated by care giver, patient weight capacity up to and including 300 lbs

# concept[].designation[].value
Multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs

# concept[].designation[].value
Transport chair, adult size, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Transport chair, adult size, heavy duty, patient weight capacity greater than 300 pounds

# concept[].designation[].value
Fully-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests

# concept[].designation[].value
Fully-reclining wheelchair, detachable arms, desk or full length, swing away detachable elevating legrests

# concept[].designation[].value
Fully-reclining wheelchair, detachable arms (desk or full length) swing away detachable footrest

# concept[].designation[].value
Hemi-wheelchair, fixed full length arms, swing away detachable elevating leg rest

# concept[].designation[].value
Hemi-wheelchair, detachable arms desk or full length arms, swing away detachable elevating leg rests

# concept[].designation[].value
Hemi-wheelchair, fixed full length arms, swing away detachable foot rests

# concept[].designation[].value
Hemi-wheelchair detachable arms desk or full length, swing away detachable footrests

# concept[].designation[].value
High strength lightweight wheelchair, fixed full length arms, swing away detachable elevating leg rests

# concept[].designation[].value
High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable elevating leg rests

# concept[].designation[].value
High strength lightweight wheelchair, fixed length arms, swing away detachable footrest

# concept[].designation[].value
High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable foot rests

# concept[].designation[].value
Wide heavy duty wheel chair, detachable arms (desk or full length), swing away detachable elevating leg rests

# concept[].designation[].value
Wide heavy duty wheelchair, detachable arms desk or full length arms, swing away detachable footrests

# concept[].designation[].value
Semi-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests

# concept[].designation[].value
Semi-reclining wheelchair, detachable arms (desk or full length) elevating leg rest

# concept[].designation[].value
Standard wheelchair, fixed full length arms, fixed or swing away detachable footrests

# concept[].designation[].value
Wheelchair, detachable arms, desk or full length, swing away detachable footrests

# concept[].designation[].value
Wheelchair, detachable arms, desk or full length swing away detachable elevating legrests

# concept[].designation[].value
Wheelchair, fixed full length arms, swing away detachable elevating legrests

# concept[].designation[].value
Manual adult size wheelchair, includes tilt in space

# concept[].designation[].value
Amputee wheelchair, fixed full length arms, swing away detachable elevating legrests

# concept[].designation[].value
Amputee wheelchair, fixed full length arms, without footrests or legrest

# concept[].designation[].value
Amputee wheelchair, detachable arms (desk or full length) without footrests or legrest

# concept[].designation[].value
Amputee wheelchair, detachable arms (desk or full length) swing away detachable footrests

# concept[].designation[].value
Amputee wheelchair, detachable arms (desk or full length) swing away detachable elevating legrests

# concept[].designation[].value
Heavy duty wheelchair, fixed full length arms, swing away detachable elevating legrests

# concept[].designation[].value
Amputee wheelchair, fixed full length arms, swing away detachable footrest

# concept[].designation[].value
Wheelchair; specially sized or constructed, (indicate brand name, model number, if any) and justification

# concept[].designation[].value
Wheelchair with fixed arm, elevating legrests

# concept[].designation[].value
Wheelchair with detachable arms, footrests

# concept[].designation[].value
Wheelchair with detachable arms, elevating legrests

# concept[].designation[].value
Wheelchair accessory, manual semi-reclining back, (recline greater than 15 degrees, but less than 80 degrees), each

# concept[].designation[].value
Wheelchair accessory, manual fully reclining back, (recline greater than 80 degrees), each

# concept[].designation[].value
Wheelchair, pediatric size, not otherwise specified

# concept[].designation[].value
Power operated vehicle (three or four wheel nonhighway) specify brand name and model number

# concept[].designation[].value
Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating system

# concept[].designation[].value
Wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating system

# concept[].designation[].value
Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating system

# concept[].designation[].value
Wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating system

# concept[].designation[].value
Wheelchair, pediatric size, rigid, adjustable, with seating system

# concept[].designation[].value
Wheelchair, pediatric size, folding, adjustable, with seating system

# concept[].designation[].value
Wheelchair, pediatric size, rigid, adjustable, without seating system

# concept[].designation[].value
Wheelchair, pediatric size, folding, adjustable, without seating system

# concept[].designation[].value
Power wheelchair, pediatric size, not otherwise specified

# concept[].designation[].value
Lightweight wheelchair, detachable arms, (desk or full length) swing away detachable, elevating legrest

# concept[].designation[].value
Lightweight wheelchair, fixed full length arms, swing away detachable footrest

# concept[].designation[].value
Lightweight wheelchair, detachable arms (desk or full length) swing away detachable footrest

# concept[].designation[].value
Lightweight wheelchair, fixed full length arms, swing away detachable elevating legrests

# concept[].designation[].value
Heavy duty wheelchair, detachable arms (desk or full length) elevating legrests

# concept[].designation[].value
Heavy duty wheelchair, fixed full length arms, swing away detachable footrest

# concept[].designation[].value
Heavy duty wheelchair, detachable arms (desk or full length) swing away detachable footrest

# concept[].designation[].value
Heavy duty wheelchair, fixed full length arms, elevating legrest

# concept[].designation[].value
Special wheelchair seat height from floor

# concept[].designation[].value
Special wheelchair seat depth, by upholstery

# concept[].designation[].value
Special wheelchair seat depth and/or width, by construction

# concept[].designation[].value
Oxygen accessory, flow regulator capable of positive inspiratory pressure

# concept[].designation[].value
Oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each

# concept[].designation[].value
Oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each

# concept[].designation[].value
Oxygen accessory, battery charger for portable concentrator, any type, replacement only, each

# concept[].designation[].value
Oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each

# concept[].designation[].value
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate

# concept[].designation[].value
Oxygen concentrator, dual delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate, each

# concept[].designation[].value
Oxygen and water vapor enriching system with heated delivery

# concept[].designation[].value
Oxygen and water vapor enriching system without heated delivery

# concept[].designation[].value
Kidney, dialysate delivery syst kidney machine, pump recirculating, air removal syst, flowrate meter, power off, heater and temperature control with alarm, i.v. poles, pressure gauge, concentrate container

# concept[].designation[].value
Air bubble detector for hemodialysis, each, replacement

# concept[].designation[].value
Pressure alarm for hemodialysis, each, replacement

# concept[].designation[].value
Bath conductivity meter for hemodialysis, each

# concept[].designation[].value
Blood leak detector for hemodialysis, each, replacement

# concept[].designation[].value
Transducer protectors/fluid barriers, for hemodialysis, any size, per 10

# concept[].designation[].value
Unipuncture control system for hemodialysis

# concept[].designation[].value
Cycler dialysis machine for peritoneal dialysis

# concept[].designation[].value
Delivery and/or installation charges for hemodialysis equipment

# concept[].designation[].value
Reverse osmosis water purification system, for hemodialysis

# concept[].designation[].value
Deionizer water purification system, for hemodialysis

# concept[].designation[].value
Blood pump for hemodialysis, replacement

# concept[].designation[].value
Water softening system, for hemodialysis

# concept[].designation[].value
Tablo hemodialysis system for the billable dialysis service

# concept[].designation[].value
Compact (portable) travel hemodialyzer system

# concept[].designation[].value
Sorbent cartridges, for hemodialysis, per 10

# concept[].designation[].value
Dialysis equipment, not otherwise specified

# concept[].designation[].value
Replacement cushions for jaw motion rehabilitation system, pkg. of 6

# concept[].designation[].value
Replacement measuring scales for jaw motion rehabilitation system, pkg. of 200

# concept[].designation[].value
Dynamic adjustable elbow extension and flexion device, includes soft interface material

# concept[].designation[].value
Static progressive stretch elbow device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Dynamic adjustable forearm pronation/supination device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable elbow extension only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable elbow flexion only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable wrist extension and flexion device, includes soft interface material

# concept[].designation[].value
Static progressive stretch wrist device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Dynamic adjustable wrist extension only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable wrist flexion only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable knee extension and flexion device, includes soft interface material

# concept[].designation[].value
Static progressive stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Dynamic knee, extension/flexion device with active resistance control

# concept[].designation[].value
Dynamic adjustable knee extension only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable knee flexion only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable ankle extension and flexion device, includes soft interface material

# concept[].designation[].value
Static progressive stretch ankle device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Static progressive stretch forearm pronation / supination device, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Replacement soft interface material, dynamic adjustable extension/flexion device

# concept[].designation[].value
Replacement soft interface material/cuffs for bi-directional static progressive stretch device

# concept[].designation[].value
Dynamic adjustable ankle extension only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable ankle flexion only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable finger extension and flexion device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable finger extension only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable finger flexion only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable toe extension only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable toe flexion only device, includes soft interface material

# concept[].designation[].value
Dynamic adjustable toe extension and flexion device, includes soft interface material

# concept[].designation[].value
Static progressive stretch toe device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Dynamic adjustable shoulder flexion / abduction / rotation device, includes soft interface material

# concept[].designation[].value
Static progressive stretch shoulder device, with or without range of motion adjustment, includes all components and accessories

# concept[].designation[].value
Communication board, non-electronic augmentative or alternative communication device

# concept[].designation[].value
Virtual reality cognitive behavioral therapy device (cbt), including pre-programmed therapy software

# concept[].designation[].value
Gastric suction pump, home model, portable or stationary, electric

# concept[].designation[].value
Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system

# concept[].designation[].value
Blood glucose monitor with integrated voice synthesizer

# concept[].designation[].value
Blood glucose monitor with integrated lancing/blood sample

# concept[].designation[].value
Adjunctive, non-implanted continuous glucose monitor or receiver

# concept[].designation[].value
Non-adjunctive, non-implanted continuous glucose monitor or receiver

# concept[].designation[].value
Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge

# concept[].designation[].value
Pulse generator system for tympanic treatment of inner ear endolymphatic fluid

# concept[].designation[].value
Manual wheelchair accessory, nonstandard seat frame, width greater than or equal to 20 inches and less than 24 inches

# concept[].designation[].value
Manual wheelchair accessory, nonstandard seat frame width, 24-27 inches

# concept[].designation[].value
Manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22 inches

# concept[].designation[].value
Manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches

# concept[].designation[].value
Manual wheelchair accessory, handrim without projections (includes ergonomic or contoured), any type, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, wheel lock assembly, complete, replacement only, each

# concept[].designation[].value
Wheelchair accessory, crutch and cane holder, each

# concept[].designation[].value
Wheelchair accessory, cylinder tank carrier, each

# concept[].designation[].value
Accessory, arm trough, with or without hand support, each

# concept[].designation[].value
Wheelchair accessory, bearings, any type, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, pneumatic propulsion tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each

# concept[].designation[].value
Manual wheelchair accessory, pneumatic caster tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, tube for pneumatic caster tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, foam filled propulsion tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, foam filled caster tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, foam propulsion tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, foam caster tire, any size, each

# concept[].designation[].value
Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, caster wheel excludes tire, any size, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, caster fork, any size, replacement only, each

# concept[].designation[].value
Manual wheelchair accessory, gear reduction drive wheel, each

# concept[].designation[].value
Manual wheelchair accessory, wheel braking system and lock, complete, each

# concept[].designation[].value
Manual wheelchair accessory, manual standing system

# concept[].designation[].value
Manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware

# concept[].designation[].value
Back, planar, for pediatric size wheelchair including fixed attaching hardware

# concept[].designation[].value
Seat, planar, for pediatric size wheelchair including fixed attaching hardware

# concept[].designation[].value
Back, contoured, for pediatric size wheelchair including fixed attaching hardware

# concept[].designation[].value
Seat, contoured, for pediatric size wheelchair including fixed attaching hardware

# concept[].designation[].value
Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features

# concept[].designation[].value
Complex rehabilitative power wheelchair accessory, power seat elevation system, any type

# concept[].designation[].value
Wheelchair accessory, power seat elevation system, any type

# concept[].designation[].value
Wheelchair accessory, power standing system, any type

# concept[].designation[].value
Power wheelchair accessory, electronic connection between wheelchair controller and one power seating system motor, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, electronic connection between wheelchair controller and two or more power seating system motors, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each

# concept[].designation[].value
Power wheelchair accessory, hand control interface, remote joystick, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, hand control interface, multiple mechanical switches, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, specialty joystick handle for hand control interface, prefabricated

# concept[].designation[].value
Power wheelchair accessory, chin cup for chin control interface

# concept[].designation[].value
Power wheelchair accessory, sip and puff interface, nonproportional, including all related electronics, mechanical stop switch, and manual swingaway mounting hardware

# concept[].designation[].value
Power wheelchair accessory, breath tube kit for sip and puff interface

# concept[].designation[].value
Power wheelchair accessory, head control interface, mechanical, proportional, including all related electronics, mechanical direction change switch, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, head control or extremity control interface, electronic, proportional, including all related electronics and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, head control interface, contact switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, head control interface, proximity switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, attendant control, proportional, including all related electronics and fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, nonstandard seat frame width, 20-23 inches

# concept[].designation[].value
Power wheelchair accessory, nonstandard seat frame width, 24-27 inches

# concept[].designation[].value
Power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches

# concept[].designation[].value
Power wheelchair accessory, nonstandard seat frame depth, 22-25 inches

# concept[].designation[].value
Power wheelchair accessory, electronic interface to operate speech generating device using power wheelchair control interface

# concept[].designation[].value
Power wheelchair accessory, group 34 non-sealed lead acid battery, each

# concept[].designation[].value
Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)

# concept[].designation[].value
Power wheelchair accessory, 22nf non-sealed lead acid battery, each

# concept[].designation[].value
Power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel cell, absorbed glassmat)

# concept[].designation[].value
Power wheelchair accessory, group 24 non-sealed lead acid battery, each

# concept[].designation[].value
Power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)

# concept[].designation[].value
Power wheelchair accessory, u-1 non-sealed lead acid battery, each

# concept[].designation[].value
Power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)

# concept[].designation[].value
Power wheelchair accessory, battery charger, single mode, for use with only one battery type, sealed or non-sealed, each

# concept[].designation[].value
Power wheelchair accessory, battery charger, dual mode, for use with either battery type, sealed or non-sealed, each

# concept[].designation[].value
Power wheelchair component, drive wheel motor, replacement only

# concept[].designation[].value
Power wheelchair component, drive wheel gear box, replacement only

# concept[].designation[].value
Power wheelchair component, integrated drive wheel motor and gear box combination, replacement only

# concept[].designation[].value
Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each

# concept[].designation[].value
Power wheelchair accessory, group 27 non-sealed lead acid battery, each

# concept[].designation[].value
Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware

# concept[].designation[].value
Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only

# concept[].designation[].value
Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only

# concept[].designation[].value
Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only

# concept[].designation[].value
Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue

# concept[].designation[].value
Power wheelchair component, actuator, replacement only

# concept[].designation[].value
Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, pneumatic caster tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, foam filled caster tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, foam caster tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, caster fork, any size, replacement only, each

# concept[].designation[].value
Power wheelchair accessory, lithium-based battery, each

# concept[].designation[].value
Wheelchair accessory, dynamic positioning hardware for back

# concept[].designation[].value
Negative pressure wound therapy electrical pump, stationary or portable

# concept[].designation[].value
Speech generating device, digitized speech, using pre-recorded messages, less than or equal to 8 minutes recording time

# concept[].designation[].value
Speech generating device, digitized speech, using pre-recorded messages, greater than 8 minutes but less than or equal to 20 minutes recording time

# concept[].designation[].value
Speech generating device, digitized speech, using pre-recorded messages, greater than 20 minutes but less than or equal to 40 minutes recording time

# concept[].designation[].value
Speech generating device, digitized speech, using pre-recorded messages, greater than 40 minutes recording time

# concept[].designation[].value
Speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device

# concept[].designation[].value
Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access

# concept[].designation[].value
Speech generating software program, for personal computer or personal digital assistant

# concept[].designation[].value
Accessory for speech generating device, mounting system

# concept[].designation[].value
Accessory for speech generating device, electromyographic sensor

# concept[].designation[].value
Accessory for speech generating device, not otherwise classified

# concept[].designation[].value
General use wheelchair seat cushion, width less than 22 inches, any depth

# concept[].designation[].value
General use wheelchair seat cushion, width 22 inches or greater, any depth

# concept[].designation[].value
Skin protection wheelchair seat cushion, width less than 22 inches, any depth

# concept[].designation[].value
Skin protection wheelchair seat cushion, width 22 inches or greater, any depth

# concept[].designation[].value
Positioning wheelchair seat cushion, width less than 22 inches, any depth

# concept[].designation[].value
Positioning wheelchair seat cushion, width 22 inches or greater, any depth

# concept[].designation[].value
Skin protection and positioning wheelchair seat cushion, width less than 22 inches, any depth

# concept[].designation[].value
Skin protection and positioning wheelchair seat cushion, width 22 inches or greater, any depth

# concept[].designation[].value
Custom fabricated wheelchair seat cushion, any size

# concept[].designation[].value
General use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware

# concept[].designation[].value
General use wheelchair back cushion, width 22 inches or greater, any height, including any type mounting hardware

# concept[].designation[].value
Positioning wheelchair back cushion, posterior, width less than 22 inches, any height, including any type mounting hardware

# concept[].designation[].value
Positioning wheelchair back cushion, posterior, width 22 inches or greater, any height, including any type mounting hardware

# concept[].designation[].value
Positioning wheelchair back cushion, posterior-lateral, width less than 22 inches, any height, including any type mounting hardware

# concept[].designation[].value
Positioning wheelchair back cushion, posterior-lateral, width 22 inches or greater, any height, including any type mounting hardware

# concept[].designation[].value
Custom fabricated wheelchair back cushion, any size, including any type mounting hardware

# concept[].designation[].value
Replacement cover for wheelchair seat cushion or back cushion, each

# concept[].designation[].value
Positioning wheelchair back cushion, planar back with lateral supports, width less than 22 inches, any height, including any type mounting hardware

# concept[].designation[].value
Positioning wheelchair back cushion, planar back with lateral supports, width 22 inches or greater, any height, including any type mounting hardware

# concept[].designation[].value
Skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth

# concept[].designation[].value
Skin protection wheelchair seat cushion, adjustable, width 22 inches or greater, any depth

# concept[].designation[].value
Skin protection and positioning wheelchair seat cushion, adjustable, width less than 22 inches, any depth

# concept[].designation[].value
Skin protection and positioning wheelchair seat cushion, adjustable, width 22 inches or greater, any depth

# concept[].designation[].value
Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable

# concept[].designation[].value
Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type

# concept[].designation[].value
Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining

# concept[].designation[].value
Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)

# concept[].designation[].value
Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support

# concept[].designation[].value
Wheelchair accessory, addition to mobile arm support, elevating proximal arm

# concept[].designation[].value
Wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control

# concept[].designation[].value
Wheelchair accessory, addition to mobile arm support, supinator

# concept[].designation[].value
Speech volume modulation system, any type, including all components and accessories

# concept[].designation[].value
Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only

# concept[].designation[].value
Gait trainer, pediatric size, posterior support, includes all accessories and components

# concept[].designation[].value
Gait trainer, pediatric size, upright support, includes all accessories and components

# concept[].designation[].value
Gait trainer, pediatric size, anterior support, includes all accessories and components

# concept[].designation[].value
Administration of influenza virus vaccine

# concept[].designation[].value
Individual counseling for pre-exposure prophylaxis (prep) by physician or qualified health care professional (qhp) to prevent human immunodeficiency virus (hiv), includes hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence, 15-30 minutes

# concept[].designation[].value
Injection of pre-exposure prophylaxis (prep) drug for hiv prevention, under skin or into muscle

# concept[].designation[].value
Individual counseling for pre-exposure prophylaxis (prep) by clinical staff to prevent human immunodeficiency virus (hiv), includes: hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence

# concept[].designation[].value
Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); first 60 minutes

# concept[].designation[].value
Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); each additional 30 minutes (list separately in addition to code for primary service)

# concept[].designation[].value
Community health integration services performed by certified or trained auxiliary personnel, including a community health worker, under the direction of a physician or other practitioner; 60 minutes per calendar month, in the following activities to address social determinants of health (sdoh) need(s) that are significantly limiting the ability to diagnose or treat problem(s) addressed in an initiating visit: person-centered assessment, performed to better understand the individualized context of the intersection between the sdoh need(s) and the problem(s) addressed in the initiating visit. ++ conducting a person-centered assessment to understand patient's life story, strengths, needs, goals, preferences and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal-setting and establishing an action plan. ++ providing tailored support to the patient as needed to accomplish the practitioner's treatment plan. practitioner, home-, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; and from home- and community-based service providers, social service providers, and caregiver (if applicable). ++ communication with practitioners, home- and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) to address the sdoh need(s). health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, and preferences, in the context of the sdoh need(s), and educating the patient on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services addressing the sdoh need(s), in ways that are more likely to promote personalized and effective diagnosis or treatment. health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care and helping secure appointments with them. facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals. facilitating and providing social and emotional support to help the patient cope with the problem(s) addressed in the initiating visit, the sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals. leveraging lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals

# concept[].designation[].value
Community health integration services, each additional 30 minutes per calendar month (list separately in addition to g0019)

# concept[].designation[].value
Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month, in the following activities: person-centered assessment, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered assessment to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the practitioner's treatment plan.  identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services.  practitioner, home, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; home- and community-based service providers; and caregiver (if applicable). ++ communication with practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s).  health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making.  building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition.  health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care,  and helping secure appointments with them. ++ providing the patient with information/resources to consider participation in clinical trials or clinical research as applicable.  facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals.  facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals.  leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals

# concept[].designation[].value
Principal illness navigation services, additional 30 minutes per calendar month (list separately in addition to g0023)

# concept[].designation[].value
Semen analysis; presence and/or motility of sperm excluding huhner

# concept[].designation[].value
Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)

# concept[].designation[].value
Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period

# concept[].designation[].value
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user

# concept[].designation[].value
Palliative care services given to patient any time during the measurement period

# concept[].designation[].value
Two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics

# concept[].designation[].value
Two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines

# concept[].designation[].value
Patients receiving palliative care during the measurement period

# concept[].designation[].value
Patient has any emergency department encounter during the performance period with place of service indicator 23

# concept[].designation[].value
Patient or care partner decline assessment

# concept[].designation[].value
On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available

# concept[].designation[].value
Clinician determines patient does not require referral

# concept[].designation[].value
Patient not referred, reason not otherwise specified

# concept[].designation[].value
Patient and/or care partner decline referral

# concept[].designation[].value
Referral to physical, occupational, speech, or recreational therapy

# concept[].designation[].value
Patients with mechanical prosthetic heart valve

# concept[].designation[].value
Patients with moderate or severe mitral stenosis

# concept[].designation[].value
Clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention

# concept[].designation[].value
Clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention

# concept[].designation[].value
Pediatric patient with minor blunt head trauma and pecarn prediction criteria are not assessed

# concept[].designation[].value
Patients who receive palliative care services any time during the intake period through the end of the measurement year

# concept[].designation[].value
With maintenance hemodialysis (in-center and home hd) for the complete reporting month

# concept[].designation[].value
Patients with a catheter that have limited life expectancy

# concept[].designation[].value
Patients under hospice care in the current reporting month

# concept[].designation[].value
Patients on peritoneal dialysis for any portion of the reporting month

# concept[].designation[].value
Advancing rheumatology patient care mips value pathways

# concept[].designation[].value
Coordinating stroke care to promote prevention and cultivate positive outcomes mips value pathways

# concept[].designation[].value
Advancing care for heart disease mips value pathways

# concept[].designation[].value
Optimizing chronic disease management mips value pathways

# concept[].designation[].value
Proposed adopting best practices and promoting patient safety within emergency medicine mips value pathways

# concept[].designation[].value
Improving care for lower extremity joint repair mips value pathways

# concept[].designation[].value
Patient safety and support of positive experiences with anesthesia mips value pathways

# concept[].designation[].value
Certified nurse midwife mips specialty set

# concept[].designation[].value
Chiropractic medicine mips specialty set

# concept[].designation[].value
Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes

# concept[].designation[].value
Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes

# concept[].designation[].value
Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes

# concept[].designation[].value
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only

# concept[].designation[].value
Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

# concept[].designation[].value
Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes

# concept[].designation[].value
Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes

# concept[].designation[].value
Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes

# concept[].designation[].value
Cervical or vaginal cancer screening; pelvic and clinical breast examination

# concept[].designation[].value
Prostate cancer screening; digital rectal examination

# concept[].designation[].value
Prostate cancer screening; prostate specific antigen test (psa)

# concept[].designation[].value
Colorectal cancer screening; colonoscopy on individual at high risk

# concept[].designation[].value
Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema

# concept[].designation[].value
Diabetes outpatient self-management training services, individual, per 30 minutes

# concept[].designation[].value
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes

# concept[].designation[].value
Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist

# concept[].designation[].value
Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist

# concept[].designation[].value
Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.

# concept[].designation[].value
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk

# concept[].designation[].value
Colorectal cancer screening; barium enema

# concept[].designation[].value
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision

# concept[].designation[].value
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician

# concept[].designation[].value
Trimming of dystrophic nails, any number

# concept[].designation[].value
Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes

# concept[].designation[].value
Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization or intensive outpatient treatment program, per session (45 minutes or more)

# concept[].designation[].value
Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)

# concept[].designation[].value
Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes

# concept[].designation[].value
Intensive outpatient services; weekly bundle, minimum of 9 services over a 7 contiguous day period, which can include individual and group therapy with physicians or psychologists (or other mental health professionals to the extent authorized under state law); occupational therapy requiring the skills of a qualified occupational therapist; services of social workers, trained psychiatric nurses, and other staff trained to work with psychiatric patients; individualized activity therapies that are not primarily recreational or diversionary; family counseling (the primary purpose of which is treatment of the individual's condition); patient training and education (to the extent that training and educational activities are closely and clearly related to individual's care and treatment); diagnostic services; and such other items and services (excluding meals and transportation) that are reasonable and necessary for the diagnosis or active treatment of the individual's condition, reasonably expected to improve or maintain the individual's condition and functional level and to prevent relapse or hospitalization, and furnished pursuant to such guidelines relating to frequency and duration of services in accordance with a physician certification and plan of treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga

# concept[].designation[].value
Principal illness navigation - peer support by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a certified peer specialist; 60 minutes per calendar month, in the following activities:  person-centered interview, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors, and including unmet sdoh needs (that are not billed separately). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the person-centered goals in the practitioner's treatment plan. identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services. practitioner, home, and community-based care communication. ++ assist the patient in communicating with their practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s). health education. helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition. developing and proposing strategies to help meet person-centered treatment goals and supporting the patient in using chosen strategies to reach person-centered treatment goals. facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet person-centered diagnosis and treatment goals. leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals

# concept[].designation[].value
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician

# concept[].designation[].value
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision

# concept[].designation[].value
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision

# concept[].designation[].value
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision

# concept[].designation[].value
Principal illness navigation - peer support, additional 30 minutes per calendar month (list separately in addition to g0140)

# concept[].designation[].value
Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision

# concept[].designation[].value
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening

# concept[].designation[].value
Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Services of clinical social worker in home health or hospice settings, each 15 minutes

# concept[].designation[].value
Services of home health/hospice aide in home health or hospice settings, each 15 minutes

# concept[].designation[].value
Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes

# concept[].designation[].value
Services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes

# concept[].designation[].value
Services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes

# concept[].designation[].value
Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting)

# concept[].designation[].value
Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)

# concept[].designation[].value
Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
External counterpulsation, per treatment session

# concept[].designation[].value
Wound closure utilizing tissue adhesive(s) only

# concept[].designation[].value
Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session

# concept[].designation[].value
Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present

# concept[].designation[].value
Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)

# concept[].designation[].value
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more)

# concept[].designation[].value
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care

# concept[].designation[].value
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care

# concept[].designation[].value
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans

# concept[].designation[].value
Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more

# concept[].designation[].value
Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)

# concept[].designation[].value
Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed

# concept[].designation[].value
Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral

# concept[].designation[].value
Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral

# concept[].designation[].value
Pet imaging whole body; melanoma for non-covered indications

# concept[].designation[].value
Pet imaging, any site, not otherwise specified

# concept[].designation[].value
Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)

# concept[].designation[].value
Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)

# concept[].designation[].value
Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)

# concept[].designation[].value
Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education

# concept[].designation[].value
Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education

# concept[].designation[].value
Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails

# concept[].designation[].value
Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results

# concept[].designation[].value
Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests

# concept[].designation[].value
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests

# concept[].designation[].value
Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment

# concept[].designation[].value
Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)

# concept[].designation[].value
Current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve

# concept[].designation[].value
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility

# concept[].designation[].value
Injection procedure for sacroiliac joint; arthrography

# concept[].designation[].value
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography

# concept[].designation[].value
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing

# concept[].designation[].value
Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)

# concept[].designation[].value
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes

# concept[].designation[].value
Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes

# concept[].designation[].value
Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial

# concept[].designation[].value
Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval

# concept[].designation[].value
Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)

# concept[].designation[].value
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)

# concept[].designation[].value
Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care

# concept[].designation[].value
Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281

# concept[].designation[].value
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care

# concept[].designation[].value
Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery

# concept[].designation[].value
Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee

# concept[].designation[].value
Noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day

# concept[].designation[].value
Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day

# concept[].designation[].value
Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses

# concept[].designation[].value
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)

# concept[].designation[].value
Low dose ct scan (ldct) for lung cancer screening

# concept[].designation[].value
Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services

# concept[].designation[].value
Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services

# concept[].designation[].value
Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services

# concept[].designation[].value
Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services

# concept[].designation[].value
Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count

# concept[].designation[].value
Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)

# concept[].designation[].value
Creation of subcutaneous pocket with insertion of 180 day implantable interstitial glucose sensor, including system activation and patient training

# concept[].designation[].value
Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activation

# concept[].designation[].value
Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)

# concept[].designation[].value
Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service,  16-30 mins time (this code is used for medicaid billing purposes)

# concept[].designation[].value
Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)

# concept[].designation[].value
Immunization counseling by a physician or other qualified health care professional when  the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)

# concept[].designation[].value
Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)

# concept[].designation[].value
Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)

# concept[].designation[].value
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)

# concept[].designation[].value
Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)

# concept[].designation[].value
Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)

# concept[].designation[].value
Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system

# concept[].designation[].value
Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system

# concept[].designation[].value
The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)

# concept[].designation[].value
Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist, clinical social worker, mental health counselor, or marriage and family therapist time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)

# concept[].designation[].value
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous

# concept[].designation[].value
Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care

# concept[].designation[].value
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room

# concept[].designation[].value
Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary

# concept[].designation[].value
Hospice evaluation and counseling services, pre-election

# concept[].designation[].value
Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment

# concept[].designation[].value
Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment

# concept[].designation[].value
Percutaneous islet cell transplant, includes portal vein catheterization and infusion

# concept[].designation[].value
Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion

# concept[].designation[].value
Laparotomy for islet cell transplant, includes portal vein catheterization and infusion

# concept[].designation[].value
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service

# concept[].designation[].value
Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)

# concept[].designation[].value
Physician service required to establish and document the need for a power mobility device

# concept[].designation[].value
Direct admission of patient for hospital observation care

# concept[].designation[].value
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)

# concept[].designation[].value
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)

# concept[].designation[].value
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)

# concept[].designation[].value
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)

# concept[].designation[].value
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)

# concept[].designation[].value
Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening

# concept[].designation[].value
Trauma response team associated with hospital critical care service

# concept[].designation[].value
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes

# concept[].designation[].value
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes

# concept[].designation[].value
Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation

# concept[].designation[].value
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation

# concept[].designation[].value
Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels

# concept[].designation[].value
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment

# concept[].designation[].value
Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report

# concept[].designation[].value
Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination

# concept[].designation[].value
Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination

# concept[].designation[].value
Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth

# concept[].designation[].value
Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth

# concept[].designation[].value
Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth

# concept[].designation[].value
Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)

# concept[].designation[].value
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes

# concept[].designation[].value
Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes

# concept[].designation[].value
Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed

# concept[].designation[].value
Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)

# concept[].designation[].value
Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)

# concept[].designation[].value
Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)

# concept[].designation[].value
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method

# concept[].designation[].value
Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens

# concept[].designation[].value
Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 41-60 specimens

# concept[].designation[].value
Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens

# concept[].designation[].value
Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour

# concept[].designation[].value
Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour

# concept[].designation[].value
Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session

# concept[].designation[].value
Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session

# concept[].designation[].value
Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day

# concept[].designation[].value
Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth

# concept[].designation[].value
Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth

# concept[].designation[].value
Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth

# concept[].designation[].value
Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)

# concept[].designation[].value
Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)

# concept[].designation[].value
Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter

# concept[].designation[].value
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening

# concept[].designation[].value
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening

# concept[].designation[].value
Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter

# concept[].designation[].value
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening

# concept[].designation[].value
Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes

# concept[].designation[].value
Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes

# concept[].designation[].value
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit

# concept[].designation[].value
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

# concept[].designation[].value
Annual alcohol misuse screening, 5 to 15 minutes

# concept[].designation[].value
Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes

# concept[].designation[].value
Annual depression screening, 5 to 15 minutes

# concept[].designation[].value
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes

# concept[].designation[].value
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes

# concept[].designation[].value
Face-to-face behavioral counseling for obesity, 15 minutes

# concept[].designation[].value
Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing

# concept[].designation[].value
Development testing, with interpretation and report, per standardized instrument form

# concept[].designation[].value
Molecular pathology procedure; physician interpretation and report

# concept[].designation[].value
Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)

# concept[].designation[].value
Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist

# concept[].designation[].value
Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen

# concept[].designation[].value
Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters

# concept[].designation[].value
Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters

# concept[].designation[].value
Low dose rate (ldr) prostate brachytherapy services, composite rate

# concept[].designation[].value
Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy

# concept[].designation[].value
Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment

# concept[].designation[].value
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain

# concept[].designation[].value
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)

# concept[].designation[].value
Hospital outpatient clinic visit for assessment and management of a patient

# concept[].designation[].value
Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)

# concept[].designation[].value
Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)

# concept[].designation[].value
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit

# concept[].designation[].value
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit

# concept[].designation[].value
Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv

# concept[].designation[].value
Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit

# concept[].designation[].value
Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit

# concept[].designation[].value
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)

# concept[].designation[].value
Hepatitis c antibody screening, for individual at high risk and other covered indication(s)

# concept[].designation[].value
Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes

# concept[].designation[].value
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test

# concept[].designation[].value
Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service

# concept[].designation[].value
Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service

# concept[].designation[].value
Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service

# concept[].designation[].value
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed

# concept[].designation[].value
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed

# concept[].designation[].value
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed

# concept[].designation[].value
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed

# concept[].designation[].value
Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies;  (services limited to rn or lpn only)

# concept[].designation[].value
Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd

# concept[].designation[].value
Dialysis procedure with single evaluation by a physician or other qualified health care professional  for acute kidney injury without esrd

# concept[].designation[].value
Skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)

# concept[].designation[].value
Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)

# concept[].designation[].value
Skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes

# concept[].designation[].value
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion

# concept[].designation[].value
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result

# concept[].designation[].value
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)

# concept[].designation[].value
Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management visit (list separately in addition to primary service)

# concept[].designation[].value
Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan;  review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies

# concept[].designation[].value
Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation;  participation in weekly caseload consultation with the psychiatric consultant;  ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant;  provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies;  monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment

# concept[].designation[].value
Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure);  (use g0504 in conjunction with g0502, g0503)

# concept[].designation[].value
Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home

# concept[].designation[].value
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)

# concept[].designation[].value
Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team

# concept[].designation[].value
Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth

# concept[].designation[].value
Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth

# concept[].designation[].value
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month

# concept[].designation[].value
Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month

# concept[].designation[].value
Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)

# concept[].designation[].value
Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)

# concept[].designation[].value
Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes

# concept[].designation[].value
Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)

# concept[].designation[].value
Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)

# concept[].designation[].value
Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)

# concept[].designation[].value
Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model

# concept[].designation[].value
Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model

# concept[].designation[].value
Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model

# concept[].designation[].value
Management of a new patient with dementia, low complexity, for use in cmmi model

# concept[].designation[].value
Management of a new patient with dementia, moderate to high complexity, for use in cmmi model

# concept[].designation[].value
Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model

# concept[].designation[].value
Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model

# concept[].designation[].value
Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model

# concept[].designation[].value
Management of established patient with dementia, low complexity, for use in cmmi model

# concept[].designation[].value
Management of established patient with dementia, moderate to high complexity, for use in cmmi model

# concept[].designation[].value
In-home respite care, 4-hour unit, for use in cmmi model

# concept[].designation[].value
Adult day center, 8-hour unit, for use in cmmi model

# concept[].designation[].value
Facility-based respite, 24-hour unit, for use in cmmi model

# concept[].designation[].value
Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)

# concept[].designation[].value
Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Coordinated care and/or referral services, such as to adequate and accessible community resources to address unmet health-related social needs, including harm reduction interventions and recovery support services a patient needs and wishes to pursue, which significantly limit the ability to diagnose or treat an opioid use disorder; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)

# concept[].designation[].value
Patient navigational services, provided directly or by referral; including helping the patient to navigate health systems and identify care providers and supportive services, to build patient self-advocacy and communication skills with care providers, and to promote patient-driven action plans and goals; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)

# concept[].designation[].value
Peer recovery support services, provided directly or by referral; including leveraging knowledge of the condition or lived experience to provide support, mentorship, or inspiration to meet oud treatment and recovery goals; conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes; developing and proposing strategies to help meet person-centered treatment goals; assisting the patient in locating or navigating recovery support services; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)

# concept[].designation[].value
Administration of a standardized, evidence-based atherosclerotic cardiovascular disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12 months

# concept[].designation[].value
Atherosclerotic cardiovascular disease (ascvd) risk management services; clinical staff time; per calendar month

# concept[].designation[].value
Caregiver training in behavior management/modification for caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; initial 30 minutes

# concept[].designation[].value
Caregiver training in behavior management/modification for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; each additional 15 minutes

# concept[].designation[].value
Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; initial 30 minutes

# concept[].designation[].value
Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; each additional 15 minutes (list separately in addition to code for primary service) (use g0542 in conjunction with g0541)

# concept[].designation[].value
Group caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face with multiple sets of caregivers

# concept[].designation[].value
Post discharge telephonic follow-up contacts performed in conjunction with a discharge from the emergency department for behavioral health or other crisis encounter, 4 calls per calendar month

# concept[].designation[].value
Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge)

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty   whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 5-10 minutes of medical consultative discussion and review

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 11-20 minutes of medical consultative discussion and review

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 21-30 minutes of medical consultative discussion and review

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 31 or more minutes of medical consultative discussion and review

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a written report to the patient's treating/requesting practitioner, 5 minutes or more of medical consultative time

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record referral service(s) provided by a treating/requesting practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, 30 minutes

# concept[].designation[].value
Supply of digital mental health treatment device and initial education and onboarding, per course of treatment that augments a behavioral therapy plan

# concept[].designation[].value
First 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing information related to the use of the dmht device, including patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month

# concept[].designation[].value
Each additional 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing data generated from the dmht device from patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month

# concept[].designation[].value
Provision of replacement patient electronics system (e.g., system pillow, handheld reader) for home pulmonary artery pressure monitoring

# concept[].designation[].value
Advanced primary care management services for a patient with one chronic condition [expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline], or fewer, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate:    consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained.    initiation during a qualifying visit for new patients or patients not seen within 3 years;    provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week;    continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments;     deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours;    overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management.    development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan with typical care plan elements when clinically relevant; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated.    ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record;    enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits).      analyze patient population data to identify gaps in care and offer additional interventions, as appropriate;    risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients;     be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology

# concept[].designation[].value
Advanced primary care management services for a patient with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate:    consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years;    provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week;    continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments;     deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours;    overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management.    development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan;  ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver;    coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated.    ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record;    enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate;    risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients;    be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology

# concept[].designation[].value
Advanced primary care management services for a patient that is a qualified medicare beneficiary with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained.    initiation during a qualifying visit for new patients or patients not seen within 3 years;    provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments;    deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours;    overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++ system-based approaches to ensure receipt of preventive services. ++ medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver;    coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated.    ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record;    enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits).    analyze patient population data to identify gaps in care and offer additional interventions, as appropriate;    risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients;    be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology

# concept[].designation[].value
Post-operative follow-up visit complexity inherent to evaluation and management services addressing surgical procedure(s), provided by a physician or qualified health care professional who is not the practitioner who performed the procedure (or in the same group practice) and is of the same or of a different specialty than the practitioner who performed the procedure, within the 90-day global period of the procedure(s), once per 90-day global period, when there has not been a formal transfer of care and requires the following required elements, when possible and applicable:    reading available surgical note to understand the relative success of the procedure, the anatomy that was affected, and potential complications that could have arisen due to the unique circumstances of the patient's operation.    research the procedure to determine expected post-operative course and potential complications (in the case of doing a post-op for a procedure outside the specialty).    evaluate and physically examine the patient to determine whether the post-operative course is progressing appropriately.    communicate with the practitioner who performed the procedure if any questions or concerns arise. (list separately in addition to office/outpatient evaluation and management visit, new or established)

# concept[].designation[].value
Safety planning interventions, each 20 minutes personally performed by the billing practitioner, including assisting the patient in the identification of the following personalized elements of a safety plan: recognizing warning signs of an impending suicidal or substance use-related crisis; employing internal coping strategies; utilizing social contacts and social settings as a means of distraction from suicidal thoughts or risky substance use; utilizing family members, significant others, caregivers, and/or friends to help resolve the crisis; contacting mental health or substance use disorder professionals or agencies; and making the environment safe

# concept[].designation[].value
Tympanostomy with local or topical anesthesia and insertion of a ventilating tube when performed with tympanostomy tube delivery device, unilateral (list separately in addition to 69433) (do not use in conjunction with 0583t)

# concept[].designation[].value
Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)

# concept[].designation[].value
Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions

# concept[].designation[].value
Creation of subcutaneous pocket with insertion of 365 day implantable interstitial glucose sensor, including system activation and patient training

# concept[].designation[].value
Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation

# concept[].designation[].value
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes

# concept[].designation[].value
Most recent hemoglobin (hgb) level > 12.0 g/dl

# concept[].designation[].value
Hemoglobin level measurement not documented, reason not given

# concept[].designation[].value
Most recent hemoglobin level <= 12.0 g/dl

# concept[].designation[].value
Improvement in visual function achieved within 90 days following cataract surgery

# concept[].designation[].value
Patient care survey was not completed by patient

# concept[].designation[].value
Improvement in visual function not achieved within 90 days following cataract surgery

# concept[].designation[].value
Satisfaction with care achieved within 90 days following cataract surgery

# concept[].designation[].value
Patient care survey was not completed by patient

# concept[].designation[].value
Satisfaction with care not achieved within 90 days following cataract surgery

# concept[].designation[].value
Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit

# concept[].designation[].value
Type, anatomic location, and activity all documented

# concept[].designation[].value
Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)

# concept[].designation[].value
No documentation of disease type, anatomic location, and activity, reason not given

# concept[].designation[].value
Clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism inveniqa semantic answers in medicine, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria program

# concept[].designation[].value
Patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month

# concept[].designation[].value
The number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month

# concept[].designation[].value
The number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months

# concept[].designation[].value
Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session

# concept[].designation[].value
Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment

# concept[].designation[].value
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes

# concept[].designation[].value
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

# concept[].designation[].value
Extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

# concept[].designation[].value
Comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.)

# concept[].designation[].value
Services for high intensity clinical services associated with the initial engagement and outreach of beneficiaries assigned to the sip component of the pcf model (do not bill with chronic care management codes)

# concept[].designation[].value
Health care practitioners rendering treatment in place (tip)

# concept[].designation[].value
A model participant (ambulance supplier/provider), the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place)

# concept[].designation[].value
Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

# concept[].designation[].value
Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a  snf or by a laboratory on behalf of a hha, any specimen source

# concept[].designation[].value
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only

# concept[].designation[].value
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).

# concept[].designation[].value
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes

# concept[].designation[].value
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes

# concept[].designation[].value
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes

# concept[].designation[].value
Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician  or other qualified health care professional  time per calendar month with the following elements: one complex chronic condition lasting  at least 3 months,  which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities

# concept[].designation[].value
Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities

# concept[].designation[].value
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results

# concept[].designation[].value
Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)

# concept[].designation[].value
Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based social determinants of health risk assessment to identify unmet health-related social needs, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code

# concept[].designation[].value
Periodic assessment; assessing periodically by an otp practitioner and includes a  review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical and psychiatric treatment needs and goals; assessment may be informed by administration of a standardized, evidence-based social determinants of health risk assessment to identify unmet health-related social needs, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code

# concept[].designation[].value
Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation

# concept[].designation[].value
Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of  greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation

# concept[].designation[].value
Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month

# concept[].designation[].value
Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month

# concept[].designation[].value
Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)

# concept[].designation[].value
Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)

# concept[].designation[].value
Documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., patient declined, other patient reasons)

# concept[].designation[].value
Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)

# concept[].designation[].value
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given

# concept[].designation[].value
Episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti)

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed

# concept[].designation[].value
Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed

# concept[].designation[].value
Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed

# concept[].designation[].value
Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months

# concept[].designation[].value
Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity

# concept[].designation[].value
Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period

# concept[].designation[].value
Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed

# concept[].designation[].value
Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed

# concept[].designation[].value
Depression, anxiety, apathy, and psychosis assessed

# concept[].designation[].value
Depression, anxiety, apathy, and psychosis not assessed

# concept[].designation[].value
Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication

# concept[].designation[].value
Patients 81 years of age and older with at least one claim/encounter for frailty during the six months prior to the measurement period through  december 31 of the measurement period

# concept[].designation[].value
Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)

# concept[].designation[].value
Procedure-related bp's not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy

# concept[].designation[].value
Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period

# concept[].designation[].value
Patients 81 years and older with a diagnosis of frailty

# concept[].designation[].value
Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater

# concept[].designation[].value
Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points

# concept[].designation[].value
Back pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater

# concept[].designation[].value
Back pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points

# concept[].designation[].value
Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater

# concept[].designation[].value
Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points

# concept[].designation[].value
Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater

# concept[].designation[].value
Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of less than 30 points

# concept[].designation[].value
Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6-20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6-20 weeks) postoperatively demonstrated an improvement of 30 points or greater

# concept[].designation[].value
Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points

# concept[].designation[].value
Leg pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater

# concept[].designation[].value
Leg pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points

# concept[].designation[].value
Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
In hospice or using hospice services during the measurement period

# concept[].designation[].value
Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period

# concept[].designation[].value
Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)

# concept[].designation[].value
Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)

# concept[].designation[].value
Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period

# concept[].designation[].value
Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period

# concept[].designation[].value
Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period

# concept[].designation[].value
Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period

# concept[].designation[].value
Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period

# concept[].designation[].value
Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period

# concept[].designation[].value
Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period

# concept[].designation[].value
Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period

# concept[].designation[].value
Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period

# concept[].designation[].value
Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason

# concept[].designation[].value
Residual score for the neck impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes

# concept[].designation[].value
Services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes

# concept[].designation[].value
Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed

# concept[].designation[].value
Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed

# concept[].designation[].value
All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project

# concept[].designation[].value
Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)

# concept[].designation[].value
Uri episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date

# concept[].designation[].value
Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)

# concept[].designation[].value
Outpatient, ed, or observation visits that result in an inpatient admission

# concept[].designation[].value
Acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation

# concept[].designation[].value
Clinician documented that patient had medical reason for not performing lower extremity neurological exam

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee

# concept[].designation[].value
Bmi not documented due to medical reason or patient refusal of height or weight measurement

# concept[].designation[].value
Patient receiving first-time biologic and/or immune response modifier therapy

# concept[].designation[].value
Documentation patient unable to communicate and informant not available

# concept[].designation[].value
Documentation caregiver is trained and certified in dementia care

# concept[].designation[].value
Patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed

# concept[].designation[].value
Patients with clinical indications for imaging of the head: head trauma

# concept[].designation[].value
Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age

# concept[].designation[].value
Patients with clinical indications for imaging of the head: abnormal neurologic exam

# concept[].designation[].value
Patients with clinical indications for imaging of the head: headache radiating to the neck

# concept[].designation[].value
Patients with clinical indications for imaging of the head: positional headaches

# concept[].designation[].value
Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age

# concept[].designation[].value
Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age)

# concept[].designation[].value
Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior

# concept[].designation[].value
Patients with clinical indications for imaging of the head: occipital headache in children

# concept[].designation[].value
Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

# concept[].designation[].value
Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user

# concept[].designation[].value
Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)

# concept[].designation[].value
Patient not screened for unhealthy alcohol use using a systematic screening method

# concept[].designation[].value
Patient identified as an unhealthy alcohol user received brief counseling

# concept[].designation[].value
Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)

# concept[].designation[].value
Patient did not receive brief counseling if identified as an unhealthy alcohol user

# concept[].designation[].value
Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)

# concept[].designation[].value
Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period

# concept[].designation[].value
Patients with pregnancy during adjuvant treatment course

# concept[].designation[].value
Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy

# concept[].designation[].value
Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)

# concept[].designation[].value
Patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy

# concept[].designation[].value
Residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)

# concept[].designation[].value
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)

# concept[].designation[].value
Initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)

# concept[].designation[].value
Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional

# concept[].designation[].value
Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

# concept[].designation[].value
Remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment

# concept[].designation[].value
Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion

# concept[].designation[].value
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion

# concept[].designation[].value
Administration and supply of tositumomab, 450 mg

# concept[].designation[].value
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)

# concept[].designation[].value
Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)

# concept[].designation[].value
Electrophysiology cardiac specialist mips specialty set

# concept[].designation[].value
Interventional radiology mips specialty set

# concept[].designation[].value
Mental/behavioral and psychiatry mips specialty set

# concept[].designation[].value
Physical therapy/occupational therapy mips specialty set

# concept[].designation[].value
Skilled nursing facility mips specialty set

# concept[].designation[].value
Speech language pathology mips specialty set

# concept[].designation[].value
Ultrasonic guidance for placement of radiation therapy fields

# concept[].designation[].value
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy

# concept[].designation[].value
Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev

# concept[].designation[].value
Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev

# concept[].designation[].value
Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev

# concept[].designation[].value
Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater

# concept[].designation[].value
Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev

# concept[].designation[].value
Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev

# concept[].designation[].value
Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev

# concept[].designation[].value
Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater

# concept[].designation[].value
Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev

# concept[].designation[].value
Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev

# concept[].designation[].value
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev

# concept[].designation[].value
Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater

# concept[].designation[].value
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session

# concept[].designation[].value
Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session

# concept[].designation[].value
Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment

# concept[].designation[].value
Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)

# concept[].designation[].value
Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

# concept[].designation[].value
Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)

# concept[].designation[].value
Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

# concept[].designation[].value
Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)

# concept[].designation[].value
Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique

# concept[].designation[].value
Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)

# concept[].designation[].value
Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed

# concept[].designation[].value
Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)

# concept[].designation[].value
Alcohol (ethanol); any specimen except breath

# concept[].designation[].value
Opiate(s), drug and metabolites, each procedure

# concept[].designation[].value
Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week)  acute treatment phase

# concept[].designation[].value
Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure

# concept[].designation[].value
Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function

# concept[].designation[].value
Left ventricular ejection fraction (lvef) not performed or documented

# concept[].designation[].value
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy

# concept[].designation[].value
Dilated macular or fundus exam not performed

# concept[].designation[].value
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed

# concept[].designation[].value
Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for screening

# concept[].designation[].value
Lower extremity neurological exam performed and documented

# concept[].designation[].value
Lower extremity neurological exam not performed

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure

# concept[].designation[].value
Footwear evaluation performed and documented

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for footwear evaluation measure

# concept[].designation[].value
Bmi is documented above normal parameters and a follow-up plan is documented

# concept[].designation[].value
Bmi is documented below normal parameters and a follow-up plan is documented

# concept[].designation[].value
Bmi documented outside normal parameters, no follow-up plan documented, no reason given

# concept[].designation[].value
Bmi is documented within normal parameters and no follow-up plan is required

# concept[].designation[].value
Bmi not documented and no reason is given

# concept[].designation[].value
Bmi not documented, documentation the patient is not eligible for bmi calculation

# concept[].designation[].value
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications

# concept[].designation[].value
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given

# concept[].designation[].value
Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an urgent or emergent medical situation)

# concept[].designation[].value
Screening for depression is documented as being positive and a follow-up plan is documented

# concept[].designation[].value
Depression screening not documented, reason not given

# concept[].designation[].value
Screening for depression not completed, documented patient or medical reason

# concept[].designation[].value
Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter

# concept[].designation[].value
Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons)

# concept[].designation[].value
Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)

# concept[].designation[].value
Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c

# concept[].designation[].value
Patient receiving antiviral treatment for hepatitis c during the measurement period

# concept[].designation[].value
Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined

# concept[].designation[].value
High or very high risk of recurrence of prostate cancer

# concept[].designation[].value
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed

# concept[].designation[].value
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons)

# concept[].designation[].value
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given

# concept[].designation[].value
Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg

# concept[].designation[].value
Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg

# concept[].designation[].value
Blood pressure measurement not performed or documented, reason not given

# concept[].designation[].value
Influenza immunization administered or previously received

# concept[].designation[].value
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

# concept[].designation[].value
Influenza immunization was not administered, reason not given

# concept[].designation[].value
I intend to report the diabetes mellitus (dm) measures group

# concept[].designation[].value
I intend to report the preventive care measures group

# concept[].designation[].value
I intend to report the chronic kidney disease (ckd) measures group

# concept[].designation[].value
I intend to report the coronary artery disease (cad) measures group

# concept[].designation[].value
I intend to report the rheumatoid arthritis (ra) measures group

# concept[].designation[].value
I intend to report the hiv/aids measures group

# concept[].designation[].value
I intend to report the perioperative care measures group

# concept[].designation[].value
I intend to report the back pain measures group

# concept[].designation[].value
All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the preventive care measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the back pain measures group have been performed for this patient

# concept[].designation[].value
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy

# concept[].designation[].value
Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given

# concept[].designation[].value
Screening for depression is documented as negative, a follow-up plan is not required

# concept[].designation[].value
Screening for depression documented as positive, follow-up plan not documented, reason not given

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for autogenous av fistula

# concept[].designation[].value
Clinician documented that patient received vascular access other than autogenous av fistula, reason not given

# concept[].designation[].value
Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter related to one of the following reasons: (1) patient refuses to participate in the screening and has reasonable decisional capacity for self-protection, or (2) patient is in an urgent or emergent situation where time is of the essence and to delay treatment to perform the screening would jeopardize the patient's health status

# concept[].designation[].value
No documentation of an elder maltreatment screen, reason not given

# concept[].designation[].value
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment

# concept[].designation[].value
Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter

# concept[].designation[].value
Functional outcome assessment using a standardized tool not documented, reason not given

# concept[].designation[].value
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required

# concept[].designation[].value
Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented within two days of assessment, reason not given

# concept[].designation[].value
I intend to report the coronary artery bypass graft (cabg) measures group

# concept[].designation[].value
I intend to report the hepatitis c measures group

# concept[].designation[].value
I intend to report the ischemic vascular disease (ivd) measures group

# concept[].designation[].value
I intend to report the heart failure (hf) measures group

# concept[].designation[].value
All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient

# concept[].designation[].value
Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation

# concept[].designation[].value
Patient has a history of active drainage from the ear within the previous 90 days

# concept[].designation[].value
Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure

# concept[].designation[].value
Patient does not have a history of active drainage from the ear within the previous 90 days

# concept[].designation[].value
Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given

# concept[].designation[].value
Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)

# concept[].designation[].value
Verification and documentation of sudden or rapidly progressive hearing loss

# concept[].designation[].value
Patient is not eligible for the "referral for otologic evaluation for sudden or rapidly progressive hearing loss" measure

# concept[].designation[].value
Patient does not have verification and documentation of sudden or rapidly progressive hearing loss

# concept[].designation[].value
Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given

# concept[].designation[].value
Prolonged postoperative intubation (> 24 hrs) required

# concept[].designation[].value
Prolonged postoperative intubation (> 24 hrs) not required

# concept[].designation[].value
Development of deep sternal wound infection/mediastinitis within 30 days postoperatively

# concept[].designation[].value
No deep sternal wound infection/mediastinitis

# concept[].designation[].value
No stroke following isolated cabg surgery

# concept[].designation[].value
Developed postoperative renal failure or required dialysis

# concept[].designation[].value
No postoperative renal failure/dialysis not required

# concept[].designation[].value
Re-exploration required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason

# concept[].designation[].value
Re-exploration not required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason

# concept[].designation[].value
Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)

# concept[].designation[].value
Lipid profile not performed, reason not given

# concept[].designation[].value
Aspirin or another antiplatelet therapy used

# concept[].designation[].value
Aspirin or another antiplatelet therapy not used, reason not given

# concept[].designation[].value
Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time last known well

# concept[].designation[].value
Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for stroke, patient admitted for elective carotid intervention)

# concept[].designation[].value
Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well, reason not given

# concept[].designation[].value
Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)

# concept[].designation[].value
Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)

# concept[].designation[].value
Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)

# concept[].designation[].value
Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)

# concept[].designation[].value
Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given

# concept[].designation[].value
Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

# concept[].designation[].value
Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis

# concept[].designation[].value
Pharmacologic therapy for osteoporosis was not prescribed, reason not given

# concept[].designation[].value
I intend to report the asthma measures group

# concept[].designation[].value
All quality actions for the applicable measures in the asthma measures group have been performed for this patient

# concept[].designation[].value
Residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
Residual score for the knee impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Residual score for the knee impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
Residual score for the hip impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Residual score for the hip impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0)

# concept[].designation[].value
Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
Residual score for the low back impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
Residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
Residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0)

# concept[].designation[].value
Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate

# concept[].designation[].value
Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not given

# concept[].designation[].value
Lvf testing documented as being performed prior to discharge or in the previous 12 months

# concept[].designation[].value
Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason

# concept[].designation[].value
Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given

# concept[].designation[].value
Current or prior left ventricular ejection fraction (lvef) < = 40% or documentation of moderate or severe lvsd

# concept[].designation[].value
Antithrombotic therapy prescribed at discharge

# concept[].designation[].value
Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))

# concept[].designation[].value
Antithrombotic therapy was not prescribed at discharge, reason not given

# concept[].designation[].value
Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge

# concept[].designation[].value
Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge

# concept[].designation[].value
Rehabilitation services were not ordered, reason not otherwise specified

# concept[].designation[].value
Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively

# concept[].designation[].value
Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively

# concept[].designation[].value
Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)

# concept[].designation[].value
Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)

# concept[].designation[].value
12-lead electrocardiogram (ecg) not performed, reason not given

# concept[].designation[].value
Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)

# concept[].designation[].value
Prescribed antibiotic on or within 3 days after the episode date

# concept[].designation[].value
Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])

# concept[].designation[].value
Hemodialysis treatment performed exactly three times per week for > 90 days

# concept[].designation[].value
Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given

# concept[].designation[].value
Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])

# concept[].designation[].value
Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])

# concept[].designation[].value
Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report

# concept[].designation[].value
Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)

# concept[].designation[].value
Specimen site is other than anatomic location of primary tumor

# concept[].designation[].value
Pt category, pn category and histologic grade were not documented in the pathology report, reason not given

# concept[].designation[].value
Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)

# concept[].designation[].value
Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)

# concept[].designation[].value
Fasting lipid profile not performed, reason not given

# concept[].designation[].value
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented

# concept[].designation[].value
Pain assessment using a standardized tool is documented as negative, no follow-up plan required

# concept[].designation[].value
No documentation of pain assessment, reason not given

# concept[].designation[].value
Elder maltreatment screen documented as positive and a follow-up plan is documented

# concept[].designation[].value
Elder maltreatment screen documented as negative, follow-up is not required

# concept[].designation[].value
Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given

# concept[].designation[].value
Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function

# concept[].designation[].value
Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function

# concept[].designation[].value
Left ventricular ejection fraction (lvef) not performed or assessed, reason not given

# concept[].designation[].value
Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)

# concept[].designation[].value
Smoking status and exposure to second hand smoke in the home not assessed, reason not given

# concept[].designation[].value
Most recent systolic blood pressure < 140 mmhg

# concept[].designation[].value
Most recent systolic blood pressure >= 140 mmhg

# concept[].designation[].value
Most recent diastolic blood pressure < 90 mmhg

# concept[].designation[].value
Most recent diastolic blood pressure >= 90 mmhg

# concept[].designation[].value
No documentation of blood pressure measurement, reason not given

# concept[].designation[].value
All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the dementia measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the cataract measures group have been performed for this patient

# concept[].designation[].value
Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)

# concept[].designation[].value
Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Lipid profile not performed, reason not given

# concept[].designation[].value
Urine protein test result documented and reviewed

# concept[].designation[].value
Documentation of diagnosis of chronic kidney disease

# concept[].designation[].value
Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)

# concept[].designation[].value
Urine protein test was not performed, reason not given

# concept[].designation[].value
Serum creatinine test result documented and reviewed

# concept[].designation[].value
Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Serum creatinine test not performed, reason not given

# concept[].designation[].value
Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Diabetes screening test not performed, reason not given

# concept[].designation[].value
Counseling for diet and physical activity performed

# concept[].designation[].value
Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Counseling for diet and physical activity not performed, reason not given

# concept[].designation[].value
Normal blood pressure reading documented, follow-up not required

# concept[].designation[].value
Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)

# concept[].designation[].value
Blood pressure reading not documented, reason not given

# concept[].designation[].value
Specimen site other than anatomic location of esophagus

# concept[].designation[].value
Specimen site other than anatomic location of prostate

# concept[].designation[].value
Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented

# concept[].designation[].value
Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has a documented intrauterine pregnancy [iup])

# concept[].designation[].value
Trans-abdominal or trans-vaginal ultrasound not performed, reason not given

# concept[].designation[].value
Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)

# concept[].designation[].value
Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given

# concept[].designation[].value
Documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)

# concept[].designation[].value
Statin medication prescribed at discharge

# concept[].designation[].value
Statin therapy not prescribed at discharge, reason not given

# concept[].designation[].value
Patient discharge to home no later than post-operative day #7

# concept[].designation[].value
Patient not discharged to home by post-operative day #7

# concept[].designation[].value
Patient discharged to home no later than post-operative day #2 following evar

# concept[].designation[].value
Patient not discharged to home by post-operative day #2 following evar

# concept[].designation[].value
Patient discharged to home no later than post-operative day #2 following cea

# concept[].designation[].value
Patient not discharged to home by post-operative day #2 following cea

# concept[].designation[].value
Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness

# concept[].designation[].value
Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)

# concept[].designation[].value
Sleep apnea symptoms not assessed, reason not given

# concept[].designation[].value
Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea

# concept[].designation[].value
Documentation of reason(s) for not measuring an apnea hypopnea index (ahi), a respiratory disturbance index (rdi), or a respiratory event index (rei) within 2 months after initial evaluation for suspected obstructive sleep apnea (e.g., medical, neurological, or psychiatric disease that prohibits successful completion of a sleep study, patients for whom a sleep study would present a bigger risk than benefit or would pose an undue burden, dementia, patients previously diagnosed with osa and severity assessed by another provider, patients who decline ahi/rdi/rei measurement, patients who had a financial reason for not completing testing, test was ordered but not completed, patients decline because their insurance (payer) does not cover the expense)

# concept[].designation[].value
Apnea hypopnea index (ahi), respiratory disturbance index (rdi), or respiratory event index (rei) not documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea, reason not given

# concept[].designation[].value
Positive airway pressure therapy prescribed

# concept[].designation[].value
Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)

# concept[].designation[].value
Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)

# concept[].designation[].value
Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)

# concept[].designation[].value
Positive airway pressure therapy not prescribed, reason not given

# concept[].designation[].value
Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented)

# concept[].designation[].value
Positive airway pressure therapy was prescribed

# concept[].designation[].value
Positive airway pressure therapy not prescribed

# concept[].designation[].value
Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy)

# concept[].designation[].value
Adherence to therapy was not assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available), reason not given

# concept[].designation[].value
Referral to a physician for an otologic evaluation performed

# concept[].designation[].value
Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)

# concept[].designation[].value
Referral to a physician for an otologic evaluation not performed, reason not given

# concept[].designation[].value
Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

# concept[].designation[].value
Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

# concept[].designation[].value
Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

# concept[].designation[].value
Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

# concept[].designation[].value
Patients not assessed for risk of bone loss, reason not given

# concept[].designation[].value
Pneumococcal vaccine administered or previously received

# concept[].designation[].value
Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)

# concept[].designation[].value
Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)

# concept[].designation[].value
Pneumococcal vaccine not administered or previously received, reason not given

# concept[].designation[].value
Patients receiving a first course of anti-tnf therapy

# concept[].designation[].value
Patient has documented immunity to hepatitis b and initiating anti-tnf therapy

# concept[].designation[].value
Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy

# concept[].designation[].value
Patient not receiving a first course of anti-tnf therapy

# concept[].designation[].value
Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion

# concept[].designation[].value
Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)

# concept[].designation[].value
Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion

# concept[].designation[].value
Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method

# concept[].designation[].value
Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)

# concept[].designation[].value
Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given

# concept[].designation[].value
Sentinel lymph node biopsy procedure performed

# concept[].designation[].value
Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer

# concept[].designation[].value
Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)

# concept[].designation[].value
Stage of breast cancer is greater than t1n0m0 or t2n0m0

# concept[].designation[].value
Sentinel lymph node biopsy procedure not performed, reason not given

# concept[].designation[].value
Biopsy results reviewed, communicated, tracked and documented

# concept[].designation[].value
Clinician documented reason that patient's biopsy results were not reviewed

# concept[].designation[].value
Biopsy results not reviewed, communicated, tracked or documented

# concept[].designation[].value
Most recent blood pressure under control

# concept[].designation[].value
Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Most recent blood pressure not under control, results documented and reviewed

# concept[].designation[].value
No documentation of blood pressure measurement, reason not given

# concept[].designation[].value
Most recent ldl-c under control, results documented and reviewed

# concept[].designation[].value
Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)

# concept[].designation[].value
Most recent ldl-c not under control, results documented and reviewed

# concept[].designation[].value
Oral aspirin or other antithrombotic therapy prescribed

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)

# concept[].designation[].value
Oral aspirin or other antithrombotic therapy was not prescribed, reason not given

# concept[].designation[].value
I intend to report the chronic obstructive pulmonary disease (copd) measures group

# concept[].designation[].value
I intend to report the inflammatory bowel disease (ibd) measures group

# concept[].designation[].value
I intend to report the sleep apnea measures group

# concept[].designation[].value
I intend to report the dementia measures group

# concept[].designation[].value
I intend to report the parkinson's disease measures group

# concept[].designation[].value
I intend to report the hypertension (htn) measures group

# concept[].designation[].value
I intend to report the cardiovascular prevention measures group

# concept[].designation[].value
I intend to report the cataract measures group

# concept[].designation[].value
Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility

# concept[].designation[].value
Patient documented to have received a burn prior to discharge

# concept[].designation[].value
Patient documented not to have received a burn prior to discharge

# concept[].designation[].value
Patient documented to have experienced a fall within asc

# concept[].designation[].value
Patient documented not to have experienced a fall within ambulatory surgical center

# concept[].designation[].value
Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event

# concept[].designation[].value
Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event

# concept[].designation[].value
Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc

# concept[].designation[].value
Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc

# concept[].designation[].value
Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time

# concept[].designation[].value
Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time

# concept[].designation[].value
Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis

# concept[].designation[].value
Current or prior left ventricular ejection fraction (lvef) <= 40% or documentation of moderately or severely depressed left ventricular systolic function

# concept[].designation[].value
Spirometry results documented (fev1/fvc < 70%)

# concept[].designation[].value
Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms

# concept[].designation[].value
Spirometry test not performed or documented, reason not given

# concept[].designation[].value
Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer

# concept[].designation[].value
Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)

# concept[].designation[].value
Adjuvant chemotherapy not prescribed or previously received, reason not given

# concept[].designation[].value
Assessment of depression severity at the initial evaluation

# concept[].designation[].value
Assessment of depression severity not documented, reason not given

# concept[].designation[].value
Suicide risk assessed at the initial evaluation

# concept[].designation[].value
Suicide risk not assessed at the initial evaluation, reason not given

# concept[].designation[].value
Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic function

# concept[].designation[].value
Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy

# concept[].designation[].value
Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons)

# concept[].designation[].value
Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given

# concept[].designation[].value
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible

# concept[].designation[].value
Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter

# concept[].designation[].value
Screening for depression documented as positive, a follow-up plan not completed, documented reason

# concept[].designation[].value
Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter

# concept[].designation[].value
Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment

# concept[].designation[].value
Ldl-c result not present or not within 12 months prior

# concept[].designation[].value
Ajcc melanoma cancer stage 0 through iic melanoma

# concept[].designation[].value
Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)

# concept[].designation[].value
Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)

# concept[].designation[].value
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented

# concept[].designation[].value
Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible

# concept[].designation[].value
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given

# concept[].designation[].value
All quality actions for the applicable measures in the oncology measures group have been performed for this patient

# concept[].designation[].value
Most recent assessment of adequacy of volume management documented

# concept[].designation[].value
Patient receiving maintenance hemodialysis in an outpatient dialysis facility

# concept[].designation[].value
Patient not receiving maintenance hemodialysis in an outpatient dialysis facility

# concept[].designation[].value
Assessment of adequacy of volume management not documented, reason not given

# concept[].designation[].value
Clinician treating major depressive disorder communicates to clinician treating comorbid condition

# concept[].designation[].value
Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given

# concept[].designation[].value
Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery

# concept[].designation[].value
Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery

# concept[].designation[].value
Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years

# concept[].designation[].value
Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)

# concept[].designation[].value
Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment

# concept[].designation[].value
Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment

# concept[].designation[].value
Fda approved oral anticoagulant is prescribed

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment)

# concept[].designation[].value
Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)

# concept[].designation[].value
No risk factors or one moderate risk factor for thromboembolism

# concept[].designation[].value
Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given

# concept[].designation[].value
One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism

# concept[].designation[].value
Most recent hemoglobin (hgb) level < 10 g/dl

# concept[].designation[].value
Hemoglobin level measurement not documented, reason not given

# concept[].designation[].value
Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)

# concept[].designation[].value
Most recent hemoglobin (hgb) level >= 10 g/dl

# concept[].designation[].value
I intend to report the oncology measures group

# concept[].designation[].value
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals

# concept[].designation[].value
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals

# concept[].designation[].value
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals

# concept[].designation[].value
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Self care functional limitation, current status, at therapy episode outset and at reporting intervals

# concept[].designation[].value
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Self care functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals

# concept[].designation[].value
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals

# concept[].designation[].value
Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Motor speech functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Coordinated care fee, risk adjusted high, initial

# concept[].designation[].value
Coordinated care fee, risk adjusted low, initial

# concept[].designation[].value
Coordinated care fee, risk adjusted maintenance

# concept[].designation[].value
Coordinated care fee, scheduled team conference

# concept[].designation[].value
Coordinated care fee, physician coordinated care oversight services

# concept[].designation[].value
Coordinated care fee, risk adjusted maintenance, level 3

# concept[].designation[].value
Coordinated care fee, risk adjusted maintenance, level 4

# concept[].designation[].value
Coordinated care fee, risk adjusted maintenance, level 5

# concept[].designation[].value
Other specified case management service not elsewhere classified

# concept[].designation[].value
Esrd demo expanded bundle including venous access and related services

# concept[].designation[].value
Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]

# concept[].designation[].value
Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutes

# concept[].designation[].value
Co-management services with the following elements: new diagnosis or acute exacerbation and stabilization of existing condition; condition which may benefit from joint care planning; condition for which specialist is taking a co-management role; condition expected to last at least 3 months; comprehensive care plan established, implemented, revised or monitored in partnership with co-managing clinicians; ongoing communication and care coordination between co-managing clinicians furnishing care

# concept[].designation[].value
Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)

# concept[].designation[].value
Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours

# concept[].designation[].value
Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

# concept[].designation[].value
Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration

# concept[].designation[].value
National committee for quality assurance - level 1 medical home

# concept[].designation[].value
National committee for quality assurance - level 2 medical home

# concept[].designation[].value
National committee for quality assurance - level 3 medical home

# concept[].designation[].value
Mapcp demonstration - state provided services

# concept[].designation[].value
Mapcp demonstration - community health teams

# concept[].designation[].value
Mapcp demonstration - physician incentive pool

# concept[].designation[].value
Evaluation for wheelchair requiring face to face visit with physician

# concept[].designation[].value
Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

# concept[].designation[].value
Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

# concept[].designation[].value
Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

# concept[].designation[].value
Attention functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Attention functional limitation, discharge status at discharge from therapy or to end reporting

# concept[].designation[].value
Memory functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Memory functional limitation, discharge status at discharge from therapy or to end reporting

# concept[].designation[].value
Voice functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Voice functional limitation, discharge status at discharge from therapy or to end reporting

# concept[].designation[].value
Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

# concept[].designation[].value
Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

# concept[].designation[].value
Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

# concept[].designation[].value
Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code

# concept[].designation[].value
Beta-blocker therapy not prescribed, reason not given

# concept[].designation[].value
Beta-blocker therapy prescribed or currently being taken

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

# concept[].designation[].value
Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

# concept[].designation[].value
Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

# concept[].designation[].value
Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression

# concept[].designation[].value
Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase

# concept[].designation[].value
Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase

# concept[].designation[].value
Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))

# concept[].designation[].value
Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

# concept[].designation[].value
Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

# concept[].designation[].value
Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))

# concept[].designation[].value
Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given

# concept[].designation[].value
Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission

# concept[].designation[].value
Patients with a positive hepatitis c antibody test

# concept[].designation[].value
Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

# concept[].designation[].value
Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

# concept[].designation[].value
Patient starting antiviral treatmentfor hepatitis c during the measurement period

# concept[].designation[].value
Patient starting antiviral treatment for hepatitis c during the measurement period

# concept[].designation[].value
Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

# concept[].designation[].value
Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

# concept[].designation[].value
Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

# concept[].designation[].value
Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)

# concept[].designation[].value
Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

# concept[].designation[].value
Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

# concept[].designation[].value
Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

# concept[].designation[].value
Cd4+ cell count or cd4+ cell percentage results documented

# concept[].designation[].value
Cd4+ cell count or percentage not documented as performed, reason not given

# concept[].designation[].value
Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given

# concept[].designation[].value
Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

# concept[].designation[].value
Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given

# concept[].designation[].value
Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)

# concept[].designation[].value
Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)

# concept[].designation[].value
Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

# concept[].designation[].value
Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

# concept[].designation[].value
Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)

# concept[].designation[].value
Foot exam was not performed, reason not given

# concept[].designation[].value
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)

# concept[].designation[].value
Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter

# concept[].designation[].value
Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

# concept[].designation[].value
Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)

# concept[].designation[].value
Chlamydia, gonorrhea, and syphilis not screened, reason not given

# concept[].designation[].value
Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period

# concept[].designation[].value
Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)

# concept[].designation[].value
All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

# concept[].designation[].value
I intend to report the total knee replacement measures group

# concept[].designation[].value
All quality actions for the applicable measures in the general surgery measures group have been performed for this patient

# concept[].designation[].value
All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

# concept[].designation[].value
I intend to report the general surgery measures group

# concept[].designation[].value
I intend to report the optimizing patient exposure to ionizing radiation measures group

# concept[].designation[].value
Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)

# concept[].designation[].value
Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

# concept[].designation[].value
Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

# concept[].designation[].value
Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

# concept[].designation[].value
Documentation of viral load less than 200 copies/ml

# concept[].designation[].value
Patient did not have two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart

# concept[].designation[].value
Patient had two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart

# concept[].designation[].value
Patient did not have a medical visit in the last 6 months

# concept[].designation[].value
Patient had a medical visit in the last 6 months

# concept[].designation[].value
Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

# concept[].designation[].value
Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

# concept[].designation[].value
Adenoma(s) or other neoplasm detected during screening colonoscopy

# concept[].designation[].value
Adenoma(s) or other neoplasm not detected during screening colonoscopy

# concept[].designation[].value
Documentation of patient discharged to home later than post-operative day 2 following cea or cas

# concept[].designation[].value
Documentation of patient discharged to home no later than post operative day 2 following cea or cas

# concept[].designation[].value
Documentation of patient death following cas

# concept[].designation[].value
Documentation of patient stroke following cas

# concept[].designation[].value
Documentation of patient stroke following cea

# concept[].designation[].value
Documentation of patient survival and absence of stroke following cas

# concept[].designation[].value
Documentation of patient death following cea

# concept[].designation[].value
Documentation of patient survival and absence of stroke following cea

# concept[].designation[].value
Documentation of patient death in the hospital following endovascular aaa repair

# concept[].designation[].value
Documentation of patient discharged alive following endovascular aaa repair

# concept[].designation[].value
Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)

# concept[].designation[].value
Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

# concept[].designation[].value
Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

# concept[].designation[].value
Documentation of patient with one or more complications or mortality within 30 days

# concept[].designation[].value
Documentation of patient with one or more complications within 90 days

# concept[].designation[].value
Documentation of patient without one or more complications and without mortality within 30 days

# concept[].designation[].value
Documentation of patient without one or more complications within 90 days

# concept[].designation[].value
Blood pressure has a systolic value of < 140 and a diastolic value of < 90

# concept[].designation[].value
Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

# concept[].designation[].value
Documentation that patient is a current non-tobacco user

# concept[].designation[].value
Documentation that patient is a current tobacco user

# concept[].designation[].value
Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)

# concept[].designation[].value
Documentation that the patient is not on daily aspirin or anti-platelet regimen

# concept[].designation[].value
Pneumococcal screening performed and documentation of vaccination received prior to discharge

# concept[].designation[].value
Pneumococcal vaccination not administered prior to discharge, reason not specified

# concept[].designation[].value
Screening performed and documentation that vaccination not indicated/patient refusal

# concept[].designation[].value
Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)

# concept[].designation[].value
Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

# concept[].designation[].value
Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

# concept[].designation[].value
Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

# concept[].designation[].value
Antibiotic regimen prescribed within 10 days after onset of symptoms

# concept[].designation[].value
Antibiotic regimen not prescribed within 10 days after onset of symptoms

# concept[].designation[].value
Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)

# concept[].designation[].value
Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

# concept[].designation[].value
Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

# concept[].designation[].value
Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

# concept[].designation[].value
Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)

# concept[].designation[].value
Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

# concept[].designation[].value
Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

# concept[].designation[].value
Specimen site other than anatomic cutaneous location

# concept[].designation[].value
Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

# concept[].designation[].value
Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given

# concept[].designation[].value
Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)

# concept[].designation[].value
Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)

# concept[].designation[].value
Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

# concept[].designation[].value
Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

# concept[].designation[].value
Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

# concept[].designation[].value
Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given

# concept[].designation[].value
Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

# concept[].designation[].value
Intervention for presence of leak of endoluminal contents through an anastomosis not required

# concept[].designation[].value
Intervention for presence of leak of endoluminal contents through an anastomosis required

# concept[].designation[].value
No return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure

# concept[].designation[].value
Unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure

# concept[].designation[].value
No unplanned hospital readmission within 30 days of principal procedure

# concept[].designation[].value
Unplanned hospital readmission within 30 days of principal procedure

# concept[].designation[].value
Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason

# concept[].designation[].value
Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

# concept[].designation[].value
Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

# concept[].designation[].value
Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family

# concept[].designation[].value
Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed

# concept[].designation[].value
Imaging study named according to standardized nomenclature

# concept[].designation[].value
Imaging study not named according to standardized nomenclature, reason not given

# concept[].designation[].value
Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

# concept[].designation[].value
Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study

# concept[].designation[].value
Count of previous ct and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies not documented in the 12-month period prior to the current study, reason not given

# concept[].designation[].value
Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

# concept[].designation[].value
All necessary data elements not included, reason not given

# concept[].designation[].value
Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

# concept[].designation[].value
Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given

# concept[].designation[].value
Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements

# concept[].designation[].value
Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

# concept[].designation[].value
Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given

# concept[].designation[].value
Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study

# concept[].designation[].value
Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed

# concept[].designation[].value
Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given

# concept[].designation[].value
Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

# concept[].designation[].value
Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)

# concept[].designation[].value
Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors

# concept[].designation[].value
Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)

# concept[].designation[].value
Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

# concept[].designation[].value
Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons

# concept[].designation[].value
Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

# concept[].designation[].value
Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

# concept[].designation[].value
More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

# concept[].designation[].value
More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

# concept[].designation[].value
More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)

# concept[].designation[].value
One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

# concept[].designation[].value
Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation)

# concept[].designation[].value
Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation)

# concept[].designation[].value
Post-partum screenings, evaluations and education performed

# concept[].designation[].value
Post-partum screenings, evaluations and education not performed

# concept[].designation[].value
Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier

# concept[].designation[].value
No documentation of negative or managed positive tb screen

# concept[].designation[].value
Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]

# concept[].designation[].value
Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record

# concept[].designation[].value
Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record

# concept[].designation[].value
Sinusitis caused by, or presumed to be caused by, bacterial infection

# concept[].designation[].value
At least two orders for high-risk medications from the same drug class

# concept[].designation[].value
At least two orders for high-risk medications from the same drug class not ordered

# concept[].designation[].value
Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater

# concept[].designation[].value
Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater

# concept[].designation[].value
Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery

# concept[].designation[].value
Patient did not have the retina attached after 6 months following only one surgery

# concept[].designation[].value
Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month)

# concept[].designation[].value
Patient did not achieve flat retinas six months post surgery

# concept[].designation[].value
Patient offered assistance with end of life issues or existing end of life plan was reviewed or updated during the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period

# concept[].designation[].value
Patient not offered assistance with end of life issues or existing end of life plan was not reviewed or updated during the measurement period

# concept[].designation[].value
Patient received screening for hcv infection within the 12 month reporting period

# concept[].designation[].value
Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)

# concept[].designation[].value
Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

# concept[].designation[].value
Screening for hcv infection not received within the 12 month reporting period, reason not given

# concept[].designation[].value
Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

# concept[].designation[].value
No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

# concept[].designation[].value
Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit

# concept[].designation[].value
Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit

# concept[].designation[].value
Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

# concept[].designation[].value
Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period

# concept[].designation[].value
Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

# concept[].designation[].value
Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

# concept[].designation[].value
Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment

# concept[].designation[].value
Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons

# concept[].designation[].value
No documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment

# concept[].designation[].value
Patient received follow-up within 30 days after discharge

# concept[].designation[].value
Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)

# concept[].designation[].value
Patient did not receive follow-up within 30 days after discharge

# concept[].designation[].value
Patient received follow-up within 7 days after discharge

# concept[].designation[].value
Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)

# concept[].designation[].value
Patient did not receive follow-up within 7 days after discharge

# concept[].designation[].value
Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

# concept[].designation[].value
Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

# concept[].designation[].value
Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

# concept[].designation[].value
Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

# concept[].designation[].value
Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

# concept[].designation[].value
Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

# concept[].designation[].value
Patient had one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays

# concept[].designation[].value
Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays

# concept[].designation[].value
Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays

# concept[].designation[].value
Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays

# concept[].designation[].value
Primary non-small cell lung cancer lung biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as nsclc-nos with an explanation

# concept[].designation[].value
Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)

# concept[].designation[].value
Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

# concept[].designation[].value
Primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow iaslc guidance or is classified as nsclc-nos but without an explanation

# concept[].designation[].value
Primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and not nsclc-nos)

# concept[].designation[].value
Documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens)]

# concept[].designation[].value
Specimen site other than anatomic location of lung, or classified as nsclc-nos

# concept[].designation[].value
Primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma)

# concept[].designation[].value
Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

# concept[].designation[].value
Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

# concept[].designation[].value
Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors

# concept[].designation[].value
Documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies, insufficient tissue, or other documented medical reasons)

# concept[].designation[].value
Specimen site other than anatomic cutaneous location

# concept[].designation[].value
Pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors

# concept[].designation[].value
Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

# concept[].designation[].value
Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period

# concept[].designation[].value
Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

# concept[].designation[].value
Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

# concept[].designation[].value
P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

# concept[].designation[].value
P2y inhibitor not prescribed at discharge

# concept[].designation[].value
Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

# concept[].designation[].value
Patients who were born in the years 1945 to 1965

# concept[].designation[].value
History of receiving blood transfusions prior to 1992

# concept[].designation[].value
Patient received one-time screening for hcv infection

# concept[].designation[].value
Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy

# concept[].designation[].value
Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

# concept[].designation[].value
One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not given

# concept[].designation[].value
Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

# concept[].designation[].value
Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)

# concept[].designation[].value
Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period

# concept[].designation[].value
Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user

# concept[].designation[].value
Tobacco assessment or tobacco cessation intervention not performed, reason not given

# concept[].designation[].value
I intend to report the sinusitis measures group

# concept[].designation[].value
All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

# concept[].designation[].value
I intend to report the acute otitis externa (aoe) measures group

# concept[].designation[].value
All quality actions for the applicable measures in the aoe measures group have been performed for this patient

# concept[].designation[].value
Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months

# concept[].designation[].value
Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

# concept[].designation[].value
Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills

# concept[].designation[].value
Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

# concept[].designation[].value
Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

# concept[].designation[].value
Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

# concept[].designation[].value
Services performed by chaplain in the hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by dietary counselor in the hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by other counselor in the hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by volunteer in the hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by care coordinator in the hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by other qualified therapist in the hospice setting, each 15 minutes

# concept[].designation[].value
Services performed by qualified pharmacist in the hospice setting, each 15 minutes

# concept[].designation[].value
Admission to medicare care choice model program (mccm)

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history;  a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination;  straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate severity.  typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services.  (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code

# concept[].designation[].value
Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

# concept[].designation[].value
Received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery

# concept[].designation[].value
Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

# concept[].designation[].value
Radiation exposure indices documented in final report for procedure using fluoroscopy

# concept[].designation[].value
Radiation exposure indices not documented in final report for procedure using fluoroscopy, reason not given

# concept[].designation[].value
Documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)

# concept[].designation[].value
Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy

# concept[].designation[].value
Antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

# concept[].designation[].value
Biologic immune response modifier prescribed

# concept[].designation[].value
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)

# concept[].designation[].value
Documentation that the patient is not on a statin medication

# concept[].designation[].value
Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5

# concept[].designation[].value
Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve  month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5

# concept[].designation[].value
Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period

# concept[].designation[].value
Individual did not have a pdc of 0.8 or greater

# concept[].designation[].value
Patient required a return to the operating room within 90 days of surgery

# concept[].designation[].value
Patient did not require a return to the operating room within 90 days of surgery

# concept[].designation[].value
Patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

# concept[].designation[].value
Patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

# concept[].designation[].value
Documentation of active injection drug use

# concept[].designation[].value
Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

# concept[].designation[].value
Patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

# concept[].designation[].value
Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

# concept[].designation[].value
Total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

# concept[].designation[].value
Patient discontinued from hemodialysis or peritoneal dialysis

# concept[].designation[].value
Documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

# concept[].designation[].value
Patient was not referred to hospice care, reason not given

# concept[].designation[].value
Patient with minor blunt head trauma had an appropriate indication(s) for a head ct

# concept[].designation[].value
Patient presented with a minor blunt head trauma  and had a head ct ordered for trauma by an emergency care provider

# concept[].designation[].value
Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar

# concept[].designation[].value
Patient had a head ct for trauma ordered by someone other than an emergency care provider  or was ordered for a reason other than trauma

# concept[].designation[].value
Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

# concept[].designation[].value
Advanced brain imaging (cta, ct, mra or mri) was not ordered

# concept[].designation[].value
Patients with a normal neurological examination

# concept[].designation[].value
Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms)

# concept[].designation[].value
Imaging needed as part of a clinical trial; or other clinician ordered the study

# concept[].designation[].value
Advanced brain imaging (cta, ct, mra or mri) was ordered

# concept[].designation[].value
Intent for potential removal at time of placement

# concept[].designation[].value
Filter removed within 3 months of placement

# concept[].designation[].value
Documented re-assessment for the appropriateness of filter removal within 3 months of placement

# concept[].designation[].value
Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

# concept[].designation[].value
Patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

# concept[].designation[].value
Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion  less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols

# concept[].designation[].value
Final reports for imaging studies stating no  follow-up imaging is recommended

# concept[].designation[].value
Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))

# concept[].designation[].value
Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up

# concept[].designation[].value
Final reports for imaging studies without an incidentally found lesion noted

# concept[].designation[].value
Incidental thyroid nodule < 1.0 cm noted in report

# concept[].designation[].value
Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended

# concept[].designation[].value
Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))

# concept[].designation[].value
Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended

# concept[].designation[].value
Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found

# concept[].designation[].value
Patient treated with a beta-lactam antibiotic as definitive therapy

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)

# concept[].designation[].value
Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

# concept[].designation[].value
Patients prescribed opiates for longer than six weeks

# concept[].designation[].value
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy

# concept[].designation[].value
Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

# concept[].designation[].value
Index date phq-score greater than 9 documented during the twelve month denominator identification period

# concept[].designation[].value
Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

# concept[].designation[].value
Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five

# concept[].designation[].value
Patients prescribed opiates for longer than six weeks

# concept[].designation[].value
Documentation of signed opioid treatment agreement at least once during opioid therapy

# concept[].designation[].value
No documentation of signed an opioid treatment agreement at least once during opioid therapy

# concept[].designation[].value
Door to puncture time of 90 minutes or less

# concept[].designation[].value
Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment)

# concept[].designation[].value
Door to puncture time of greater than 90 minutes, no reason given

# concept[].designation[].value
Patients prescribed opiates for longer than six weeks

# concept[].designation[].value
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy

# concept[].designation[].value
Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy

# concept[].designation[].value
Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

# concept[].designation[].value
Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider

# concept[].designation[].value
Patient has documentation of ventricular shunt, brain tumor, or coagulopathy

# concept[].designation[].value
Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma

# concept[].designation[].value
Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

# concept[].designation[].value
Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

# concept[].designation[].value
Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

# concept[].designation[].value
Symptomatic aaas that required urgent/emergent (non-elective) repair

# concept[].designation[].value
Patient discharge to home no later than post-operative day #7

# concept[].designation[].value
Patient not discharged to home by post-operative day #7

# concept[].designation[].value
Patient survey score improved from baseline following treatment

# concept[].designation[].value
Patient survey score did not improve from baseline following treatment

# concept[].designation[].value
Intraoperative cystoscopy performed to evaluate for lower tract injury

# concept[].designation[].value
Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death

# concept[].designation[].value
Intraoperative cystoscopy not performed to evaluate for lower tract injury

# concept[].designation[].value
Documentation of an order for anti-platelet agents

# concept[].designation[].value
Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents

# concept[].designation[].value
Order for anti-platelet agents was not documented in the patient's record, reason not given

# concept[].designation[].value
Photodocumentation of two or more cecal landmarks to establish a complete examination

# concept[].designation[].value
Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

# concept[].designation[].value
Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination

# concept[].designation[].value
Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

# concept[].designation[].value
Preoperative assessment not documented, reason not given

# concept[].designation[].value
Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

# concept[].designation[].value
Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

# concept[].designation[].value
Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

# concept[].designation[].value
Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

# concept[].designation[].value
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

# concept[].designation[].value
Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

# concept[].designation[].value
Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user

# concept[].designation[].value
Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery

# concept[].designation[].value
Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)

# concept[].designation[].value
Patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

# concept[].designation[].value
Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days  post-surgery

# concept[].designation[].value
Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)

# concept[].designation[].value
Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

# concept[].designation[].value
Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery

# concept[].designation[].value
Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)

# concept[].designation[].value
Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

# concept[].designation[].value
Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved

# concept[].designation[].value
Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)

# concept[].designation[].value
Health-related quality of life not assessed with tool during at least two visits or quality of life score declined

# concept[].designation[].value
Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

# concept[].designation[].value
Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

# concept[].designation[].value
Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

# concept[].designation[].value
Documentation of planned hybrid or staged procedure

# concept[].designation[].value
Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

# concept[].designation[].value
Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)

# concept[].designation[].value
Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

# concept[].designation[].value
Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

# concept[].designation[].value
Patients with 90 day mrs score of 0 to 2

# concept[].designation[].value
Patients in whom mrs score could not be obtained at 90 day follow-up

# concept[].designation[].value
Patients with 90 day mrs score greater than 2

# concept[].designation[].value
Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

# concept[].designation[].value
Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

# concept[].designation[].value
Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented

# concept[].designation[].value
Patient has been treated with a systemic or biologic medication for psoriasis for at least six months

# concept[].designation[].value
Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

# concept[].designation[].value
A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

# concept[].designation[].value
Patient transferred directly from anesthetizing location to pacu or other non-icu location

# concept[].designation[].value
Transfer of care during an anesthetic or to the intensive care unit

# concept[].designation[].value
A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

# concept[].designation[].value
Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits

# concept[].designation[].value
Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)

# concept[].designation[].value
Patients greater than or equal to 86 years of age who received a  colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions

# concept[].designation[].value
Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure

# concept[].designation[].value
Any ldl-c laboratory result >= 190 mg/dl

# concept[].designation[].value
Patients who are currently statin therapy users or received an order (prescription) for statin therapy

# concept[].designation[].value
Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

# concept[].designation[].value
Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl

# concept[].designation[].value
Documentation of medical reason(s) for not currently being a statin   therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)

# concept[].designation[].value
I intend to report the multiple chronic conditions measures group

# concept[].designation[].value
All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

# concept[].designation[].value
I intend to report the diabetic retinopathy measures group

# concept[].designation[].value
All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

# concept[].designation[].value
I intend to report the cardiovascular prevention measures group

# concept[].designation[].value
Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

# concept[].designation[].value
Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period

# concept[].designation[].value
All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

# concept[].designation[].value
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services.  g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement

# concept[].designation[].value
This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary

# concept[].designation[].value
This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary

# concept[].designation[].value
This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary

# concept[].designation[].value
This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary

# concept[].designation[].value
Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project

# concept[].designation[].value
This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary

# concept[].designation[].value
Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project

# concept[].designation[].value
Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team

# concept[].designation[].value
Hospice services provided to patient any time during the measurement period

# concept[].designation[].value
Patients using hospice services any time during the measurement period

# concept[].designation[].value
Patient admitted for performance of elective carotid intervention

# concept[].designation[].value
Patient receiving hospice services any time during the measurement period

# concept[].designation[].value
Patient had hospice services any time during the measurement period

# concept[].designation[].value
Hospice services received by patient any time during the measurement period

# concept[].designation[].value
Patient use of hospice services any time during the measurement period

# concept[].designation[].value
Hospice services utilized by patient any time during the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., patient intolerance or history of side effects)

# concept[].designation[].value
Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator

# concept[].designation[].value
Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., cost of treatment or lack of insurance)

# concept[].designation[].value
Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date

# concept[].designation[].value
Ajcc breast cancer stage i: t1 mic or t1a documented

# concept[].designation[].value
Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented

# concept[].designation[].value
Low (or very low) risk of recurrence, prostate cancer

# concept[].designation[].value
Patient received hospice services any time during the measurement period

# concept[].designation[].value
Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy

# concept[].designation[].value
Hospice services used by patient any time during the measurement period

# concept[].designation[].value
Patient was provided hospice services any time during the measurement period

# concept[].designation[].value
Patients with a diagnosis or past history of total colectomy or colorectal cancer

# concept[].designation[].value
Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal   infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patient is using hospice services any time during the measurement period

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason

# concept[].designation[].value
Documentation stating the patient has had a diagnosis of bipolar disorder

# concept[].designation[].value
Hospice services for patient provided any time during the measurement period

# concept[].designation[].value
Patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair

# concept[].designation[].value
Hospice services for patient occurred any time during the measurement period

# concept[].designation[].value
Patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair

# concept[].designation[].value
Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher

# concept[].designation[].value
Hospice services for patient received any time during the measurement period

# concept[].designation[].value
Patients who had documentation of use of anticoagulant medications overlapping the measurement year

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available

# concept[].designation[].value
Hospice services given to patient any time during the measurement period

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Psychiatric symptoms not assessed, reason not otherwise specified

# concept[].designation[].value
Patient not eligible due to active diagnosis of hypertension

# concept[].designation[].value
Documented reason for not screening or recommending a follow-up for high blood pressure

# concept[].designation[].value
Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)

# concept[].designation[].value
Patient is undergoing palliative dialysis with a catheter

# concept[].designation[].value
Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant

# concept[].designation[].value
Patient is undergoing palliative dialysis with a catheter

# concept[].designation[].value
Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant

# concept[].designation[].value
Patient died at any time during the 24-month measurement period

# concept[].designation[].value
Documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of the essence)

# concept[].designation[].value
A finding of an incidental pulmonary nodule

# concept[].designation[].value
Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)

# concept[].designation[].value
Surgical procedures that included the use of silicone oil

# concept[].designation[].value
Surgical procedures that included the use of silicone oil

# concept[].designation[].value
Patient in hospice at any time during the measurement period

# concept[].designation[].value
History of preoperative posterior capsule rupture

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays

# concept[].designation[].value
Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays

# concept[].designation[].value
Patient has been treated with a systemic medication for psoriasis vulgaris

# concept[].designation[].value
Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

# concept[].designation[].value
Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment

# concept[].designation[].value
Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment

# concept[].designation[].value
Patients who utilize hospice services any time during the measurement period

# concept[].designation[].value
Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months

# concept[].designation[].value
At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time

# concept[].designation[].value
Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)

# concept[].designation[].value
At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given

# concept[].designation[].value
Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

# concept[].designation[].value
Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively  (e.g., intolerance or other medical reason)

# concept[].designation[].value
Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

# concept[].designation[].value
Patients who have a diagnosis of pregnancy at any time during the measurement period

# concept[].designation[].value
Patients who are breastfeeding at any time during the performance period

# concept[].designation[].value
Patients who have a diagnosis of rhabdomyolysis at any time during the performance period

# concept[].designation[].value
Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)

# concept[].designation[].value
History of or active diagnosis of familial hypercholesterolemia

# concept[].designation[].value
Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy

# concept[].designation[].value
Pathologists/dermatopathologists providing a second opinion on a biopsy

# concept[].designation[].value
Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist

# concept[].designation[].value
Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist

# concept[].designation[].value
Patient alive as of the last day of the measurement year

# concept[].designation[].value
Most recent bp is less than or equal to 140/90 mm hg

# concept[].designation[].value
Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits

# concept[].designation[].value
Most recent bp is greater than 140/90 mm hg, or blood pressure not documented

# concept[].designation[].value
Most recent tobacco status is tobacco free

# concept[].designation[].value
Most recent tobacco status is not tobacco free

# concept[].designation[].value
Patient is currently on a daily aspirin or other antiplatelet

# concept[].designation[].value
Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)

# concept[].designation[].value
Patient is not currently on a daily aspirin or other antiplatelet

# concept[].designation[].value
Patient is currently on a statin therapy

# concept[].designation[].value
Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period

# concept[].designation[].value
Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period

# concept[].designation[].value
Patients who are identified as having an intolerance or allergy to beta-blocker therapy

# concept[].designation[].value
Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami

# concept[].designation[].value
Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patients who received cervical cytology or an hpv test

# concept[].designation[].value
Patients who did not receive cervical cytology or an hpv test

# concept[].designation[].value
Any patients who had no asthma controller medications dispensed during the measurement year

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Patient achieved a pdc of at least 75% for their asthma controller medication

# concept[].designation[].value
Patient did not achieve a pdc of at least 75% for their asthma controller medication

# concept[].designation[].value
Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure

# concept[].designation[].value
Patient did not die within 30 days of the procedure or during the index hospitalization

# concept[].designation[].value
Death occurring during the index acute care hospitalization

# concept[].designation[].value
Death did not occur during the index acute care hospitalization

# concept[].designation[].value
Death occurring after discharge from the hospital but within 30 days post procedure

# concept[].designation[].value
Death did not occur after discharge from the hospital within 30 days post procedure

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Documentation of a chlamydia screening test with proper follow-up

# concept[].designation[].value
No documentation of a chlamydia screening test with proper follow-up

# concept[].designation[].value
Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)

# concept[].designation[].value
Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation

# concept[].designation[].value
Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation

# concept[].designation[].value
Patient transferred to practice after initiation of chemotherapy

# concept[].designation[].value
Her2-targeted therapies not administered during the initial course of treatment

# concept[].designation[].value
Her2-targeted therapies administered during the initial course of treatment

# concept[].designation[].value
Ajcc stage at breast cancer diagnosis = ii or iii

# concept[].designation[].value
Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b

# concept[].designation[].value
Patient transfer to practice after initiation of chemotherapy

# concept[].designation[].value
Patient has metastatic disease at diagnosis

# concept[].designation[].value
Trastuzumab administered within 12 months of diagnosis

# concept[].designation[].value
Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)

# concept[].designation[].value
Trastuzumab not administered within 12 months of diagnosis

# concept[].designation[].value
Patient has metastatic disease at diagnosis

# concept[].designation[].value
Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab

# concept[].designation[].value
Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab

# concept[].designation[].value
Patient has metastatic disease at diagnosis

# concept[].designation[].value
Patient did not receive anti-egfr monoclonal antibody therapy

# concept[].designation[].value
Patient received anti-egfr monoclonal antibody therapy

# concept[].designation[].value
Patient received systemic cancer-directed therapy in the last 14 days of life

# concept[].designation[].value
Patient did not receive systemic cancer-directed therapy in the last 14 days of life

# concept[].designation[].value
Patient had more than one emergency department visit in the last 30 days of life

# concept[].designation[].value
Patient had one or less emergency department visits in the last 30 days of life

# concept[].designation[].value
Patient admitted to the icu in the last 30 days of life

# concept[].designation[].value
Patient was not admitted to the icu in the last 30 days of life

# concept[].designation[].value
Patient spent less than three days in hospice care

# concept[].designation[].value
Patient spent greater than or equal to three days in hospice care

# concept[].designation[].value
Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons)

# concept[].designation[].value
Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes

# concept[].designation[].value
Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, 10-20 minutes

# concept[].designation[].value
Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more than 20 minutes

# concept[].designation[].value
First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions

# concept[].designation[].value
Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions

# concept[].designation[].value
Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12

# concept[].designation[].value
The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session

# concept[].designation[].value
The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21

# concept[].designation[].value
Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24

# concept[].designation[].value
Behavioral counseling for diabetes prevention, in-person, group, 60 minutes

# concept[].designation[].value
Behavioral counseling for diabetes prevention, distance learning, 60 minutes

# concept[].designation[].value
Maintenance 5% wl from baseline weight in months 7-12

# concept[].designation[].value
Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model.  a supplier may only receive one bridge payment per mdpp beneficiary

# concept[].designation[].value
Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em)  hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only)

# concept[].designation[].value
Documentation of patient reason(s) for not performing a dilated macular examination

# concept[].designation[].value
Dilated macular exam was not performed, reason not otherwise specified

# concept[].designation[].value
Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)

# concept[].designation[].value
Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate

# concept[].designation[].value
Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given

# concept[].designation[].value
Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed

# concept[].designation[].value
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified

# concept[].designation[].value
Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Patient screened for tobacco use and identified as a tobacco user

# concept[].designation[].value
Patient screened for tobacco use and identified as a tobacco non-user

# concept[].designation[].value
Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)

# concept[].designation[].value
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)

# concept[].designation[].value
Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)

# concept[].designation[].value
Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)

# concept[].designation[].value
Documentation of medical reason(s) for not  providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)

# concept[].designation[].value
Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant  systemic therapy

# concept[].designation[].value
Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy

# concept[].designation[].value
Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified

# concept[].designation[].value
Functional status  performed once in the last 12 months

# concept[].designation[].value
Documentation of advanced stage dementia and caregiver knowledge is limited

# concept[].designation[].value
Functional status not performed, reason not otherwise specified

# concept[].designation[].value
Screening performed and positive and provision of recommendations

# concept[].designation[].value
No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified

# concept[].designation[].value
Safety concerns screen provided and if positive then documented mitigation recommendations

# concept[].designation[].value
Safety concerns screen provided and negative

# concept[].designation[].value
Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)

# concept[].designation[].value
Safety concerns screening not provided, reason not otherwise specified

# concept[].designation[].value
Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources

# concept[].designation[].value
Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment

# concept[].designation[].value
Fda-approved anticoagulant not prescribed, reason not given

# concept[].designation[].value
Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)

# concept[].designation[].value
Patients who are receiving comfort care only

# concept[].designation[].value
Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women

# concept[].designation[].value
Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)

# concept[].designation[].value
Adenoma(s) or colorectal cancer detected during screening colonoscopy

# concept[].designation[].value
Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

# concept[].designation[].value
Adenoma(s) or colorectal cancer not detected during screening colonoscopy

# concept[].designation[].value
Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus

# concept[].designation[].value
Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period

# concept[].designation[].value
Pathologists/dermatopathologists is the same clinician who performed the biopsy

# concept[].designation[].value
Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)

# concept[].designation[].value
Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively

# concept[].designation[].value
Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy

# concept[].designation[].value
Back pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively

# concept[].designation[].value
Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year  (9 to 15 months) postoperatively

# concept[].designation[].value
Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular,  idiopathic or congenital lumbar scoliosis

# concept[].designation[].value
Back pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively

# concept[].designation[].value
Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy

# concept[].designation[].value
Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively

# concept[].designation[].value
Patient exhibits 2 or more risk factors for post-operative vomiting

# concept[].designation[].value
Cases in which an inhalational anesthetic is used only for induction

# concept[].designation[].value
Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

# concept[].designation[].value
Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)

# concept[].designation[].value
Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

# concept[].designation[].value
Documentation of medical reason(s) for prescribing systemic antimicrobials

# concept[].designation[].value
Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy

# concept[].designation[].value
Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy

# concept[].designation[].value
Patient received at least one well-child visit with a pcp during the performance period

# concept[].designation[].value
Patient did not receive at least one well-child visit with a pcp during the performance period

# concept[].designation[].value
Children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report

# concept[].designation[].value
Children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report

# concept[].designation[].value
Patient was referred to another clinician or specialist during the measurement period

# concept[].designation[].value
Clinician who referred the patient to another clinician received a report from the clinician to whom the patient was referred

# concept[].designation[].value
Clinician who referred the patient to another clinician did not receive a report from the clinician to whom the patient was referred

# concept[].designation[].value
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity

# concept[].designation[].value
Documentation of medical reason(s) for not performing a dilated macular examination

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: an expanded problem focused history;  an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting  problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a detailed history;  a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology

# concept[].designation[].value
Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary  connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code

# concept[].designation[].value
Palliative care services provided to patient any time during the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine)

# concept[].designation[].value
Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

# concept[].designation[].value
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

# concept[].designation[].value
Palliative care services used by patient any time during the measurement period

# concept[].designation[].value
Patient was provided palliative care services any time during the measurement period

# concept[].designation[].value
Patient is using palliative care services any time during the measurement period

# concept[].designation[].value
Patients who use palliative care services any time during the measurement period

# concept[].designation[].value
Documentation stating the patient has received or is currently receiving palliative or hospice care

# concept[].designation[].value
Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter

# concept[].designation[].value
Documentation of medical reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, piecemeal removal of adenomas, or sessile serrated polyps >= 20 mm in size, last colonoscopy found greater than 10 adenomas, lower gastrointestinal bleeding, or patient at high risk for colon cancer due to underlying medical history ([i.e. crohn's disease, ulcerative colitis, personal or family history of colon cancer, hereditary colorectal cancer syndromes])

# concept[].designation[].value
Documentation of system reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., unable to locate previous colonoscopy report, patient cannot provide precise date or details from previous colonoscopy, previous colonoscopy report was incomplete)

# concept[].designation[].value
Behavioral health screening to determine eligibility for admission to treatment program

# concept[].designation[].value
Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs

# concept[].designation[].value
Behavioral health counseling and therapy, per 15 minutes

# concept[].designation[].value
Alcohol and/or drug services; group counseling by a clinician

# concept[].designation[].value
Alcohol and/or drug services; case management

# concept[].designation[].value
Alcohol and/or drug services; crisis intervention (outpatient)

# concept[].designation[].value
Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)

# concept[].designation[].value
Alcohol and/or drug services; acute detoxification (hospital inpatient)

# concept[].designation[].value
Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)

# concept[].designation[].value
Alcohol and/or drug services; acute detoxification (residential addiction program inpatient)

# concept[].designation[].value
Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)

# concept[].designation[].value
Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)

# concept[].designation[].value
Alcohol and/or drug services; ambulatory detoxification

# concept[].designation[].value
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education

# concept[].designation[].value
Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting)

# concept[].designation[].value
Behavioral health; residential (hospital residential treatment program), without room and board, per diem

# concept[].designation[].value
Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem

# concept[].designation[].value
Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem

# concept[].designation[].value
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)

# concept[].designation[].value
Alcohol and/or drug training service (for staff and personnel not employed by providers)

# concept[].designation[].value
Alcohol and/or drug intervention service (planned facilitation)

# concept[].designation[].value
Behavioral health outreach service (planned approach to reach a targeted population)

# concept[].designation[].value
Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude)

# concept[].designation[].value
Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)

# concept[].designation[].value
Alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)

# concept[].designation[].value
Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law)

# concept[].designation[].value
Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment

# concept[].designation[].value
Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)

# concept[].designation[].value
Mental health assessment, by non-physician

# concept[].designation[].value
Mental health service plan development by non-physician

# concept[].designation[].value
Medication training and support, per 15 minutes

# concept[].designation[].value
Mental health partial hospitalization, treatment, less than 24 hours

# concept[].designation[].value
Community psychiatric supportive treatment, face-to-face, per 15 minutes

# concept[].designation[].value
Community psychiatric supportive treatment program, per diem

# concept[].designation[].value
Assertive community treatment, face-to-face, per 15 minutes

# concept[].designation[].value
Assertive community treatment program, per diem

# concept[].designation[].value
Foster care, child, non-therapeutic, per diem

# concept[].designation[].value
Foster care, child, non-therapeutic, per month

# concept[].designation[].value
Respite care services, not in the home, per diem

# concept[].designation[].value
Mental health services, not otherwise specified

# concept[].designation[].value
Alcohol and/or other drug abuse services, not otherwise specified

# concept[].designation[].value
Alcohol and/or other drug testing: collection and handling only, specimens other than blood

# concept[].designation[].value
Alcohol and/or drug services, brief intervention, per 15 minutes

# concept[].designation[].value
Missing and murdered indigenous persons (mmip) mental health and clinical care

# concept[].designation[].value
Historical trauma (ht) mental health and clinical care for indigenous persons

# concept[].designation[].value
Prenatal care, at-risk enhanced service; antepartum management

# concept[].designation[].value
Prenatal care, at risk enhanced service; care coordination

# concept[].designation[].value
Prenatal care, at-risk enhanced service; education

# concept[].designation[].value
Prenatal care, at-risk enhanced service; follow-up home visit

# concept[].designation[].value
Prenatal care, at-risk enhanced service package (includes h1001-h1004)

# concept[].designation[].value
Non-medical family planning education, per session

# concept[].designation[].value
Family assessment by licensed behavioral health professional for state defined purposes

# concept[].designation[].value
Comprehensive medication services, per 15 minutes

# concept[].designation[].value
Crisis intervention service, per 15 minutes

# concept[].designation[].value
Behavioral health day treatment, per hour

# concept[].designation[].value
Psychiatric health facility service, per diem

# concept[].designation[].value
Skills training and development, per 15 minutes

# concept[].designation[].value
Comprehensive community support services, per 15 minutes

# concept[].designation[].value
Comprehensive community support services, per diem

# concept[].designation[].value
Psychosocial rehabilitation services, per 15 minutes

# concept[].designation[].value
Psychosocial rehabilitation services, per diem

# concept[].designation[].value
Therapeutic behavioral services, per 15 minutes

# concept[].designation[].value
Therapeutic behavioral services, per diem

# concept[].designation[].value
Community-based wrap-around services, per 15 minutes

# concept[].designation[].value
Community-based wrap-around services, per diem

# concept[].designation[].value
Ongoing support to maintain employment, per 15 minutes

# concept[].designation[].value
Ongoing support to maintain employment, per diem

# concept[].designation[].value
Psychoeducational service, per 15 minutes

# concept[].designation[].value
Sexual offender treatment service, per 15 minutes

# concept[].designation[].value
Sexual offender treatment service, per diem

# concept[].designation[].value
Mental health clubhouse services, per 15 minutes

# concept[].designation[].value
Mental health clubhouse services, per diem

# concept[].designation[].value
Multisystemic therapy for juveniles, per 15 minutes

# concept[].designation[].value
Alcohol and/or drug abuse halfway house services, per diem

# concept[].designation[].value
Alcohol and/or other drug treatment program, per hour

# concept[].designation[].value
Alcohol and/or other drug treatment program, per diem

# concept[].designation[].value
Developmental delay prevention activities, dependent child of client, per 15 minutes

# concept[].designation[].value
Skills training and development, per diem

# concept[].designation[].value
Coordinated specialty care, team-based, for first episode psychosis, per month

# concept[].designation[].value
Coordinated specialty care, team-based, for first episode psychosis, per encounter

# concept[].designation[].value
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Injection, acetaminophen, not otherwise specified,10 mg

# concept[].designation[].value
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg

# concept[].designation[].value
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg

# concept[].designation[].value
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg

# concept[].designation[].value
Injection, acetaminophen 10 mg and ibuprofen 3 mg

# concept[].designation[].value
Injection, adenosine for therapeutic use,  6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)

# concept[].designation[].value
Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)

# concept[].designation[].value
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)

# concept[].designation[].value
Injection, adrenalin, epinephrine, 0.1 mg

# concept[].designation[].value
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg

# concept[].designation[].value
Injection, alatrofloxacin mesylate, 100 mg

# concept[].designation[].value
Injection, sodium thiosulfate (pedmark), 100 mg

# concept[].designation[].value
Injection, sodium thiosulfate (hope), 100 mg

# concept[].designation[].value
Injection, methyldopate hcl, up to 250 mg

# concept[].designation[].value
Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)

# concept[].designation[].value
Injection, avalglucosidase alfa-ngpt, 4 mg

# concept[].designation[].value
Injection, alglucosidase alfa, 10 mg, not otherwise specified

# concept[].designation[].value
Injection, alglucosidase alfa, (lumizyme), 10 mg

# concept[].designation[].value
Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg

# concept[].designation[].value
Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg

# concept[].designation[].value
Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Injection, amiodarone hydrochloride, 30 mg

# concept[].designation[].value
Injection, amiodarone hydrochloride (nexterone), 30 mg

# concept[].designation[].value
Injection, amphotericin b lipid complex, 10 mg

# concept[].designation[].value
Injection, amphotericin b cholesteryl sulfate complex, 10 mg

# concept[].designation[].value
Injection, amphotericin b liposome, 10 mg

# concept[].designation[].value
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm

# concept[].designation[].value
Injection, succinylcholine chloride, up to 20 mg

# concept[].designation[].value
Injection, apomorphine hydrochloride, 1 mg

# concept[].designation[].value
Injection, metaraminol bitartrate, per 10 mg

# concept[].designation[].value
Injection, chloroquine hydrochloride, up to 250 mg

# concept[].designation[].value
Injection, aripiprazole, intramuscular, 0.25 mg

# concept[].designation[].value
Injection, aripiprazole (abilify maintena), 1 mg

# concept[].designation[].value
Injection, aripiprazole (abilify asimtufii), 1 mg

# concept[].designation[].value
Injection, baclofen, 50 mcg for intrathecal trial

# concept[].designation[].value
Injection, benztropine mesylate, per 1 mg

# concept[].designation[].value
Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg

# concept[].designation[].value
Injection, penicillin g benzathine and penicillin g procaine, 100,000 units

# concept[].designation[].value
Injection, penicillin g benzathine, 100,000 units

# concept[].designation[].value
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine

# concept[].designation[].value
Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine

# concept[].designation[].value
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine

# concept[].designation[].value
Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine

# concept[].designation[].value
Injection, buprenorphine extended-release (brixadi), 1 mg

# concept[].designation[].value
Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy

# concept[].designation[].value
Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy

# concept[].designation[].value
Injection, buprenorphine hydrochloride, 0.1 mg

# concept[].designation[].value
Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)

# concept[].designation[].value
Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units

# concept[].designation[].value
Injection, c-1 esterase inhibitor (human), berinert, 10 units

# concept[].designation[].value
Injection, c-1 esterase inhibitor (human), cinryze, 10 units

# concept[].designation[].value
Injection, c-1 esterase inhibitor (human), (haegarda), 10 units

# concept[].designation[].value
Injection, edetate calcium disodium, up to 1000 mg

# concept[].designation[].value
Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)

# concept[].designation[].value
Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)

# concept[].designation[].value
Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)

# concept[].designation[].value
Cinacalcet, oral, 1 mg, (for esrd on dialysis)

# concept[].designation[].value
Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)

# concept[].designation[].value
Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)

# concept[].designation[].value
Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)

# concept[].designation[].value
Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)

# concept[].designation[].value
Injection, calcium gluconate (fresenius kabi), per 10 ml

# concept[].designation[].value
Injection, calcium gluconate (wg critical care), per 10 ml

# concept[].designation[].value
Injection, calcium gluconate, not otherwise specified, 10 mg

# concept[].designation[].value
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg

# concept[].designation[].value
Calcium acetate, oral, 23 mg (for esrd on dialysis)

# concept[].designation[].value
Injection, calcium glycerophosphate and calcium lactate, per 10 ml

# concept[].designation[].value
Injection, calcitonin salmon, up to 400 units

# concept[].designation[].value
Injection, leucovorin calcium, per 50 mg

# concept[].designation[].value
Injection, levoleucovorin, not otherwise specified, 0.5 mg

# concept[].designation[].value
Injection, levoleucovorin (khapzory), 0.5 mg

# concept[].designation[].value
Injection, levothyroxine sodium, not otherwise specified, 10 mcg

# concept[].designation[].value
Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg

# concept[].designation[].value
Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg

# concept[].designation[].value
Injection, bupivicaine, not otherwise specified, 0.5 mg

# concept[].designation[].value
Injection, mepivacaine hydrochloride, per 10 ml

# concept[].designation[].value
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg

# concept[].designation[].value
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg

# concept[].designation[].value
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg

# concept[].designation[].value
Injection, cefepime hydrochloride, 500 mg

# concept[].designation[].value
Injection, ceftolozane 50 mg and tazobactam 25 mg

# concept[].designation[].value
Injection, ceftriaxone sodium, per 250 mg

# concept[].designation[].value
Injection, sterile cefuroxime sodium, per 750 mg

# concept[].designation[].value
Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg

# concept[].designation[].value
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg

# concept[].designation[].value
Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg

# concept[].designation[].value
Injection, cephapirin sodium, up to 1 gm

# concept[].designation[].value
Injection, ceftazidime and avibactam, 0.5 g/0.125 g

# concept[].designation[].value
Injection, ceftizoxime sodium, per 500 mg

# concept[].designation[].value
Injection, centruroides immune f(ab)2, up to 120 milligrams

# concept[].designation[].value
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Injection, chloramphenicol sodium succinate, up to 1 gm

# concept[].designation[].value
Injection, chorionic gonadotropin, per 1,000 usp units

# concept[].designation[].value
Injection, clonidine hydrochloride, 1 mg

# concept[].designation[].value
Injection, clindamycin phosphate, 300 mg

# concept[].designation[].value
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg

# concept[].designation[].value
Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

# concept[].designation[].value
Injection, cabotegravir and rilpivirine, 2mg/3mg

# concept[].designation[].value
Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg

# concept[].designation[].value
Injection, cilastatin sodium; imipenem, per 250 mg

# concept[].designation[].value
Injection, ciprofloxacin for intravenous infusion, 200 mg

# concept[].designation[].value
Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

# concept[].designation[].value
Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

# concept[].designation[].value
Injection, colistimethate sodium, up to 150 mg

# concept[].designation[].value
Injection, collagenase, clostridium histolyticum, 0.01 mg

# concept[].designation[].value
Injection, prochlorperazine, up to 10 mg

# concept[].designation[].value
Injection, corticorelin ovine triflutate, 1 microgram

# concept[].designation[].value
Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified

# concept[].designation[].value
Injection, corticotropin, up to 40 units

# concept[].designation[].value
Injection, corticotropin (acthar gel), up to 40 units

# concept[].designation[].value
Injection, corticotropin (ani), up to 40 units

# concept[].designation[].value
Injection, cosyntropin, not otherwise specified, 0.25 mg

# concept[].designation[].value
Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram

# concept[].designation[].value
Injection, crotalidae immune f(ab')2 (equine), 120 mg

# concept[].designation[].value
Injection, cytomegalovirus immune globulin intravenous (human), per vial

# concept[].designation[].value
Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg

# concept[].designation[].value
Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg

# concept[].designation[].value
Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg

# concept[].designation[].value
Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg

# concept[].designation[].value
Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)

# concept[].designation[].value
Injection, darbepoetin alfa, 1 microgram (non-esrd use)

# concept[].designation[].value
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)

# concept[].designation[].value
Injection, argatroban, 1 mg (for non-esrd use)

# concept[].designation[].value
Injection, argatroban, 1 mg (for esrd on dialysis)

# concept[].designation[].value
Injection, epoetin alfa, (for non-esrd use), 1000 units

# concept[].designation[].value
Injection, epoetin alfa, 1000 units (for esrd on dialysis)

# concept[].designation[].value
Injection, epoetin beta, 1 microgram, (for esrd on dialysis)

# concept[].designation[].value
Injection, epoetin beta, 1 microgram, (for non esrd use)

# concept[].designation[].value
Daprodustat, oral, 1 mg, (for esrd on dialysis)

# concept[].designation[].value
Injection, peginesatide, 0.1 mg (for esrd on dialysis)

# concept[].designation[].value
Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)

# concept[].designation[].value
Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)

# concept[].designation[].value
Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg

# concept[].designation[].value
Injection, deferoxamine mesylate, 500 mg

# concept[].designation[].value
Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)

# concept[].designation[].value
Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)

# concept[].designation[].value
Injection, testosterone enanthate and estradiol valerate, up to 1 cc

# concept[].designation[].value
Vadadustat, oral, 1 mg (for esrd on dialysis)

# concept[].designation[].value
Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)

# concept[].designation[].value
Injection, brompheniramine maleate, per 10 mg

# concept[].designation[].value
Injection, depo-estradiol cypionate, up to 5 mg

# concept[].designation[].value
Injection, methylprednisolone acetate, 1 mg

# concept[].designation[].value
Injection, methylprednisolone acetate, 20 mg

# concept[].designation[].value
Injection, methylprednisolone acetate, 40 mg

# concept[].designation[].value
Injection, methylprednisolone acetate, 80 mg

# concept[].designation[].value
Injection, medroxyprogesterone acetate, 1 mg

# concept[].designation[].value
Injection, testosterone cypionate and estradiol cypionate, up to 1 ml

# concept[].designation[].value
Injection, testosterone cypionate, up to 100 mg

# concept[].designation[].value
Injection, testosterone cypionate, 1 cc, 200 mg

# concept[].designation[].value
Injection, dexamethasone 9 percent, intraocular, 1 microgram

# concept[].designation[].value
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg

# concept[].designation[].value
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml

# concept[].designation[].value
Injection, dexamethasone sodium phosphate, 1 mg

# concept[].designation[].value
Injection, dihydroergotamine mesylate, per 1 mg

# concept[].designation[].value
Injection, acetazolamide sodium, up to 500 mg

# concept[].designation[].value
Injection, digoxin immune fab (ovine), per vial

# concept[].designation[].value
Injection, dexrazoxane hydrochloride, per 250 mg

# concept[].designation[].value
Injection, diphenhydramine hcl, up to 50 mg

# concept[].designation[].value
Injection, cetirizine hydrochloride, 0.5 mg

# concept[].designation[].value
Injection, cipaglucosidase alfa-atga, 5 mg

# concept[].designation[].value
Injection, chlorothiazide sodium, per 500 mg

# concept[].designation[].value
Injection, dmso, dimethyl sulfoxide, 50%, 50 ml

# concept[].designation[].value
Injection, dobutamine hydrochloride, per 250 mg

# concept[].designation[].value
Injection, amitriptyline hcl, up to 20 mg

# concept[].designation[].value
Injection, ergonovine maleate, up to 0.2 mg

# concept[].designation[].value
Injection, erythromycin lactobionate, per 500 mg

# concept[].designation[].value
Injection, estradiol valerate, up to 10 mg

# concept[].designation[].value
Injection, estrogen conjugated, per 25 mg

# concept[].designation[].value
Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes

# concept[].designation[].value
Injection, fosaprepitant (focinvez), 1 mg

# concept[].designation[].value
Injection, etidronate disodium, per 300 mg

# concept[].designation[].value
Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram

# concept[].designation[].value
Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron

# concept[].designation[].value
Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron

# concept[].designation[].value
Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron

# concept[].designation[].value
Injection, fomivirsen sodium, intraocular, 1.65 mg

# concept[].designation[].value
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

# concept[].designation[].value
Injection, foscarnet sodium, per 1000 mg

# concept[].designation[].value
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg

# concept[].designation[].value
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, gamma globulin, intramuscular, 1 cc

# concept[].designation[].value
Injection, immune globulin (cutaquig), 100 mg

# concept[].designation[].value
Injection, immune globulin (alyglo), 500 mg

# concept[].designation[].value
Injection, immune globulin (asceniv), 500 mg

# concept[].designation[].value
Injection, immune globulin (cuvitru), 100 mg

# concept[].designation[].value
Injection, immune globulin (bivigam), 500 mg

# concept[].designation[].value
Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, immune globulin (xembify), 100 mg

# concept[].designation[].value
Injection, immune globulin (hizentra), 100 mg

# concept[].designation[].value
Injection, gamma globulin, intramuscular, over 10 cc

# concept[].designation[].value
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, immune globulin (vivaglobin), 100 mg

# concept[].designation[].value
Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg

# concept[].designation[].value
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml

# concept[].designation[].value
Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml

# concept[].designation[].value
Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg

# concept[].designation[].value
Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg

# concept[].designation[].value
Injection, garamycin, gentamicin, up to 80 mg

# concept[].designation[].value
Injection, glycopyrrolate (glyrx-pf), 0.1 mg

# concept[].designation[].value
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

# concept[].designation[].value
Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg

# concept[].designation[].value
Injection, gold sodium thiomalate, up to 50 mg

# concept[].designation[].value
Injection, golimumab, 1 mg, for intravenous use

# concept[].designation[].value
Injection, glucagon hydrochloride, per 1 mg

# concept[].designation[].value
Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg

# concept[].designation[].value
Injection, gonadorelin hydrochloride, per 100 mcg

# concept[].designation[].value
Injection, granisetron hydrochloride, 100 mcg

# concept[].designation[].value
Injection, granisetron, extended-release, 0.1 mg

# concept[].designation[].value
Injection, haloperidol decanoate, per 50 mg

# concept[].designation[].value
Injection, heparin sodium, (heparin lock flush), per 10 units

# concept[].designation[].value
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units

# concept[].designation[].value
Injection, heparin sodium, per 1000 units

# concept[].designation[].value
Injection, dalteparin sodium, per 2500 iu

# concept[].designation[].value
Injection, tetanus immune globulin, human, up to 250 units

# concept[].designation[].value
Injection, histrelin acetate, 10 micrograms

# concept[].designation[].value
Injection, hydrocortisone acetate, up to 25 mg

# concept[].designation[].value
Injection, hydrocortisone sodium phosphate, up to 50 mg

# concept[].designation[].value
Injection, hydrocortisone sodium succinate, up to 100 mg

# concept[].designation[].value
Injection, hydroxyprogesterone caproate, 1 mg

# concept[].designation[].value
Injection, hydroxyprogesterone caproate, (makena), 10 mg

# concept[].designation[].value
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg

# concept[].designation[].value
Injection, infliximab, excludes biosimilar, 10 mg

# concept[].designation[].value
Injection, infliximab-dyyb (zymfentra), 10 mg

# concept[].designation[].value
Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg

# concept[].designation[].value
Injection, droperidol and fentanyl citrate, up to 2 ml ampule

# concept[].designation[].value
Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units

# concept[].designation[].value
Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

# concept[].designation[].value
Insulin for administration through dme (i.e., insulin pump) per 50 units

# concept[].designation[].value
Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Injection, kanamycin sulfate, up to 500 mg

# concept[].designation[].value
Injection, kanamycin sulfate, up to 75 mg

# concept[].designation[].value
Injection, ketorolac tromethamine, per 15 mg

# concept[].designation[].value
Injection, cephalothin sodium, up to 1 gram

# concept[].designation[].value
Injection, labetalol hydrochloride, 5 mg

# concept[].designation[].value
Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg

# concept[].designation[].value
Injection, aripiprazole lauroxil, (aristada initio), 1 mg

# concept[].designation[].value
Injection, aripiprazole lauroxil, (aristada), 1 mg

# concept[].designation[].value
Injection, leuprolide acetate (for depot suspension), per 3.75 mg

# concept[].designation[].value
Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg

# concept[].designation[].value
Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg

# concept[].designation[].value
Injection, levorphanol tartrate, up to 2 mg

# concept[].designation[].value
Injection, hyoscyamine sulfate, up to 0.25 mg

# concept[].designation[].value
Injection, chlordiazepoxide hcl, up to 100 mg

# concept[].designation[].value
Injection, lidocaine hcl for intravenous infusion, 10 mg

# concept[].designation[].value
Injection, lidocaine hcl in 5% dextrose, 1 mg

# concept[].designation[].value
Injection, lidocaine hydrochloride, 1 mg

# concept[].designation[].value
Injection, lidocaine hcl with epinephrine, 1 mg

# concept[].designation[].value
Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg

# concept[].designation[].value
Injection, meperidine hydrochloride, per 100 mg

# concept[].designation[].value
Injection, meperidine and promethazine hcl, up to 50 mg

# concept[].designation[].value
Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg

# concept[].designation[].value
Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg

# concept[].designation[].value
Injection, meropenem and vaborbactam, 10mg/10mg (20mg)

# concept[].designation[].value
Injection, methylergonovine maleate, up to 0.2 mg

# concept[].designation[].value
Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg

# concept[].designation[].value
Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg

# concept[].designation[].value
Injection, midazolam hydrochloride, per 1 mg

# concept[].designation[].value
Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg

# concept[].designation[].value
Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg

# concept[].designation[].value
Injection, minocycline hydrochloride, 1 mg

# concept[].designation[].value
Injection, morphine sulfate, up to 10 mg

# concept[].designation[].value
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg

# concept[].designation[].value
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg

# concept[].designation[].value
Injection, morphine sulfate (preservative-free sterile solution), per 10 mg

# concept[].designation[].value
Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg

# concept[].designation[].value
Injection, nalbuphine hydrochloride, per 10 mg

# concept[].designation[].value
Injection, naloxone hydrochloride, per 1 mg

# concept[].designation[].value
Injection, naloxone hydrochloride (zimhi), 1 mg

# concept[].designation[].value
Injection, nandrolone decanoate, up to 50 mg

# concept[].designation[].value
Injection, risankizumab-rzaa, intravenous, 1 mg

# concept[].designation[].value
Injection, octreotide, depot form for intramuscular injection, 1 mg

# concept[].designation[].value
Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg

# concept[].designation[].value
Injection, olanzapine, long-acting, 1 mg

# concept[].designation[].value
Injection, orphenadrine citrate, up to 60 mg

# concept[].designation[].value
Injection, phenylephrine hcl, up to 1 ml

# concept[].designation[].value
Injection, chloroprocaine hydrochloride, per 30 ml

# concept[].designation[].value
Injection, chloroprocaine hydrochloride, per 1 mg

# concept[].designation[].value
Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg

# concept[].designation[].value
Chloroprocaine hcl ophthalmic, 3% gel, 1 mg

# concept[].designation[].value
Injection, ondansetron hydrochloride, per 1 mg

# concept[].designation[].value
Injection, oritavancin (orbactiv), 10 mg

# concept[].designation[].value
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg

# concept[].designation[].value
Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg

# concept[].designation[].value
Injection, pamidronate disodium, per 30 mg

# concept[].designation[].value
Injection, oxytetracycline hcl, up to 50 mg

# concept[].designation[].value
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg

# concept[].designation[].value
Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg

# concept[].designation[].value
Injection, pasireotide long acting, 1 mg

# concept[].designation[].value
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg

# concept[].designation[].value
Injection, pegunigalsidase alfa-iwxj, 1 mg

# concept[].designation[].value
Injection, penicillin g procaine, aqueous, up to 600,000 units

# concept[].designation[].value
Injection, pentastarch, 10% solution, 100 ml

# concept[].designation[].value
Injection, pentobarbital sodium, per 50 mg

# concept[].designation[].value
Injection, penicillin g potassium, up to 600,000 units

# concept[].designation[].value
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)

# concept[].designation[].value
Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg

# concept[].designation[].value
Injection, promethazine hcl, up to 50 mg

# concept[].designation[].value
Injection, phenobarbital sodium, up to 120 mg

# concept[].designation[].value
Injection, phenobarbital sodium (sezaby), 1 mg

# concept[].designation[].value
Injection, desmopressin acetate, per 1 mcg

# concept[].designation[].value
Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit

# concept[].designation[].value
Injection, prednisolone acetate, up to 1 ml

# concept[].designation[].value
Injection, fluphenazine decanoate, up to 25 mg

# concept[].designation[].value
Injection, oxacillin sodium, up to 250 mg

# concept[].designation[].value
Injection, neostigmine methylsulfate, up to 0.5 mg

# concept[].designation[].value
Injection, protein c concentrate, intravenous, human, 10 iu

# concept[].designation[].value
Injection, pralidoxime chloride, up to 1 gm

# concept[].designation[].value
Injection, phentolamine mesylate, up to 5 mg

# concept[].designation[].value
Injection, metoclopramide hcl, up to 10 mg

# concept[].designation[].value
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

# concept[].designation[].value
Injection, ranitidine hydrochloride, 25 mg

# concept[].designation[].value
Injection, pegcetacoplan, intravitreal, 1 mg

# concept[].designation[].value
Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml

# concept[].designation[].value
Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)

# concept[].designation[].value
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)

# concept[].designation[].value
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu

# concept[].designation[].value
Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu

# concept[].designation[].value
Injection, risperidone (risperdal consta), 0.5 mg

# concept[].designation[].value
Injection, ropivacaine hydrochloride, 1 mg

# concept[].designation[].value
Injection, risperidone, (perseris), 0.5 mg

# concept[].designation[].value
Injection, risperidone (rykindo), 0.5 mg

# concept[].designation[].value
Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms

# concept[].designation[].value
Injection, sargramostim (gm-csf), 50 mcg

# concept[].designation[].value
Injection, secretin, synthetic, human, 1 microgram

# concept[].designation[].value
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg

# concept[].designation[].value
Injection, methylprednisolone sodium succinate, 5 mg

# concept[].designation[].value
Injection, methylprednisolone sodium succinate, up to 40 mg

# concept[].designation[].value
Injection, methylprednisolone sodium succinate, up to 125 mg

# concept[].designation[].value
Injection, streptokinase, per 250,000 iu

# concept[].designation[].value
Injection, plasminogen, human-tvmh, 1 mg

# concept[].designation[].value
Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

# concept[].designation[].value
Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)

# concept[].designation[].value
Injection, terbutaline sulfate, up to 1 mg

# concept[].designation[].value
Injection, testosterone enanthate, up to 100 mg

# concept[].designation[].value
Injection, testosterone enanthate, up to 200 mg

# concept[].designation[].value
Injection, testosterone suspension, up to 50 mg

# concept[].designation[].value
Injection, testosterone undecanoate, 1 mg

# concept[].designation[].value
Injection, testosterone propionate, up to 100 mg

# concept[].designation[].value
Injection, chlorpromazine hcl, up to 50 mg

# concept[].designation[].value
Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial

# concept[].designation[].value
Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg

# concept[].designation[].value
Injection, secukinumab, intravenous, 1 mg

# concept[].designation[].value
Injection, trimethobenzamide hcl, up to 200 mg

# concept[].designation[].value
Injection, tobramycin sulfate, up to 80 mg

# concept[].designation[].value
Injection, thiethylperazine maleate, up to 10 mg

# concept[].designation[].value
Injection, triamcinolone acetonide (xipere), 1 mg

# concept[].designation[].value
Injection, triamcinolone acetonide, preservative free, 1 mg

# concept[].designation[].value
Injection, triamcinolone acetonide, not otherwise specified, 10 mg

# concept[].designation[].value
Injection, triamcinolone diacetate, per 5 mg

# concept[].designation[].value
Injection, triamcinolone hexacetonide, per 5 mg

# concept[].designation[].value
Injection, trimetrexate glucuronate, per 25 mg

# concept[].designation[].value
Injection, spectinomycin dihydrochloride, up to 2 gm

# concept[].designation[].value
Ustekinumab, for subcutaneous injection, 1 mg

# concept[].designation[].value
Ustekinumab, for intravenous injection, 1 mg

# concept[].designation[].value
Injection, iv, urokinase, 250,000 i.u. vial

# concept[].designation[].value
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg

# concept[].designation[].value
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg

# concept[].designation[].value
Injection, vedolizumab, intravenous, 1 mg

# concept[].designation[].value
Injection, velaglucerase alfa, 100 units

# concept[].designation[].value
Injection, voretigene neparvovec-rzyl, 1 billion vector genomes

# concept[].designation[].value
Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes

# concept[].designation[].value
Injection, triflupromazine hcl, up to 20 mg

# concept[].designation[].value
Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml

# concept[].designation[].value
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

# concept[].designation[].value
Injection, hydroxocobalamin, intravenous, 25 mg

# concept[].designation[].value
Injection, phytonadione (vitamin k), per 1 mg

# concept[].designation[].value
Injection, hyaluronidase, up to 150 units

# concept[].designation[].value
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)

# concept[].designation[].value
Injection, hyaluronidase, ovine, preservative free, per 1000 usp units

# concept[].designation[].value
Injection, hyaluronidase, recombinant, 1 usp unit

# concept[].designation[].value
Injection, magnesium sulfate, per 500 mg

# concept[].designation[].value
Injection, potassium chloride, per 2 meq

# concept[].designation[].value
Drug administered through a metered dose inhaler

# concept[].designation[].value
Unclassified drug or biological used for esrd on dialysis

# concept[].designation[].value
Infusion, normal saline solution , 1000 cc

# concept[].designation[].value
Infusion, normal saline solution, sterile (500 ml = 1 unit)

# concept[].designation[].value
5% dextrose/normal saline (500 ml = 1 unit)

# concept[].designation[].value
Infusion, normal saline solution, 250 cc

# concept[].designation[].value
5% dextrose in lactated ringers infusion, up to 1000 cc

# concept[].designation[].value
Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity

# concept[].designation[].value
Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

# concept[].designation[].value
Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg

# concept[].designation[].value
Injection, adamts13, recombinant-krhn, 10 iu

# concept[].designation[].value
Injection, human fibrinogen concentrate (fibryga), 1 mg

# concept[].designation[].value
Injection, human fibrinogen concentrate, not otherwise specified, 1 mg

# concept[].designation[].value
Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco

# concept[].designation[].value
Injection, factor xiii (antihemophilic factor, human), 1 i.u.

# concept[].designation[].value
Injection, factor xiii a-subunit, (recombinant), per iu

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu

# concept[].designation[].value
Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco

# concept[].designation[].value
Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.

# concept[].designation[].value
Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.

# concept[].designation[].value
Injection, von willebrand factor complex (humate-p), per iu vwf:rco

# concept[].designation[].value
Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.

# concept[].designation[].value
Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram

# concept[].designation[].value
Factor viii (antihemophilic factor, human) per i.u.

# concept[].designation[].value
Factor viii (antihemophilic factor (porcine)), per i.u.

# concept[].designation[].value
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified

# concept[].designation[].value
Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.

# concept[].designation[].value
Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified

# concept[].designation[].value
Injection, antithrombin recombinant, 50 i.u.

# concept[].designation[].value
Hemophilia clotting factor, not otherwise classified

# concept[].designation[].value
Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu

# concept[].designation[].value
Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.

# concept[].designation[].value
Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.

# concept[].designation[].value
Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu

# concept[].designation[].value
Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu

# concept[].designation[].value
Injection, factor viii fc fusion protein (recombinant), per iu

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.

# concept[].designation[].value
Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.

# concept[].designation[].value
Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram

# concept[].designation[].value
Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.

# concept[].designation[].value
Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.

# concept[].designation[].value
Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each

# concept[].designation[].value
Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each

# concept[].designation[].value
Contraceptive supply, hormone containing vaginal ring, each

# concept[].designation[].value
Contraceptive supply, hormone containing patch, each

# concept[].designation[].value
Levonorgestrel (contraceptive) implant system, including implants and supplies

# concept[].designation[].value
Etonogestrel (contraceptive) implant system, including implant and supplies

# concept[].designation[].value
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)

# concept[].designation[].value
Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram

# concept[].designation[].value
Ganciclovir, 4.5 mg, long-acting implant

# concept[].designation[].value
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

# concept[].designation[].value
Injection, dexamethasone, intravitreal implant, 0.1 mg

# concept[].designation[].value
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg

# concept[].designation[].value
Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg

# concept[].designation[].value
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

# concept[].designation[].value
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose

# concept[].designation[].value
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose

# concept[].designation[].value
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose

# concept[].designation[].value
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose

# concept[].designation[].value
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg

# concept[].designation[].value
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg

# concept[].designation[].value
Hyaluronan or derivative, visco-3, for intra-articular injection, per dose

# concept[].designation[].value
Capsaicin 8% patch, per 10 square centimeters

# concept[].designation[].value
Capsaicin 8% patch, per square centimeter

# concept[].designation[].value
Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml

# concept[].designation[].value
Instillation, ciprofloxacin otic suspension, 6 mg

# concept[].designation[].value
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg

# concept[].designation[].value
Injection, bimatoprost, intracameral implant, 1 microgram

# concept[].designation[].value
Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)

# concept[].designation[].value
Injection, travoprost, intracameral implant, 1 microgram

# concept[].designation[].value
Mometasone furoate sinus implant, 10 micrograms

# concept[].designation[].value
Mometasone furoate sinus implant, (sinuva), 10 micrograms

# concept[].designation[].value
Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg

# concept[].designation[].value
Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg

# concept[].designation[].value
Tacrolimus, immediate release, oral, 1 mg

# concept[].designation[].value
Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg

# concept[].designation[].value
Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg

# concept[].designation[].value
Prednisone, immediate release or delayed release, oral, 1 mg

# concept[].designation[].value
Mycophenolate mofetil (myhibbin), oral suspension, 100 mg

# concept[].designation[].value
Immunosuppressive drug, not otherwise classified

# concept[].designation[].value
Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

# concept[].designation[].value
Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram

# concept[].designation[].value
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms

# concept[].designation[].value
Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms

# concept[].designation[].value
Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg

# concept[].designation[].value
Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram

# concept[].designation[].value
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg

# concept[].designation[].value
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg

# concept[].designation[].value
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg

# concept[].designation[].value
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg

# concept[].designation[].value
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg

# concept[].designation[].value
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

# concept[].designation[].value
Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg

# concept[].designation[].value
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

# concept[].designation[].value
Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

# concept[].designation[].value
Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

# concept[].designation[].value
Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams

# concept[].designation[].value
Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams

# concept[].designation[].value
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram

# concept[].designation[].value
Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

# concept[].designation[].value
Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms

# concept[].designation[].value
Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram

# concept[].designation[].value
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Mannitol, administered through an inhaler, 5 mg

# concept[].designation[].value
Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams

# concept[].designation[].value
Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams

# concept[].designation[].value
Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams

# concept[].designation[].value
Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams

# concept[].designation[].value
Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg

# concept[].designation[].value
Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg

# concept[].designation[].value
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

# concept[].designation[].value
Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams

# concept[].designation[].value
Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

# concept[].designation[].value
Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

# concept[].designation[].value
Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams

# concept[].designation[].value
Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg

# concept[].designation[].value
Noc drugs, inhalation solution administered through dme

# concept[].designation[].value
Noc drugs, other than inhalation drugs, administered through dme

# concept[].designation[].value
Compounded drug, not otherwise classified

# concept[].designation[].value
Antiemetic drug, rectal/suppository, not otherwise specified

# concept[].designation[].value
Prescription drug, oral, non chemotherapeutic, nos

# concept[].designation[].value
Antiemetic drug, oral, not otherwise specified

# concept[].designation[].value
Netupitant 300 mg and palonosetron 0.5 mg, oral

# concept[].designation[].value
Prescription drug, oral, chemotherapeutic, nos

# concept[].designation[].value
Injection, doxorubicin hydrochloride, 10 mg

# concept[].designation[].value
Injection, aldesleukin, per single use vial

# concept[].designation[].value
Injection, asparaginase (erwinaze), 1,000 iu

# concept[].designation[].value
Injection, asparaginase, not otherwise specified, 10,000 units

# concept[].designation[].value
Injection, asparaginase, recombinant, (rylaze), 0.1 mg

# concept[].designation[].value
Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram

# concept[].designation[].value
Bcg live intravesical instillation, 1 mg

# concept[].designation[].value
Injection, bendamustine hydrochloride, 1 mg

# concept[].designation[].value
Injection, bendamustine hcl (bendeka), 1 mg

# concept[].designation[].value
Injection, belantamab mafodotin-blmf, 0.5 mg

# concept[].designation[].value
Injection, bortezomib, not otherwise specified, 0.1 mg

# concept[].designation[].value
Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg

# concept[].designation[].value
Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg

# concept[].designation[].value
Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg

# concept[].designation[].value
Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg

# concept[].designation[].value
Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg

# concept[].designation[].value
Injection, bendamustine hydrochloride (vivimusta), 1 mg

# concept[].designation[].value
Injection, bendamustine hydrochloride (apotex), 1 mg

# concept[].designation[].value
Injection, bendamustine hydrochloride (baxter), 1 mg

# concept[].designation[].value
Injection, cisplatin, powder or solution, 10 mg

# concept[].designation[].value
Injection, mirvetuximab soravtansine-gynx, 1 mg

# concept[].designation[].value
Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg

# concept[].designation[].value
Injection, cyclophosphamide (auromedics), 5 mg

# concept[].designation[].value
Injection, cyclophosphamide (avyxa), 5 mg

# concept[].designation[].value
Injection, cyclophosphamide (ingenus), 5 mg

# concept[].designation[].value
Injection, cyclophosphamide (sandoz), 5 mg

# concept[].designation[].value
Injection, cyclophosphamide, not otherwise specified, 5 mg

# concept[].designation[].value
Injection, cyclophosphamide (baxter), 5 mg

# concept[].designation[].value
Injection, calaspargase pegol-mknl, 10 units

# concept[].designation[].value
Injection, daratumumab, 10 mg and hyaluronidase-fihj

# concept[].designation[].value
Injection, daunorubicin citrate, liposomal formulation, 10 mg

# concept[].designation[].value
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

# concept[].designation[].value
Injection, denileukin diftitox, 300 micrograms

# concept[].designation[].value
Injection, enfortumab vedotin-ejfv, 0.25 mg

# concept[].designation[].value
Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg

# concept[].designation[].value
Injection, gemcitabine hydrochloride, (infugem), 100 mg

# concept[].designation[].value
Injection, gemcitabine hydrochloride (infugem), 200 mg

# concept[].designation[].value
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

# concept[].designation[].value
Injection, gemtuzumab ozogamicin, 0.1 mg

# concept[].designation[].value
Injection, idarubicin hydrochloride, 5 mg

# concept[].designation[].value
Injection, interferon alfacon-1, recombinant, 1 microgram

# concept[].designation[].value
Injection, interferon, alfa-2a, recombinant, 3 million units

# concept[].designation[].value
Injection, interferon, alfa-2b, recombinant, 1 million units

# concept[].designation[].value
Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu

# concept[].designation[].value
Injection, interferon, gamma 1-b, 3 million units

# concept[].designation[].value
Leuprolide acetate (for depot suspension), 7.5 mg

# concept[].designation[].value
Injection, inotuzumab ozogamicin, 0.1 mg

# concept[].designation[].value
Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg

# concept[].designation[].value
Injection, melphalan hydrochloride, not otherwise specified, 50 mg

# concept[].designation[].value
Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg

# concept[].designation[].value
Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg

# concept[].designation[].value
Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg

# concept[].designation[].value
Injection, omacetaxine mepesuccinate, 0.01 mg

# concept[].designation[].value
Injection, paclitaxel protein-bound particles, 1 mg

# concept[].designation[].value
Injection, pegaspargase, per single dose vial

# concept[].designation[].value
Mitomycin pyelocalyceal instillation, 1 mg

# concept[].designation[].value
Injection, pemetrexed (avyxa), not therapeutically equivalent to j9305, 10 mg

# concept[].designation[].value
Injection, mitoxantrone hydrochloride, per 5 mg

# concept[].designation[].value
Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg

# concept[].designation[].value
Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg

# concept[].designation[].value
Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg

# concept[].designation[].value
Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg

# concept[].designation[].value
Injection, pemetrexed, not otherwise specified, 10 mg

# concept[].designation[].value
Injection, polatuzumab vedotin-piiq, 1 mg

# concept[].designation[].value
Injection, rituximab 10 mg and hyaluronidase

# concept[].designation[].value
Injection, moxetumomab pasudotox-tdfk, 0.01 mg

# concept[].designation[].value
Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg

# concept[].designation[].value
Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg

# concept[].designation[].value
Injection, sacituzumab govitecan-hziy, 2.5 mg

# concept[].designation[].value
Injection, romidepsin, non-lyophilized, 0.1 mg

# concept[].designation[].value
Injection, romidepsin, lyophilized, 0.1 mg

# concept[].designation[].value
Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg

# concept[].designation[].value
Injection, pemetrexed ditromethamine, 10 mg

# concept[].designation[].value
Injection, pemetrexed (pemrydi rtu), 10 mg

# concept[].designation[].value
Injection, talimogene laherparepvec, per 1 million plaque forming units

# concept[].designation[].value
Injection, sirolimus protein-bound particles, 1 mg

# concept[].designation[].value
Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc

# concept[].designation[].value
Injection, ado-trastuzumab emtansine, 1 mg

# concept[].designation[].value
Injection, trastuzumab, excludes biosimilar, 10 mg

# concept[].designation[].value
Injection, trastuzumab, 10 mg and hyaluronidase-oysk

# concept[].designation[].value
Injection, valrubicin, intravesical, 200 mg

# concept[].designation[].value
Injection, fam-trastuzumab deruxtecan-nxki, 1 mg

# concept[].designation[].value
Injection, loncastuximab tesirine-lpyl, 0.075 mg

# concept[].designation[].value
Injection, efbemalenograstim alfa-vuxw, 0.5 mg

# concept[].designation[].value
Injection, vincristine sulfate liposome, 1 mg

# concept[].designation[].value
Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg

# concept[].designation[].value
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg

# concept[].designation[].value
Not otherwise classified, antineoplastic drugs

# concept[].designation[].value
Standard - weight frame motorized/power wheelchair

# concept[].designation[].value
Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking

# concept[].designation[].value
Detachable, non-adjustable height armrest, replacement only, each

# concept[].designation[].value
Detachable, adjustable height armrest, base, replacement only, each

# concept[].designation[].value
Detachable, adjustable height armrest, upper portion, replacement only, each

# concept[].designation[].value
Standard size footplate, replacement only, each

# concept[].designation[].value
Footrest, lower extension tube, replacement only, each

# concept[].designation[].value
Footrest, upper hanger bracket, replacement only, each

# concept[].designation[].value
Footrest, complete assembly, replacement only, each

# concept[].designation[].value
Elevating legrest, lower extension tube, replacement only, each

# concept[].designation[].value
Elevating legrest, upper hanger bracket, replacement only, each

# concept[].designation[].value
Cam release assembly, footrest or legrest, replacement only, each

# concept[].designation[].value
Swingaway, detachable footrests, replacement only, each

# concept[].designation[].value
Seat height less than 17" or equal to or greater than 21" for a high strength, lightweight, or ultralightweight wheelchair

# concept[].designation[].value
Rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each

# concept[].designation[].value
Rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each

# concept[].designation[].value
Front caster assembly, complete, with pneumatic tire, replacement only, each

# concept[].designation[].value
Front caster assembly, complete, with semi-pneumatic tire, replacement only, each

# concept[].designation[].value
Front caster assembly, complete, with solid tire, replacement only, each

# concept[].designation[].value
Drive belt for power wheelchair, replacement only

# concept[].designation[].value
Wheelchair component or accessory, not otherwise specified

# concept[].designation[].value
Elevating leg rests, pair (for use with capped rental wheelchair base)

# concept[].designation[].value
Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)

# concept[].designation[].value
Temporary replacement for patient owned equipment being repaired, any type

# concept[].designation[].value
Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each

# concept[].designation[].value
Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service

# concept[].designation[].value
Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system

# concept[].designation[].value
Replacement battery for external infusion pump owned by patient, silver oxide, 1.5 volt, each

# concept[].designation[].value
Replacement battery for external infusion pump owned by patient, silver oxide, 3 volt, each

# concept[].designation[].value
Replacement battery for external infusion pump owned by patient, alkaline, 1.5 volt, each

# concept[].designation[].value
Replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each

# concept[].designation[].value
Replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each

# concept[].designation[].value
Automatic external defibrillator, with integrated electrocardiogram analysis, garment type

# concept[].designation[].value
Replacement battery for automated external defibrillator, garment type only, each

# concept[].designation[].value
Replacement garment for use with automated external defibrillator, each

# concept[].designation[].value
Replacement electrodes for use with automated external defibrillator, garment type only, each

# concept[].designation[].value
Wheelchair accessory, wheelchair seat or back cushion, does not meet specific code criteria or no written coding verification from dme pdac

# concept[].designation[].value
Addition to lower extremity orthosis, removable soft interface, all components, replacement only, each

# concept[].designation[].value
Controlled dose inhalation drug delivery system

# concept[].designation[].value
Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)

# concept[].designation[].value
Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing

# concept[].designation[].value
Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes

# concept[].designation[].value
Repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes

# concept[].designation[].value
Suction pump, home model, portable, for use on wounds

# concept[].designation[].value
Absorptive wound dressing for use with suction pump, home model, portable, pad size 16 square inches or less

# concept[].designation[].value
Absorptive wound dressing for use with suction pump, home model, portable, pad size more than 16 square inches but less than or equal to 48 square inches

# concept[].designation[].value
Absorptive wound dressing for use with suction pump, home model, portable, pad size greater than 48 square inches

# concept[].designation[].value
Power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power operated vehicle, not otherwise classified

# concept[].designation[].value
Power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more

# concept[].designation[].value
Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more

# concept[].designation[].value
Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more

# concept[].designation[].value
Power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more

# concept[].designation[].value
Power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more

# concept[].designation[].value
Power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more

# concept[].designation[].value
Power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds

# concept[].designation[].value
Power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds

# concept[].designation[].value
Power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds

# concept[].designation[].value
Power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds

# concept[].designation[].value
Power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds

# concept[].designation[].value
Power wheelchair, not otherwise classified

# concept[].designation[].value
Power mobility device, not coded by dme pdac or does not meet criteria

# concept[].designation[].value
Customized durable medical equipment, other than wheelchair

# concept[].designation[].value
Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf

# concept[].designation[].value
For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each

# concept[].designation[].value
Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type

# concept[].designation[].value
Cranial electrotherapy stimulation (ces) system, any type

# concept[].designation[].value
Low frequency ultrasonic diathermy treatment device for home use

# concept[].designation[].value
Disposable collection and storage bag for breast milk, any size, any type, each

# concept[].designation[].value
Suction pump, home model, portable or stationary, electric, any type, for use with external urine management system

# concept[].designation[].value
Bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright(s), knee joints any type, with or without ankle joints any type, includes all components and accessories, motors, microprocessors, sensors

# concept[].designation[].value
Speech volume modulation system, any type, including all components and accessories

# concept[].designation[].value
Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each

# concept[].designation[].value
Activation device for intraurethral drainage device with valve, replacement only, each

# concept[].designation[].value
Charger and base station for intraurethral activation device, replacement only

# concept[].designation[].value
Enema tube, with or without adapter, any type, replacement only, each

# concept[].designation[].value
Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control

# concept[].designation[].value
Foot, adductus positioning device, adjustable

# concept[].designation[].value
Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve

# concept[].designation[].value
Monthly supplies for use of device coded at k1016

# concept[].designation[].value
External upper limb tremor stimulator of the peripheral nerves of the wrist

# concept[].designation[].value
Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist

# concept[].designation[].value
Exsufflation belt, includes all supplies and accessories

# concept[].designation[].value
Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type

# concept[].designation[].value
Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm

# concept[].designation[].value
Non-pneumatic compression controller with sequential calibrated gradient pressure

# concept[].designation[].value
Non-pneumatic sequential compression garment, full arm

# concept[].designation[].value
Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical

# concept[].designation[].value
Oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application

# concept[].designation[].value
Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply

# concept[].designation[].value
External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only

# concept[].designation[].value
Non-pneumatic sequential compression garment, full leg

# concept[].designation[].value
Non-pneumatic sequential compression garment, half leg

# concept[].designation[].value
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count

# concept[].designation[].value
Molecular diagnostic test reader, nonprescription self-administered and self-collected use, fda approved, authorized or cleared

# concept[].designation[].value
Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month

# concept[].designation[].value
Docking station for use with oral device/appliance used to reduce upper airway collapsibility

# concept[].designation[].value
Cranial cervical orthosis, congenital torticollis type, with or without soft interface material, adjustable range of motion joint, custom fabricated

# concept[].designation[].value
Cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Cervical, flexible, thermoplastic collar, molded to patient

# concept[].designation[].value
Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)

# concept[].designation[].value
Cervical, collar, molded to patient model

# concept[].designation[].value
Cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic extension, prefabricated, off-the-shelf

# concept[].designation[].value
Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars (somi, guilford, taylor types)

# concept[].designation[].value
Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars, and thoracic extension

# concept[].designation[].value
Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf

# concept[].designation[].value
Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, custom fabricated

# concept[].designation[].value
Tlso flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf

# concept[].designation[].value
Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf

# concept[].designation[].value
Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Tlso, triplanar control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, triplanar control, modular segmented spinal system, four rigid plastic shells, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf

# concept[].designation[].value
Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal, and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf

# concept[].designation[].value
Tlso, triplanar control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction to scapula, lateral strength provided by pelvic, thoracic, and lateral frame pieces, rotational strength provided by subclavicular extensions, restricts gross trunk motion in sagittal, coronal, and transverse planes, provides intracavitary pressure to reduce load on the intervertebral disks, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, triplanar control, hyperextension, rigid anterior and lateral frame extends from symphysis pubis to sternal notch with two anterior components (one pubic and one sternal), posterior and lateral pads with straps and closures, limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, triplanar control, one piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated

# concept[].designation[].value
Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated

# concept[].designation[].value
Tlso, triplanar control, two piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated

# concept[].designation[].value
Tlso, triplanar control, two piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated

# concept[].designation[].value
Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping reinforced anterior, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior extends from symphysis pubis to xiphoid, anterior opening, restricts gross trunk motion in sagittal and coronal planes, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, sagittal-coronal control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tlso, sagittal-coronal control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated

# concept[].designation[].value
Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels placed over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panels, lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated

# concept[].designation[].value
Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf

# concept[].designation[].value
Ctlso, anterior-posterior-lateral-control, molded to patient model, with interface material, (minerva type)

# concept[].designation[].value
Halo procedure, cervical halo incorporated into jacket vest

# concept[].designation[].value
Halo procedure, cervical halo incorporated into plaster body jacket

# concept[].designation[].value
Halo procedure, cervical halo incorporated into milwaukee type orthosis

# concept[].designation[].value
Addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material

# concept[].designation[].value
Addition to halo procedure, replacement liner/interface material

# concept[].designation[].value
Stocking supporter grips, prefabricated, off-the-shelf, set of four (4)

# concept[].designation[].value
Protective body sock, prefabricated, off-the-shelf, each

# concept[].designation[].value
Addition to spinal orthosis, not otherwise specified

# concept[].designation[].value
Cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of furnishing initial orthosis, including model

# concept[].designation[].value
Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Tension based scoliosis orthosis and accessory pads, includes fitting and adjustment

# concept[].designation[].value
Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis orthosis, axilla sling

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, kyphosis pad

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, kyphosis pad, floating

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, lumbar bolster pad

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, sternal pad

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, thoracic pad

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, trapezius sling

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, outrigger

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical extensions

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, lumbar sling

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather

# concept[].designation[].value
Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather, molded to patient model

# concept[].designation[].value
Addition to ctlso, scoliosis orthosis, cover for upright, each

# concept[].designation[].value
Addition to tlso, (low profile), lateral thoracic extension

# concept[].designation[].value
Addition to tlso, (low profile), anterior thoracic extension

# concept[].designation[].value
Addition to tlso, (low profile), milwaukee type superstructure

# concept[].designation[].value
Addition to tlso, (low profile), lumbar derotation pad

# concept[].designation[].value
Addition to tlso, (low profile), anterior asis pad

# concept[].designation[].value
Addition to tlso, (low profile), anterior thoracic derotation pad

# concept[].designation[].value
Addition to tlso, (low profile), abdominal pad

# concept[].designation[].value
Addition to tlso, (low profile), rib gusset (elastic), each

# concept[].designation[].value
Addition to tlso, (low profile), lateral trochanteric pad

# concept[].designation[].value
Other scoliosis procedure, body jacket molded to patient model

# concept[].designation[].value
Other scoliosis procedure, post-operative body jacket

# concept[].designation[].value
Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated

# concept[].designation[].value
Spinal orthosis, not otherwise specified

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, flexible, frejka type with cover, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an inidividual with expertise

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, flexible, (frejka cover only), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, flexible, (pavlik harness), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, semi-flexible (von rosen type), custom fabricated

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, static, pelvic band or spreader bar, thigh cuffs, custom fabricated

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, static, adjustable, (ilfled type), prefabricated, includes fitting and adjustment

# concept[].designation[].value
Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, static, plastic, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Hip orthosis, abduction control of hip joints, dynamic, pelvic control, adjustable hip motion control, thigh cuffs (rancho hip action type), custom fabricated

# concept[].designation[].value
Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hip orthosis, abduction control of hip joint, postoperative hip abduction type, custom fabricated

# concept[].designation[].value
Hip orthosis, abduction control of hip joint, postoperative hip abduction type, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction and internal rotation control, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Legg perthes orthosis, (toronto type), custom fabricated

# concept[].designation[].value
Legg perthes orthosis, (newington type), custom fabricated

# concept[].designation[].value
Legg perthes orthosis, trilateral, (tachdijan type), custom fabricated

# concept[].designation[].value
Legg perthes orthosis, (scottish rite type), custom fabricated

# concept[].designation[].value
Legg perthes orthosis, (patten bottom type), custom fabricated

# concept[].designation[].value
Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Knee orthosis, elastic with joints, prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf

# concept[].designation[].value
Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf

# concept[].designation[].value
Knee orthosis, without knee joint, rigid, custom fabricated

# concept[].designation[].value
Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated

# concept[].designation[].value
Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated

# concept[].designation[].value
Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated

# concept[].designation[].value
Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis, swedish type, prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf

# concept[].designation[].value
Knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk)

# concept[].designation[].value
Ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom fabricated

# concept[].designation[].value
Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf

# concept[].designation[].value
Ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf

# concept[].designation[].value
Ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Ankle foot orthosis, single upright with static or adjustable stop (phelps or perlstein type), custom fabricated

# concept[].designation[].value
Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Afo, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Ankle foot orthosis, plastic or other material, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction), custom fabricated

# concept[].designation[].value
Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, plastic with ankle joint, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, plastic or other material with ankle joint, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated

# concept[].designation[].value
Ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup, calf band/cuff (double bar 'bk' orthosis), custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, any material, single or double upright, stance control, automatic lock and swing phase release, any type activation, includes ankle joint, any type, custom fabricated

# concept[].designation[].value
Knee ankle foot device, any material, single or double upright, swing and stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), without knee joint, custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs (double bar 'ak' orthosis), custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs, (double bar 'ak' orthosis), without knee joint, custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, full plastic, static (pediatric size), without free motion ankle, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Knee ankle foot orthosis, full plastic, double upright, with or without free motion knee, with or without free motion ankle, custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, with or without free motion ankle, custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, full plastic, with or without free motion knee, multi-axis ankle, custom fabricated

# concept[].designation[].value
Hip knee ankle foot orthosis, torsion control, bilateral rotation straps, pelvic band/belt, custom fabricated

# concept[].designation[].value
Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip joint, pelvic band/belt, custom fabricated

# concept[].designation[].value
Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball bearing hip joint, pelvic band/ belt, custom fabricated

# concept[].designation[].value
Hip knee ankle foot orthosis, torsion control, unilateral rotation straps, pelvic band/belt, custom fabricated

# concept[].designation[].value
Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip joint, pelvic band/belt, custom fabricated

# concept[].designation[].value
Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball bearing hip joint, pelvic band/ belt, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, thermoplastic type casting material, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom fabricated

# concept[].designation[].value
Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, thermoplastic type casting material, custom fabricated

# concept[].designation[].value
Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, custom fabricated

# concept[].designation[].value
Kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Addition to lower extremity fracture orthosis, plastic shoe insert with ankle joints

# concept[].designation[].value
Addition to lower extremity fracture orthosis, drop lock knee joint

# concept[].designation[].value
Addition to lower extremity fracture orthosis, limited motion knee joint

# concept[].designation[].value
Addition to lower extremity fracture orthosis, adjustable motion knee joint, lerman type

# concept[].designation[].value
Addition to lower extremity fracture orthosis, quadrilateral brim

# concept[].designation[].value
Addition to lower extremity fracture orthosis, waist belt

# concept[].designation[].value
Addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh flange, and pelvic belt

# concept[].designation[].value
Addition to lower extremity, limited ankle motion, each joint

# concept[].designation[].value
Addition to lower extremity, dorsiflexion assist (plantar flexion resist), each joint

# concept[].designation[].value
Addition to lower extremity, dorsiflexion and plantar flexion assist/resist, each joint

# concept[].designation[].value
Addition to lower extremity, split flat caliper stirrups and plate attachment

# concept[].designation[].value
Addition to lower extremity orthosis, rocker bottom for total contact ankle foot orthosis, for custom fabricated orthosis only

# concept[].designation[].value
Addition to lower extremity, round caliper and plate attachment

# concept[].designation[].value
Addition to lower extremity, foot plate, molded to patient model, stirrup attachment

# concept[].designation[].value
Addition to lower extremity, reinforced solid stirrup (scott-craig type)

# concept[].designation[].value
Addition to lower extremity, long tongue stirrup

# concept[].designation[].value
Addition to lower extremity, varus/valgus correction ('t') strap, padded/lined or malleolus pad

# concept[].designation[].value
Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined

# concept[].designation[].value
Addition to lower extremity, molded inner boot

# concept[].designation[].value
Addition to lower extremity, abduction bar (bilateral hip involvement), jointed, adjustable

# concept[].designation[].value
Addition to lower extremity, abduction bar-straight

# concept[].designation[].value
Addition to lower extremity, non-molded lacer, for custom fabricated orthosis only

# concept[].designation[].value
Addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only

# concept[].designation[].value
Addition to lower extremity, anterior swing band

# concept[].designation[].value
Addition to lower extremity, pre-tibial shell, molded to patient model

# concept[].designation[].value
Addition to lower extremity, prosthetic type, (bk) socket, molded to patient model, (used for 'ptb' 'afo' orthoses)

# concept[].designation[].value
Addition to lower extremity, extended steel shank

# concept[].designation[].value
Addition to lower extremity, patten bottom

# concept[].designation[].value
Addition to lower extremity, torsion control, ankle joint and half solid stirrup

# concept[].designation[].value
Addition to lower extremity, torsion control, straight knee joint, each joint

# concept[].designation[].value
Addition to lower extremity, straight knee joint, heavy duty, each joint

# concept[].designation[].value
Addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint

# concept[].designation[].value
Addition to lower extremity, offset knee joint, each joint

# concept[].designation[].value
Addition to lower extremity, offset knee joint, heavy duty, each joint

# concept[].designation[].value
Addition to lower extremity orthosis, suspension sleeve

# concept[].designation[].value
Addition to knee lock with integrated release mechanism (bail, cable, or equal), any material, each joint

# concept[].designation[].value
Addition to knee joint, disc or dial lock for adjustable knee flexion, each joint

# concept[].designation[].value
Addition to knee joint, ratchet lock for active and progressive knee extension, each joint

# concept[].designation[].value
Addition to knee joint, lift loop for drop lock ring

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight bearing, ring

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded to patient model

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom fitted

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim molded to patient model

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim, custom fitted

# concept[].designation[].value
Addition to lower extremity, thigh-weight bearing, lacer, non-molded

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, lacer, molded to patient model

# concept[].designation[].value
Addition to lower extremity, thigh/weight bearing, high roll cuff

# concept[].designation[].value
Addition to lower extremity, pelvic control, hip joint, clevis type two position joint, each

# concept[].designation[].value
Addition to lower extremity, pelvic control, pelvic sling

# concept[].designation[].value
Addition to lower extremity, pelvic control, hip joint, clevis type, or thrust bearing, free, each

# concept[].designation[].value
Addition to lower extremity, pelvic control, hip joint, clevis or thrust bearing, lock, each

# concept[].designation[].value
Addition to lower extremity, pelvic control, hip joint, heavy duty, each

# concept[].designation[].value
Addition to lower extremity, pelvic control, hip joint, adjustable flexion, each

# concept[].designation[].value
Addition to lower extremity, pelvic control, hip joint, adjustable flexion, extension, abduction control, each

# concept[].designation[].value
Addition to lower extremity, pelvic control, plastic, molded to patient model, reciprocating hip joint and cables

# concept[].designation[].value
Addition to lower extremity, pelvic control, metal frame, reciprocating hip joint and cables

# concept[].designation[].value
Addition to lower extremity, pelvic control, band and belt, unilateral

# concept[].designation[].value
Addition to lower extremity, pelvic control, band and belt, bilateral

# concept[].designation[].value
Addition to lower extremity, pelvic and thoracic control, gluteal pad, each

# concept[].designation[].value
Addition to lower extremity, thoracic control, thoracic band

# concept[].designation[].value
Addition to lower extremity, thoracic control, paraspinal uprights

# concept[].designation[].value
Addition to lower extremity, thoracic control, lateral support uprights

# concept[].designation[].value
Addition to lower extremity orthosis, plating chrome or nickel, per bar

# concept[].designation[].value
Addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, per segment, for custom fabricated orthosis only

# concept[].designation[].value
Addition to lower extremity orthosis, extension, per extension, per bar (for lineal adjustment for growth)

# concept[].designation[].value
Orthotic side bar disconnect device, per bar

# concept[].designation[].value
Addition to lower extremity orthosis, non-corrosive finish, per bar

# concept[].designation[].value
Addition to lower extremity orthosis, drop lock retainer, each

# concept[].designation[].value
Addition to lower extremity orthosis, knee control, full kneecap

# concept[].designation[].value
Addition to lower extremity orthosis, knee control, knee cap, medial or lateral pull, for use with custom fabricated orthosis only

# concept[].designation[].value
Addition to lower extremity orthosis, knee control, condylar pad

# concept[].designation[].value
Addition to lower extremity orthosis, soft interface for molded plastic, below knee section

# concept[].designation[].value
Addition to lower extremity orthosis, soft interface for molded plastic, above knee section

# concept[].designation[].value
Addition to lower extremity orthosis, tibial length sock, fracture or equal, each

# concept[].designation[].value
Addition to lower extremity orthosis, femoral length sock, fracture or equal, each

# concept[].designation[].value
Addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each

# concept[].designation[].value
Lower extremity orthoses, not otherwise specified

# concept[].designation[].value
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each

# concept[].designation[].value
Foot, insert, removable, molded to patient model, spenco, each

# concept[].designation[].value
Foot, insert, removable, molded to patient model, plastazote or equal, each

# concept[].designation[].value
Foot, insert, removable, molded to patient model, silicone gel, each

# concept[].designation[].value
Foot, insert, removable, molded to patient model, longitudinal arch support, each

# concept[].designation[].value
Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each

# concept[].designation[].value
Foot, insert, removable, formed to patient foot, each

# concept[].designation[].value
Foot, insert/plate, removable, addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, each

# concept[].designation[].value
Foot, arch support, removable, premolded, longitudinal, each

# concept[].designation[].value
Foot, arch support, removable, premolded, metatarsal, each

# concept[].designation[].value
Foot, arch support, removable, premolded, longitudinal/ metatarsal, each

# concept[].designation[].value
Foot, arch support, non-removable attached to shoe, longitudinal, each

# concept[].designation[].value
Foot, arch support, non-removable attached to shoe, metatarsal, each

# concept[].designation[].value
Foot, arch support, non-removable attached to shoe, longitudinal/metatarsal, each

# concept[].designation[].value
Foot, abduction rotation bar, including shoes

# concept[].designation[].value
Foot, abduction rotation bar, without shoes

# concept[].designation[].value
Foot, adjustable shoe-styled positioning device

# concept[].designation[].value
Foot, adductus positioning device, adjustable

# concept[].designation[].value
Foot, plastic, silicone or equal, heel stabilizer, prefabricated, off-the-shelf, each

# concept[].designation[].value
Orthopedic shoe, oxford with supinator or pronator, infant

# concept[].designation[].value
Orthopedic shoe, oxford with supinator or pronator, child

# concept[].designation[].value
Orthopedic shoe, oxford with supinator or pronator, junior

# concept[].designation[].value
Orthopedic shoe, hightop with supinator or pronator, infant

# concept[].designation[].value
Orthopedic shoe, hightop with supinator or pronator, child

# concept[].designation[].value
Orthopedic shoe, hightop with supinator or pronator, junior

# concept[].designation[].value
Orthopedic footwear, ladies shoe, oxford, each

# concept[].designation[].value
Orthopedic footwear, ladies shoe, depth inlay, each

# concept[].designation[].value
Orthopedic footwear, ladies shoe, hightop, depth inlay, each

# concept[].designation[].value
Orthopedic footwear, mens shoe, oxford, each

# concept[].designation[].value
Orthopedic footwear, mens shoe, depth inlay, each

# concept[].designation[].value
Orthopedic footwear, mens shoe, hightop, depth inlay, each

# concept[].designation[].value
Orthopedic footwear, woman's shoe, oxford, used as an integral part of a brace (orthosis)

# concept[].designation[].value
Orthopedic footwear, man's shoe, oxford, used as an integral part of a brace (orthosis)

# concept[].designation[].value
Orthopedic footwear, custom shoe, depth inlay, each

# concept[].designation[].value
Orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe, each

# concept[].designation[].value
Foot, shoe molded to patient model, silicone shoe, each

# concept[].designation[].value
Foot, shoe molded to patient model, plastazote (or similar), custom fabricated, each

# concept[].designation[].value
Foot, molded shoe plastazote (or similar) custom fitted, each

# concept[].designation[].value
Orthopedic footwear, additional charge for split size

# concept[].designation[].value
Lift, elevation, heel, tapered to metatarsals, per inch

# concept[].designation[].value
Lift, elevation, heel and sole, neoprene, per inch

# concept[].designation[].value
Lift, elevation, heel and sole, cork, per inch

# concept[].designation[].value
Lift, elevation, metal extension (skate)

# concept[].designation[].value
Lift, elevation, inside shoe, tapered, up to one-half inch

# concept[].designation[].value
Orthopedic shoe addition, insole, leather

# concept[].designation[].value
Orthopedic shoe addition, insole, rubber

# concept[].designation[].value
Orthopedic shoe addition, insole, felt covered with leather

# concept[].designation[].value
Orthopedic shoe addition, toe tap standard

# concept[].designation[].value
Orthopedic shoe addition, toe tap, horseshoe

# concept[].designation[].value
Orthopedic shoe addition, special extension to instep (leather with eyelets)

# concept[].designation[].value
Orthopedic shoe addition, convert instep to velcro closure

# concept[].designation[].value
Orthopedic shoe addition, convert firm shoe counter to soft counter

# concept[].designation[].value
Transfer of an orthosis from one shoe to another, caliper plate, existing

# concept[].designation[].value
Transfer of an orthosis from one shoe to another, caliper plate, new

# concept[].designation[].value
Transfer of an orthosis from one shoe to another, solid stirrup, existing

# concept[].designation[].value
Transfer of an orthosis from one shoe to another, solid stirrup, new

# concept[].designation[].value
Transfer of an orthosis from one shoe to another, dennis browne splint (riveton), both shoes

# concept[].designation[].value
Orthopedic shoe, modification, addition or transfer, not otherwise specified

# concept[].designation[].value
Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf

# concept[].designation[].value
Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf

# concept[].designation[].value
Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf

# concept[].designation[].value
Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder orthosis, abduction positioning (airplane design), thoracic component and support bar, with or without nontorsion joint/turnbuckle, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder orthosis, vest type abduction restrainer, canvas webbing type or equal, prefabricated, off-the-shelf

# concept[].designation[].value
Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf

# concept[].designation[].value
Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf

# concept[].designation[].value
Elbow orthosis, double upright with forearm/arm cuffs, free motion, custom fabricated

# concept[].designation[].value
Elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion assist, custom fabricated

# concept[].designation[].value
Elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock with active control, custom fabricated

# concept[].designation[].value
Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific  patient by an individual with expertise

# concept[].designation[].value
Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf

# concept[].designation[].value
Elbow orthosis, rigid, without joints, includes soft interface material, prefabricated, off-the-shelf

# concept[].designation[].value
Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type

# concept[].designation[].value
Addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each

# concept[].designation[].value
Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, wrist or finger driven, custom fabricated

# concept[].designation[].value
Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, cable driven, custom fabricated

# concept[].designation[].value
Wrist hand finger orthosis, external powered, electric, custom fabricated

# concept[].designation[].value
Wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf

# concept[].designation[].value
Hand finger orthosis (hfo), flexion glove with elastic finger control, prefabricated, off-the-shelf

# concept[].designation[].value
Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf

# concept[].designation[].value
Hand orthosis, metacarpal fracture orthosis, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf

# concept[].designation[].value
Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), non torsion joint/spring, extension/flexion, may include soft interface material, prefabricated, off-the-shelf

# concept[].designation[].value
Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf

# concept[].designation[].value
Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf

# concept[].designation[].value
Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Addition of joint to upper extremity orthosis, any material; per joint

# concept[].designation[].value
Shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand orthosis, abduction positioning, erb's palsey design, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment

# concept[].designation[].value
Upper extremity fracture orthosis, humeral, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments

# concept[].designation[].value
Upper extremity fracture orthosis, radius/ulnar, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Upper extremity fracture orthosis, wrist, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Addition to upper extremity orthosis, sock, fracture or equal, each

# concept[].designation[].value
Upper limb orthosis, not otherwise specified

# concept[].designation[].value
Replace girdle for spinal orthosis (ctlso or so)

# concept[].designation[].value
Replacement strap, any orthosis, includes all components, any length, any type

# concept[].designation[].value
Replace quadrilateral socket brim, molded to patient model

# concept[].designation[].value
Replace quadrilateral socket brim, custom fitted

# concept[].designation[].value
Replace molded thigh lacer, for custom fabricated orthosis only

# concept[].designation[].value
Replace non-molded thigh lacer, for custom fabricated orthosis only

# concept[].designation[].value
Replace molded calf lacer, for custom fabricated orthosis only

# concept[].designation[].value
Replace non-molded calf lacer, for custom fabricated orthosis only

# concept[].designation[].value
Replace proximal and distal upright for kafo

# concept[].designation[].value
Replace metal bands kafo, proximal thigh

# concept[].designation[].value
Replace metal bands kafo-afo, calf or distal thigh

# concept[].designation[].value
Replace leather cuff kafo, proximal thigh

# concept[].designation[].value
Replace leather cuff kafo-afo, calf or distal thigh

# concept[].designation[].value
Repair of orthotic device, labor component, per 15 minutes

# concept[].designation[].value
Repair of orthotic device, repair or replace minor parts

# concept[].designation[].value
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf

# concept[].designation[].value
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf

# concept[].designation[].value
Pneumatic full leg splint, prefabricated, off-the-shelf

# concept[].designation[].value
Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf

# concept[].designation[].value
Replacement, soft interface material, static afo

# concept[].designation[].value
Replace soft interface material, foot drop splint

# concept[].designation[].value
Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise

# concept[].designation[].value
Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf

# concept[].designation[].value
Foot drop splint, recumbent positioning device, prefabricated, off-the-shelf

# concept[].designation[].value
Ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom, anterior tibial shell, soft interface, custom arch support, plastic or other material, includes straps and closures, custom fabricated

# concept[].designation[].value
Partial foot, shoe insert with longitudinal arch, toe filler

# concept[].designation[].value
Partial foot, molded socket, ankle height, with toe filler

# concept[].designation[].value
Partial foot, molded socket, tibial tubercle height, with toe filler

# concept[].designation[].value
Ankle, symes, metal frame, molded leather socket, articulated ankle/foot

# concept[].designation[].value
Below knee, molded socket, shin, sach foot

# concept[].designation[].value
Below knee, plastic socket, joints and thigh lacer, sach foot

# concept[].designation[].value
Knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot

# concept[].designation[].value
Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, sach foot

# concept[].designation[].value
Above knee, molded socket, single axis constant friction knee, shin, sach foot

# concept[].designation[].value
Above knee, short prosthesis, no knee joint ('stubbies'), with foot blocks, no ankle joints, each

# concept[].designation[].value
Above knee, short prosthesis, no knee joint ('stubbies'), with articulated ankle/foot, dynamically aligned, each

# concept[].designation[].value
Above knee, for proximal femoral focal deficiency, constant friction knee, shin, sach foot

# concept[].designation[].value
Hip disarticulation, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot

# concept[].designation[].value
Hip disarticulation, tilt table type; molded socket, locking hip joint, single axis constant friction knee, shin, sach foot

# concept[].designation[].value
Hemipelvectomy, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot

# concept[].designation[].value
Below knee, molded socket, shin, sach foot, endoskeletal system

# concept[].designation[].value
Knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system

# concept[].designation[].value
Above knee, molded socket, open end, sach foot, endoskeletal system, single axis knee

# concept[].designation[].value
Hip disarticulation, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot

# concept[].designation[].value
Hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee, each additional cast change and realignment

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change 'ak' or knee disarticulation

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing, incl. fitting, alignment and supension, 'ak' or knee disarticulation, each additional cast change and realignment

# concept[].designation[].value
Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, below knee

# concept[].designation[].value
Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, above knee

# concept[].designation[].value
Initial, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed

# concept[].designation[].value
Initial, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed

# concept[].designation[].value
Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model

# concept[].designation[].value
Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed

# concept[].designation[].value
Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model

# concept[].designation[].value
Preparatory, below knee 'ptb' type socket, non-alignable system, no cover, sach foot, prefabricated, adjustable open end socket

# concept[].designation[].value
Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, laminated socket, molded to model

# concept[].designation[].value
Preparatory, above knee- knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model

# concept[].designation[].value
Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed

# concept[].designation[].value
Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model

# concept[].designation[].value
Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open end socket

# concept[].designation[].value
Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon no cover, sach foot, laminated socket, molded to model

# concept[].designation[].value
Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, thermoplastic or equal, molded to patient model

# concept[].designation[].value
Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, laminated socket, molded to patient model

# concept[].designation[].value
Addition to lower extremity, endoskeletal system, above knee, hydracadence system

# concept[].designation[].value
Addition to lower extremity, endoskeletal system, above knee - knee disarticulation, 4 bar linkage, with friction swing phase control

# concept[].designation[].value
Addition to lower extremity, endoskeletal system, above knee-knee disarticulation, 4 bar linkage, with hydraulic swing phase control

# concept[].designation[].value
Addition to lower extremity, exoskeletal system, above knee-knee disarticulation, 4 bar linkage, with pneumatic swing phase control

# concept[].designation[].value
Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control

# concept[].designation[].value
Addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control

# concept[].designation[].value
Addition to lower extremity, quick change self-aligning unit, above knee or below knee, each

# concept[].designation[].value
Addition to lower extremity, test socket, symes

# concept[].designation[].value
Addition to lower extremity, test socket, below knee

# concept[].designation[].value
Addition to lower extremity, test socket, knee disarticulation

# concept[].designation[].value
Addition to lower extremity, test socket, above knee

# concept[].designation[].value
Addition to lower extremity, test socket, hip disarticulation

# concept[].designation[].value
Addition to lower extremity, test socket, hemipelvectomy

# concept[].designation[].value
Addition to lower extremity, below knee, acrylic socket

# concept[].designation[].value
Addition to lower extremity, symes type, expandable wall socket

# concept[].designation[].value
Addition to lower extremity, above knee or knee disarticulation, acrylic socket

# concept[].designation[].value
Addition to lower extremity, symes type, 'ptb' brim design socket

# concept[].designation[].value
Addition to lower extremity, symes type, posterior opening (canadian) socket

# concept[].designation[].value
Addition to lower extremity, symes type, medial opening socket

# concept[].designation[].value
Addition to lower extremity, below knee, total contact

# concept[].designation[].value
Addition to lower extremity, below knee, leather socket

# concept[].designation[].value
Addition to lower extremity, below knee, wood socket

# concept[].designation[].value
Addition to lower extremity, knee disarticulation, leather socket

# concept[].designation[].value
Addition to lower extremity, above knee, leather socket

# concept[].designation[].value
Addition to lower extremity, hip disarticulation, flexible inner socket, external frame

# concept[].designation[].value
Addition to lower extremity, above knee, wood socket

# concept[].designation[].value
Addition to lower extremity, below knee, flexible inner socket, external frame

# concept[].designation[].value
Addition to lower extremity, below knee, air, fluid, gel or equal, cushion socket

# concept[].designation[].value
Addition to lower extremity, below knee suction socket

# concept[].designation[].value
Addition to lower extremity, above knee, air, fluid, gel or equal, cushion socket

# concept[].designation[].value
Addition to lower extremity, ischial containment/narrow m-l socket

# concept[].designation[].value
Additions to lower extremity, total contact, above knee or knee disarticulation socket

# concept[].designation[].value
Addition to lower extremity, above knee, flexible inner socket, external frame

# concept[].designation[].value
Addition to lower extremity, suction suspension, above knee or knee disarticulation socket

# concept[].designation[].value
Addition to lower extremity, knee disarticulation, expandable wall socket

# concept[].designation[].value
Addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast, plastazote or equal)

# concept[].designation[].value
Addition to lower extremity, socket insert, below knee (kemblo, pelite, aliplast, plastazote or equal)

# concept[].designation[].value
Addition to lower extremity, socket insert, knee disarticulation (kemblo, pelite, aliplast, plastazote or equal)

# concept[].designation[].value
Addition to lower extremity, socket insert, above knee (kemblo, pelite, aliplast, plastazote or equal)

# concept[].designation[].value
Addition to lower extremity, socket insert, multi-durometer symes

# concept[].designation[].value
Addition to lower extremity, socket insert, multi-durometer, below knee

# concept[].designation[].value
Addition to lower extremity, below knee, cuff suspension

# concept[].designation[].value
Addition  to lower extremity, below knee, molded distal cushion

# concept[].designation[].value
Addition to lower extremity, below knee, molded supracondylar suspension ('pts' or similar)

# concept[].designation[].value
Addition to lower extremity, below knee / above knee suspension locking mechanism (shuttle, lanyard or equal), excludes socket insert

# concept[].designation[].value
Addition to lower extremity, below knee, removable medial brim suspension

# concept[].designation[].value
Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism

# concept[].designation[].value
Additions to lower extremity, below knee, knee joints, single axis, pair

# concept[].designation[].value
Additions to lower extremity, below knee, knee joints, polycentric, pair

# concept[].designation[].value
Additions to lower extremity, below knee, joint covers, pair

# concept[].designation[].value
Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism

# concept[].designation[].value
Addition to lower extremity, below knee, thigh lacer, nonmolded

# concept[].designation[].value
Addition to lower extremity, below knee/above knee, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)

# concept[].designation[].value
Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded

# concept[].designation[].value
Addition to lower extremity, below knee/above knee, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)

# concept[].designation[].value
Addition to lower extremity, below knee, fork strap

# concept[].designation[].value
Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with or without valve, any material, each

# concept[].designation[].value
Addition to lower extremity, below knee, back check (extension control)

# concept[].designation[].value
Addition to lower extremity, below knee, waist belt, webbing

# concept[].designation[].value
Addition to lower extremity, below knee, waist belt, padded and lined

# concept[].designation[].value
Addition to lower extremity, above knee, pelvic control belt, light

# concept[].designation[].value
Addition to lower extremity, above knee, pelvic control belt, padded and lined

# concept[].designation[].value
Addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each

# concept[].designation[].value
Addition to lower extremity, above knee or knee disarticulation, pelvic joint

# concept[].designation[].value
Addition to lower extremity, above knee or knee disarticulation, pelvic band

# concept[].designation[].value
Addition to lower extremity, above knee or knee disarticulation, silesian bandage

# concept[].designation[].value
All lower extremity prostheses, shoulder harness

# concept[].designation[].value
Replacement, socket, below knee, molded to patient model

# concept[].designation[].value
Replacement, socket, above knee/knee disarticulation, including attachment plate, molded to patient model

# concept[].designation[].value
Replacement, socket, hip disarticulation, including hip joint, molded to patient model

# concept[].designation[].value
Ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only

# concept[].designation[].value
Custom shaped protective cover, below knee

# concept[].designation[].value
Custom shaped protective cover, above knee

# concept[].designation[].value
Custom shaped protective cover, knee disarticulation

# concept[].designation[].value
Custom shaped protective cover, hip disarticulation

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, manual lock

# concept[].designation[].value
Additions exoskeletal knee-shin system, single axis, manual lock, ultra-light material

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, variable friction swing phase control

# concept[].designation[].value
Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock

# concept[].designation[].value
Addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, fluid swing phase control

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, external joints fluid swing phase control

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control

# concept[].designation[].value
Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase control

# concept[].designation[].value
Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system

# concept[].designation[].value
Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system, heavy duty

# concept[].designation[].value
Addition to lower extremity, user adjustable, mechanical, residual limb volume management system

# concept[].designation[].value
Addition, exoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition, exoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, manual lock

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light material

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)

# concept[].designation[].value
Addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase control, mechanical stance phase lock

# concept[].designation[].value
Addition, endoskeletal knee-shin system, polycentric, mechanical stance phase lock

# concept[].designation[].value
Addition, endoskeletal knee-shin system, polycentric, friction swing, and stance phase control

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, fluid swing phase control

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, hydraulic swing phase control, with miniature high activity frame

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, fluid swing and stance phase control

# concept[].designation[].value
Addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase control

# concept[].designation[].value
Addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic swing phase control

# concept[].designation[].value
Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control

# concept[].designation[].value
Addition, endoskeletal, knee-shin system, stance flexion feature, adjustable

# concept[].designation[].value
Addition to endoskeletal knee-shin system, fluid stance extension, dampening feature, with or without adjustability

# concept[].designation[].value
Addition, endoskeletal system, above knee or hip disarticulation, knee extension assist

# concept[].designation[].value
Addition, endoskeletal system, hip disarticulation, mechanical hip extension assist

# concept[].designation[].value
Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type

# concept[].designation[].value
Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type

# concept[].designation[].value
Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type

# concept[].designation[].value
Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)

# concept[].designation[].value
Addition, endoskeletal system, below knee, alignable system

# concept[].designation[].value
Addition, endoskeletal system, above knee or hip disarticulation, alignable system

# concept[].designation[].value
Addition, endoskeletal system, above knee, knee disarticulation or hip disarticulation, manual lock

# concept[].designation[].value
Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type

# concept[].designation[].value
Addition, endoskeletal system, high activity knee control frame

# concept[].designation[].value
Addition, endoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition, endoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition, endoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic control, rotation control, with or without flexion and/or extension control

# concept[].designation[].value
Addition, endoskeletal system, below knee, flexible protective outer surface covering system

# concept[].designation[].value
Addition, endoskeletal system, above knee, flexible protective outer surface covering system

# concept[].designation[].value
Addition, endoskeletal system, hip disarticulation, flexible protective outer surface covering system

# concept[].designation[].value
Addition to lower limb prosthesis, multiaxial ankle with swing phase active dorsiflexion feature

# concept[].designation[].value
Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)

# concept[].designation[].value
All lower extremity prostheses, foot, external keel, sach foot

# concept[].designation[].value
All lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only

# concept[].designation[].value
All lower extremity prostheses, foot, flexible keel

# concept[].designation[].value
Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source

# concept[].designation[].value
All lower extremity prostheses, foot, single axis ankle/foot

# concept[].designation[].value
All lower extremity prosthesis, combination single axis ankle and flexible keel foot

# concept[].designation[].value
All lower extremity prostheses, energy storing foot (seattle carbon copy ii or equal)

# concept[].designation[].value
All lower extremity prostheses, foot, multiaxial ankle/foot

# concept[].designation[].value
All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece system

# concept[].designation[].value
All lower extremity prostheses, flex foot system

# concept[].designation[].value
All lower extremity prostheses, flex-walk system or equal

# concept[].designation[].value
All exoskeletal lower extremity prostheses, axial rotation unit

# concept[].designation[].value
All endoskeletal lower extremity prosthesis, axial rotation unit, with or without adjustability

# concept[].designation[].value
All endoskeletal lower extremity prostheses, dynamic prosthetic pylon

# concept[].designation[].value
All lower extremity prostheses, multi-axial rotation unit ('mcp' or equal)

# concept[].designation[].value
All lower extremity prosthesis, shank foot system with vertical loading pylon

# concept[].designation[].value
Addition to lower limb prosthesis, vertical shock reducing pylon feature

# concept[].designation[].value
Addition to lower extremity prosthesis, user adjustable heel height

# concept[].designation[].value
Addition to lower extremity prostheses, osseointegrated external prosthetic connector

# concept[].designation[].value
Lower extremity prosthesis, not otherwise specified

# concept[].designation[].value
Partial hand, little and/or ring finger remaining

# concept[].designation[].value
Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device

# concept[].designation[].value
Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)

# concept[].designation[].value
Wrist disarticulation, molded socket, flexible elbow hinges, triceps pad

# concept[].designation[].value
Wrist disarticulation, molded socket with expandable interface, flexible elbow hinges, triceps pad

# concept[].designation[].value
Below elbow, molded socket, flexible elbow hinge, triceps pad

# concept[].designation[].value
Below elbow, molded socket, (muenster or northwestern suspension types)

# concept[].designation[].value
Below elbow, molded double wall split socket, step-up hinges, half cuff

# concept[].designation[].value
Below elbow, molded double wall split socket, stump activated locking hinge, half cuff

# concept[].designation[].value
Elbow disarticulation, molded socket, outside locking hinge, forearm

# concept[].designation[].value
Elbow disarticulation, molded socket with expandable interface, outside locking hinges, forearm

# concept[].designation[].value
Above elbow, molded double wall socket, internal locking elbow, forearm

# concept[].designation[].value
Shoulder disarticulation, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm

# concept[].designation[].value
Shoulder disarticulation, passive restoration (shoulder cap only)

# concept[].designation[].value
Interscapular thoracic, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm

# concept[].designation[].value
Interscapular thoracic, passive restoration (shoulder cap only)

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, wrist disarticulation or below elbow

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, elbow disarticulation or above elbow

# concept[].designation[].value
Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, shoulder disarticulation or interscapular thoracic

# concept[].designation[].value
Immediate post surgical or early fitting, each additional cast change and realignment

# concept[].designation[].value
Immediate post surgical or early fitting, application of rigid dressing only

# concept[].designation[].value
Below elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping

# concept[].designation[].value
Elbow disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping

# concept[].designation[].value
Above elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping

# concept[].designation[].value
Shoulder disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping

# concept[].designation[].value
Interscapular thoracic, molded socket, endoskeletal system, including soft prosthetic tissue shaping

# concept[].designation[].value
Preparatory, wrist disarticulation or below elbow, single wall plastic socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, molded to patient model

# concept[].designation[].value
Preparatory, wrist disarticulation or below elbow, single wall socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, direct formed

# concept[].designation[].value
Preparatory, elbow disarticulation or above elbow, single wall plastic socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, molded to patient model

# concept[].designation[].value
Preparatory, elbow disarticulation or above elbow, single wall socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, direct formed

# concept[].designation[].value
Preparatory, shoulder disarticulation or interscapular thoracic, single wall plastic socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, molded to patient model

# concept[].designation[].value
Preparatory, shoulder disarticulation or interscapular thoracic, single wall socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, direct formed

# concept[].designation[].value
Upper extremity additions, polycentric hinge, pair

# concept[].designation[].value
Upper extremity additions, single pivot hinge, pair

# concept[].designation[].value
Upper extremity additions, flexible metal hinge, pair

# concept[].designation[].value
Addition to upper extremity prosthesis, external powered, additional switch, any type

# concept[].designation[].value
Upper extremity addition, disconnect locking wrist unit

# concept[].designation[].value
Upper extremity addition, additional disconnect insert for locking wrist unit, each

# concept[].designation[].value
Upper extremity addition, flexion/extension wrist unit, with or without friction

# concept[].designation[].value
Upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device

# concept[].designation[].value
Upper extremity addition, spring assisted rotational wrist unit with latch release

# concept[].designation[].value
Upper extremity addition, flexion/extension and rotation wrist unit

# concept[].designation[].value
Upper extremity addition, rotation wrist unit with cable lock

# concept[].designation[].value
Upper extremity addition, quick disconnect hook adapter, otto bock or equal

# concept[].designation[].value
Upper extremity addition, quick disconnect lamination collar with coupling piece, otto bock or equal

# concept[].designation[].value
Upper extremity addition, stainless steel, any wrist

# concept[].designation[].value
Upper extremity addition, latex suspension sleeve, each

# concept[].designation[].value
Upper extremity addition, lift assist for elbow

# concept[].designation[].value
Upper extremity addition, nudge control elbow lock

# concept[].designation[].value
Upper extremity addition to prosthesis, electric locking feature, only for use with manually powered elbow

# concept[].designation[].value
Upper extremity additions, shoulder abduction joint, pair

# concept[].designation[].value
Upper extremity addition, excursion amplifier, pulley type

# concept[].designation[].value
Upper extremity addition, excursion amplifier, lever type

# concept[].designation[].value
Upper extremity addition, shoulder flexion-abduction joint, each

# concept[].designation[].value
Upper extremity addition, shoulder joint, multipositional locking, flexion, adjustable abduction friction control, for use with body powered or external powered system

# concept[].designation[].value
Upper extremity addition, shoulder lock mechanism, body powered actuator

# concept[].designation[].value
Upper extremity addition, shoulder lock mechanism, external powered actuator

# concept[].designation[].value
Upper extremity addition, shoulder universal joint, each

# concept[].designation[].value
Upper extremity addition, standard control cable, extra

# concept[].designation[].value
Upper extremity addition, heavy duty control cable

# concept[].designation[].value
Upper extremity addition, teflon, or equal, cable lining

# concept[].designation[].value
Upper extremity addition, hook to hand, cable adapter

# concept[].designation[].value
Upper extremity addition, harness, chest or shoulder, saddle type

# concept[].designation[].value
Upper extremity addition, harness, (e.g., figure of eight type), single cable design

# concept[].designation[].value
Upper extremity addition, harness, (e.g., figure of eight type), dual cable design

# concept[].designation[].value
Upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow

# concept[].designation[].value
Upper extremity addition, test socket, wrist disarticulation or below elbow

# concept[].designation[].value
Upper extremity addition, test socket, elbow disarticulation or above elbow

# concept[].designation[].value
Upper extremity addition, test socket, shoulder disarticulation or interscapular thoracic

# concept[].designation[].value
Upper extremity addition, suction socket

# concept[].designation[].value
Upper extremity addition, frame type socket, below elbow or wrist disarticulation

# concept[].designation[].value
Upper extremity addition, frame type socket, above elbow or elbow disarticulation

# concept[].designation[].value
Upper extremity addition, frame type socket, shoulder disarticulation

# concept[].designation[].value
Upper extremity addition, frame type socket, interscapular-thoracic

# concept[].designation[].value
Upper extremity addition, removable insert, each

# concept[].designation[].value
Upper extremity addition, silicone gel insert or equal, each

# concept[].designation[].value
Upper extremity addition, locking elbow, forearm counterbalance

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/above elbow, lock mechanism, excludes socket insert

# concept[].designation[].value
Terminal device, passive hand/mitt, any material, any size

# concept[].designation[].value
Terminal device, sport/recreational/work attachment, any material, any size

# concept[].designation[].value
Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined

# concept[].designation[].value
Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined

# concept[].designation[].value
Terminal device, hand, mechanical, voluntary opening, any material, any size

# concept[].designation[].value
Terminal device, hand, mechanical, voluntary closing, any material, any size

# concept[].designation[].value
Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric

# concept[].designation[].value
Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric

# concept[].designation[].value
Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric

# concept[].designation[].value
Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric

# concept[].designation[].value
Terminal device, multiple articulating digit, includes motor(s), initial issue or replacement

# concept[].designation[].value
Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined

# concept[].designation[].value
Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined

# concept[].designation[].value
Addition to terminal device, modifier wrist unit

# concept[].designation[].value
Addition to terminal device, precision pinch device

# concept[].designation[].value
Electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)

# concept[].designation[].value
Automatic grasp feature, addition to upper limb electric prosthetic terminal device

# concept[].designation[].value
Microprocessor control feature, addition to upper limb prosthetic terminal device

# concept[].designation[].value
Replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power

# concept[].designation[].value
Replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power

# concept[].designation[].value
Replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power

# concept[].designation[].value
Addition to upper extremity prosthesis, glove for terminal device, any material, prefabricated, includes fitting and adjustment

# concept[].designation[].value
Addition to upper extremity prosthesis, glove for terminal device, any material, custom fabricated

# concept[].designation[].value
Hand restoration (casts, shading and measurements included), partial hand, with glove, thumb or one finger remaining

# concept[].designation[].value
Hand restoration (casts, shading and measurements included), partial hand, with glove, multiple fingers remaining

# concept[].designation[].value
Hand restoration (casts, shading and measurements included), partial hand, with glove, no fingers remaining

# concept[].designation[].value
Hand restoration (shading, and measurements included), replacement glove for above

# concept[].designation[].value
Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal, switch, cables, two batteries and one charger, switch control of terminal device

# concept[].designation[].value
Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device

# concept[].designation[].value
Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device

# concept[].designation[].value
Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device

# concept[].designation[].value
Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device

# concept[].designation[].value
Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device

# concept[].designation[].value
Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device

# concept[].designation[].value
Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device

# concept[].designation[].value
Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device

# concept[].designation[].value
Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device

# concept[].designation[].value
Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device

# concept[].designation[].value
Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device

# concept[].designation[].value
Electric hand, switch or myoelectric controlled, adult

# concept[].designation[].value
Electric hand, switch or myoelectric, controlled, pediatric

# concept[].designation[].value
Electric hook, switch or myoelectric controlled, adult

# concept[].designation[].value
Electric hook, switch or myoelectric controlled, pediatric

# concept[].designation[].value
Electronic elbow, hosmer or equal, switch controlled

# concept[].designation[].value
Electronic elbow, microprocessor sequential control of elbow and terminal device

# concept[].designation[].value
Electronic elbow, microprocessor simultaneous control of elbow and terminal device

# concept[].designation[].value
Electronic elbow, adolescent, variety village or equal, switch controlled

# concept[].designation[].value
Electronic elbow, child, variety village or equal, switch controlled

# concept[].designation[].value
Electronic elbow, adolescent, variety village or equal, myoelectronically controlled

# concept[].designation[].value
Electronic elbow, child, variety village or equal, myoelectronically controlled

# concept[].designation[].value
Electronic wrist rotator, otto bock or equal

# concept[].designation[].value
Lithium ion battery, rechargeable, replacement

# concept[].designation[].value
Lithium ion battery charger, replacement only

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)

# concept[].designation[].value
Addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material

# concept[].designation[].value
Addition to upper extremity prosthesis, above elbow disarticulation, acrylic material

# concept[].designation[].value
Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material

# concept[].designation[].value
Upper extremity prosthesis, not otherwise specified

# concept[].designation[].value
Repair of prosthetic device, repair or replace minor parts

# concept[].designation[].value
Repair prosthetic device, labor component, per 15 minutes

# concept[].designation[].value
Prosthetic donning sleeve, any material, each

# concept[].designation[].value
Gasket or seal, for use with prosthetic socket insert, any type, each

# concept[].designation[].value
Tension ring, for vacuum erection device, any type, replacement only, each

# concept[].designation[].value
Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type

# concept[].designation[].value
Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type

# concept[].designation[].value
Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type

# concept[].designation[].value
External breast prosthesis garment, with mastectomy form, post mastectomy

# concept[].designation[].value
Breast prosthesis, silicone or equal, without integral adhesive

# concept[].designation[].value
Breast prosthesis, silicone or equal, with integral adhesive

# concept[].designation[].value
Nipple prosthesis, prefabricated, reusable, any type, each

# concept[].designation[].value
Nipple prosthesis, custom fabricated, reusable, any material, any type, each

# concept[].designation[].value
Custom breast prosthesis, post mastectomy, molded to patient model

# concept[].designation[].value
Breast prosthesis, not otherwise specified

# concept[].designation[].value
Nasal prosthesis, provided by a non-physician

# concept[].designation[].value
Midfacial prosthesis, provided by a non-physician

# concept[].designation[].value
Orbital prosthesis, provided by a non-physician

# concept[].designation[].value
Upper facial prosthesis, provided by a non-physician

# concept[].designation[].value
Hemi-facial prosthesis, provided by a non-physician

# concept[].designation[].value
Auricular prosthesis, provided by a non-physician

# concept[].designation[].value
Partial facial prosthesis, provided by a non-physician

# concept[].designation[].value
Nasal septal prosthesis, provided by a non-physician

# concept[].designation[].value
Unspecified maxillofacial prosthesis, by report, provided by a non-physician

# concept[].designation[].value
Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician

# concept[].designation[].value
Truss, addition to standard pad, water pad

# concept[].designation[].value
Truss, addition to standard pad, scrotal pad

# concept[].designation[].value
Prosthetic sheath/sock, including a gel cushion layer, below knee or above knee, each

# concept[].designation[].value
Prosthetic sock, multiple ply, below knee, each

# concept[].designation[].value
Prosthetic sock, multiple ply, above knee, each

# concept[].designation[].value
Prosthetic sock, multiple ply, upper limb, each

# concept[].designation[].value
Prosthetic sock, single ply, fitting, below knee, each

# concept[].designation[].value
Prosthetic sock, single ply, fitting, above knee, each

# concept[].designation[].value
Prosthetic sock, single ply, fitting, upper limb, each

# concept[].designation[].value
Unlisted procedure for miscellaneous prosthetic services

# concept[].designation[].value
Artificial larynx replacement battery / accessory, any type

# concept[].designation[].value
Tracheo-esophageal voice prosthesis, patient inserted, any type, each

# concept[].designation[].value
Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type

# concept[].designation[].value
Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each

# concept[].designation[].value
Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10

# concept[].designation[].value
Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each

# concept[].designation[].value
Tracheoesophageal puncture dilator, replacement only, each

# concept[].designation[].value
Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each

# concept[].designation[].value
Implantable breast prosthesis, silicone or equal

# concept[].designation[].value
Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies

# concept[].designation[].value
Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies

# concept[].designation[].value
Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies

# concept[].designation[].value
Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies

# concept[].designation[].value
Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies

# concept[].designation[].value
Miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system

# concept[].designation[].value
Cochlear device, includes all internal and external components

# concept[].designation[].value
Headset/headpiece for use with cochlear implant device, replacement

# concept[].designation[].value
Microphone for use with cochlear implant device, replacement

# concept[].designation[].value
Transmitting coil for use with cochlear implant device, replacement

# concept[].designation[].value
Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement

# concept[].designation[].value
Cochlear implant, external speech processor and controller, integrated system, replacement

# concept[].designation[].value
Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each

# concept[].designation[].value
Alkaline battery for use with cochlear implant device, any size, replacement, each

# concept[].designation[].value
Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each

# concept[].designation[].value
Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each

# concept[].designation[].value
External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each

# concept[].designation[].value
Cochlear implant, external speech processor, component, replacement

# concept[].designation[].value
Cochlear implant, external controller component, replacement

# concept[].designation[].value
Transmitting coil and cable, integrated, for use with cochlear implant device, replacement

# concept[].designation[].value
Metacarpal phalangeal joint replacement, two or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon), for surgical implantation (all sizes, includes entire system)

# concept[].designation[].value
Interphalangeal joint spacer, silicone or equal, each

# concept[].designation[].value
Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size

# concept[].designation[].value
Vascular graft material, synthetic, implant

# concept[].designation[].value
Electrical stimulator supplies (external) for use with implantable neurostimulator, per month

# concept[].designation[].value
Implantable neurostimulator, pulse generator, any type

# concept[].designation[].value
Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only

# concept[].designation[].value
Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver

# concept[].designation[].value
Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement

# concept[].designation[].value
Implantable neurostimulator pulse generator, single array, rechargeable, includes extension

# concept[].designation[].value
Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension

# concept[].designation[].value
Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension

# concept[].designation[].value
Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension

# concept[].designation[].value
External recharging system for battery (internal) for use with implantable neurostimulator, replacement only

# concept[].designation[].value
Auditory osseointegrated device, includes all internal and external components

# concept[].designation[].value
Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each

# concept[].designation[].value
Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment

# concept[].designation[].value
Auditory osseointegrated device abutment, any length, replacement only

# concept[].designation[].value
External recharging system for battery (external) for use with implantable neurostimulator, replacement only

# concept[].designation[].value
Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each

# concept[].designation[].value
Miscellaneous component, supply or accessory for use with total artificial heart system

# concept[].designation[].value
Prosthetic implant, not otherwise specified

# concept[].designation[].value
Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated

# concept[].designation[].value
Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated

# concept[].designation[].value
External lower extremity sensory prosthetic device, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg

# concept[].designation[].value
Receptor sole for use with l8720, replacement, each

# concept[].designation[].value
Orthotic and prosthetic supply, accessory, and/or service component of another hcpcs "l" code

# concept[].designation[].value
Advancing cancer care mips value pathways

# concept[].designation[].value
Optimal care for kidney health mips value pathways

# concept[].designation[].value
Optimal care for patients with episodic neurological conditions mips value pathways

# concept[].designation[].value
Quality care for patients with neurological conditions mips value pathway

# concept[].designation[].value
Value in primary care mips value pathway

# concept[].designation[].value
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services

# concept[].designation[].value
Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders

# concept[].designation[].value
Intragastric hypothermia using gastric freezing

# concept[].designation[].value
Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home

# concept[].designation[].value
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring

# concept[].designation[].value
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

# concept[].designation[].value
Intravenous injection, bebtelovimab, includes injection and post administration monitoring

# concept[].designation[].value
Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

# concept[].designation[].value
Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring

# concept[].designation[].value
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring

# concept[].designation[].value
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses

# concept[].designation[].value
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses

# concept[].designation[].value
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring

# concept[].designation[].value
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

# concept[].designation[].value
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring

# concept[].designation[].value
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency

# concept[].designation[].value
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring

# concept[].designation[].value
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

# concept[].designation[].value
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose

# concept[].designation[].value
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose

# concept[].designation[].value
Iv chelation therapy (chemical endarterectomy)

# concept[].designation[].value
Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician

# concept[].designation[].value
Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given

# concept[].designation[].value
Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy

# concept[].designation[].value
Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)

# concept[].designation[].value
Tb screening not performed or results not interpreted, reason not given

# concept[].designation[].value
Disease activity not assessed, reason not given

# concept[].designation[].value
>=50% of total number of a patient's outpatient ra encounters assessed

# concept[].designation[].value
<50% of total number of a patient's outpatient ra encounters assessed

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Discharge/discontinuation of the episode of care documented in the medical record

# concept[].designation[].value
Patient admitted to palliative care services

# concept[].designation[].value
Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients

# concept[].designation[].value
Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5

# concept[].designation[].value
Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5

# concept[].designation[].value
Patient had only urgent care visits during the performance period

# concept[].designation[].value
Patients who were in hospice at any time during the performance period

# concept[].designation[].value
Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

# concept[].designation[].value
Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five

# concept[].designation[].value
Patients who were in hospice at any time during the performance period

# concept[].designation[].value
Patients who were in hospice at any time during the performance period

# concept[].designation[].value
Imaging of the head (ct or mri) was obtained

# concept[].designation[].value
Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained

# concept[].designation[].value
Imaging of the head (ct or mri) was not obtained, reason not given

# concept[].designation[].value
Patients with clinical indications for imaging of the head

# concept[].designation[].value
Patients with no clinical indications for imaging of the head

# concept[].designation[].value
Adults currently taking pharmacotherapy for oud

# concept[].designation[].value
Pharmacotherapy for oud initiated after june 30th of performance period

# concept[].designation[].value
Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days

# concept[].designation[].value
Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment

# concept[].designation[].value
Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days

# concept[].designation[].value
Patients with a diagnosis of lumbar spine region cancer at the time of the procedure

# concept[].designation[].value
Patients with a diagnosis of lumbar spine region fracture at the time of the procedure

# concept[].designation[].value
Patients with a diagnosis of lumbar spine region infection at the time of the procedure

# concept[].designation[].value
Patients with a diagnosis of lumbar idiopathic or congenital scoliosis

# concept[].designation[].value
Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis

# concept[].designation[].value
Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71

# concept[].designation[].value
Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively

# concept[].designation[].value
Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

# concept[].designation[].value
Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively

# concept[].designation[].value
Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

# concept[].designation[].value
Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis

# concept[].designation[].value
Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Patient had only urgent care visits during the performance period

# concept[].designation[].value
Aspirin or another antiplatelet therapy used

# concept[].designation[].value
Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease

# concept[].designation[].value
Aspirin or another antiplatelet therapy not used, reason not given

# concept[].designation[].value
Patient was a permanent nursing home resident at any time during the performance period

# concept[].designation[].value
Patient was in hospice or receiving palliative care at any time during the performance period

# concept[].designation[].value
Patient died prior to the end of the performance period

# concept[].designation[].value
Patients receiving high doses of immunosuppressive therapy

# concept[].designation[].value
Shingrix vaccine documented as administered or previously received

# concept[].designation[].value
Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

# concept[].designation[].value
Shingrix vaccine not documented as administered, reason not given

# concept[].designation[].value
Hospice services for patient provided any time during the measurement period

# concept[].designation[].value
Patient not screened for future fall risk, reason not given

# concept[].designation[].value
Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
The start of an episode of care documented in the medical record

# concept[].designation[].value
Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

# concept[].designation[].value
Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)

# concept[].designation[].value
Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized

# concept[].designation[].value
Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively

# concept[].designation[].value
Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment

# concept[].designation[].value
Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only

# concept[].designation[].value
Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)

# concept[].designation[].value
Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record

# concept[].designation[].value
Ongoing care not medically possible because the patient was  discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery

# concept[].designation[].value
Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)

# concept[].designation[].value
Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available

# concept[].designation[].value
Current or prior left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function

# concept[].designation[].value
Patients with a history of heart transplant or with a left ventricular assist device (lvad)

# concept[].designation[].value
Patients with a history of heart transplant or with a left ventricular assist device (lvad)

# concept[].designation[].value
Patient with diagnosis of osteoporosis on date of encounter

# concept[].designation[].value
Hospice services provided to patient any time during the measurement period

# concept[].designation[].value
Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period

# concept[].designation[].value
Patient received active chemotherapy any time during the measurement period

# concept[].designation[].value
Patient received bone marrow transplant any time during the measurement period

# concept[].designation[].value
Patient had history of immunocompromising conditions prior to or during the measurement period

# concept[].designation[].value
Hospice services provided to patient any time during the measurement period

# concept[].designation[].value
Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday

# concept[].designation[].value
Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday

# concept[].designation[].value
Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday

# concept[].designation[].value
Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday

# concept[].designation[].value
Patients with dementia any time during the patient's history through the end of the measurement period

# concept[].designation[].value
Patients who use hospice services any time during the measurement period

# concept[].designation[].value
Pathology report for tissue specimens produced from wide local excisions or re-excisions

# concept[].designation[].value
In hospice or using hospice services during the measurement period

# concept[].designation[].value
Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)

# concept[].designation[].value
Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period

# concept[].designation[].value
Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)

# concept[].designation[].value
Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period

# concept[].designation[].value
Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)

# concept[].designation[].value
Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period

# concept[].designation[].value
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)

# concept[].designation[].value
Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period

# concept[].designation[].value
Patients on immune checkpoint inhibitor therapy

# concept[].designation[].value
Grade 2 or above diarrhea and/or grade 2 or above colitis

# concept[].designation[].value
Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)

# concept[].designation[].value
Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)

# concept[].designation[].value
Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given

# concept[].designation[].value
Patients who have an order for or are receiving hospice or palliative care

# concept[].designation[].value
Patients with a diagnosis of end stage renal disease (esrd)

# concept[].designation[].value
Patients with a diagnosis of chronic kidney disease (ckd) stage 5

# concept[].designation[].value
Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed

# concept[].designation[].value
Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)

# concept[].designation[].value
Hospice services provided to patient any time during the measurement period

# concept[].designation[].value
Patients with an existing diagnosis of squamous cell carcinoma of the esophagus

# concept[].designation[].value
Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both

# concept[].designation[].value
Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)

# concept[].designation[].value
Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given

# concept[].designation[].value
Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4

# concept[].designation[].value
Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score

# concept[].designation[].value
Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter

# concept[].designation[].value
Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period

# concept[].designation[].value
Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)

# concept[].designation[].value
Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)

# concept[].designation[].value
Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given

# concept[].designation[].value
Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4

# concept[].designation[].value
Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score

# concept[].designation[].value
Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter

# concept[].designation[].value
Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety

# concept[].designation[].value
Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety

# concept[].designation[].value
At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses

# concept[].designation[].value
At least two orders for high-risk medications from the same drug class, (table 4), not ordered

# concept[].designation[].value
Most recent glycemic status assessment (hba1c or gmi) level > 9.0%

# concept[].designation[].value
Glycemic status assessment (hba1c or gmi) level is missing, or was not performed during the measurement period

# concept[].designation[].value
No history of spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) and present spirometry is >= 70%

# concept[].designation[].value
Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed

# concept[].designation[].value
Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)

# concept[].designation[].value
No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter

# concept[].designation[].value
Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)

# concept[].designation[].value
Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)

# concept[].designation[].value
Anaphylaxis due to the vaccine on or before the date of the encounter

# concept[].designation[].value
Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy

# concept[].designation[].value
Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy

# concept[].designation[].value
Glaucoma plan of care not documented, reason not otherwise specified

# concept[].designation[].value
Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level

# concept[].designation[].value
Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level

# concept[].designation[].value
Iop measurement not documented, reason not otherwise specified

# concept[].designation[].value
Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test

# concept[].designation[].value
Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection

# concept[].designation[].value
Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given

# concept[].designation[].value
Patient receives hcv antibody test with nonreactive result

# concept[].designation[].value
Patient receives hcv antibody test with reactive result

# concept[].designation[].value
Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given

# concept[].designation[].value
Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia

# concept[].designation[].value
Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period

# concept[].designation[].value
Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)

# concept[].designation[].value
Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)

# concept[].designation[].value
Patient did not respond to the question of patient felt heard and understood by this provider and team

# concept[].designation[].value
Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care

# concept[].designation[].value
Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem

# concept[].designation[].value
Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life

# concept[].designation[].value
Patient provided a response other than "completely true" for the question of patient felt heard and understood by this provider and team

# concept[].designation[].value
Patient provided a response other than "completely true" for the question of patient felt this provider and team put my best interests first when making recommendations about my care

# concept[].designation[].value
Patient provided a response other than "completely true" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem

# concept[].designation[].value
Patient provided a response other than "completely true" for the question of patient felt this provider and team understood what is important to me in my life

# concept[].designation[].value
Patient responded "completely true" for the question of patient felt this provider and team put my best interests first when making recommendations about my care

# concept[].designation[].value
Patient responded "completely true" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem

# concept[].designation[].value
Patient responded "completely true" for the question of patient felt this provider and team understood what is important to me in my life

# concept[].designation[].value
Patient responded as "completely true" for the question of patient felt heard and understood by this provider and team

# concept[].designation[].value
Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement)

# concept[].designation[].value
Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit

# concept[].designation[].value
Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal)

# concept[].designation[].value
Patients who were deceased when the hu survey reached them

# concept[].designation[].value
Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)

# concept[].designation[].value
Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified

# concept[].designation[].value
Cvd risk assessment performed, have a documented calculated risk score

# concept[].designation[].value
Patient status documented within the first year of initiating dialysis

# concept[].designation[].value
Patient status not documented within the first year of initiating dialysis

# concept[].designation[].value
Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysis

# concept[].designation[].value
Patients who had a transplant prior to initiation of dialysis

# concept[].designation[].value
Patients in hospice on their initiation of dialysis date or during the month of evaluation

# concept[].designation[].value
Patients age 75 or older on their initiation of dialysis date

# concept[].designation[].value
Cms medical evidence form 2728 for dialysis patients: initial form completed

# concept[].designation[].value
Patients admitted to a skilled nursing facility (snf)

# concept[].designation[].value
Patients not observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period

# concept[].designation[].value
Patients observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period

# concept[].designation[].value
Receiving esrd mcp dialysis services by the provider on the last day of the reporting month

# concept[].designation[].value
Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period

# concept[].designation[].value
Patients with dementia at any time prior to or during the month

# concept[].designation[].value
Patients observed on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period

# concept[].designation[].value
Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 form

# concept[].designation[].value
Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that month

# concept[].designation[].value
Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting period

# concept[].designation[].value
Bmi documented outside normal parameters, no follow-up plan documented, no reason given

# concept[].designation[].value
Colorectal cancer screening results documented and reviewed

# concept[].designation[].value
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented

# concept[].designation[].value
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given

# concept[].designation[].value
Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy

# concept[].designation[].value
Blood pressure reading not documented, reason not given

# concept[].designation[].value
Patient screened for tobacco use and identified as a tobacco non-user

# concept[].designation[].value
Patient screened for tobacco use and identified as a tobacco user

# concept[].designation[].value
Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period

# concept[].designation[].value
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified

# concept[].designation[].value
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason

# concept[].designation[].value
Bmi is documented below normal parameters and a follow-up plan is documented

# concept[].designation[].value
Documented reason for not screening or recommending a follow-up for high blood pressure

# concept[].designation[].value
Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)

# concept[].designation[].value
Patient not eligible due to active diagnosis of hypertension

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period

# concept[].designation[].value
Bmi is documented above normal parameters and a follow-up plan is documented

# concept[].designation[].value
Normal blood pressure reading documented, follow-up not required

# concept[].designation[].value
Patients with a diagnosis or past history of total colectomy or colorectal cancer

# concept[].designation[].value
Bmi is documented within normal parameters and no follow-up plan is required

# concept[].designation[].value
Bmi not documented due to medical reason or patient refusal of height or weight measurement

# concept[].designation[].value
Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter

# concept[].designation[].value
Influenza immunization administered or previously received

# concept[].designation[].value
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

# concept[].designation[].value
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)

# concept[].designation[].value
Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed

# concept[].designation[].value
Hospice services provided to patient any time during the measurement period

# concept[].designation[].value
Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

# concept[].designation[].value
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

# concept[].designation[].value
Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period

# concept[].designation[].value
Documentation stating the patient has received or is currently receiving palliative or hospice care

# concept[].designation[].value
Influenza immunization was not administered, reason not given

# concept[].designation[].value
Palliative care services provided to patient any time during the measurement period

# concept[].designation[].value
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user

# concept[].designation[].value
Anaphylaxis due to the vaccine on or before the date of the encounter

# concept[].designation[].value
Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period

# concept[].designation[].value
Bmi not documented and no reason is given

# concept[].designation[].value
Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified

# concept[].designation[].value
Patients who are counseled on connection with a csp and explicitly opt out

# concept[].designation[].value
Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp

# concept[].designation[].value
Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening

# concept[].designation[].value
Patients who screened positive for at least 1 of the 5 hrsns

# concept[].designation[].value
Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg

# concept[].designation[].value
Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye

# concept[].designation[].value
Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented

# concept[].designation[].value
Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)

# concept[].designation[].value
Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)

# concept[].designation[].value
Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks

# concept[].designation[].value
Patients with a diagnosis of acute vitreous hemorrhage

# concept[].designation[].value
Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter

# concept[].designation[].value
Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)

# concept[].designation[].value
Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam

# concept[].designation[].value
Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks

# concept[].designation[].value
Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter

# concept[].designation[].value
Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)

# concept[].designation[].value
Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks

# concept[].designation[].value
Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period

# concept[].designation[].value
Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period

# concept[].designation[].value
Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period

# concept[].designation[].value
Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period

# concept[].designation[].value
Patients who died during the performance period

# concept[].designation[].value
Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses

# concept[].designation[].value
Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score

# concept[].designation[].value
Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score

# concept[].designation[].value
Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period

# concept[].designation[].value
Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)

# concept[].designation[].value
Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)

# concept[].designation[].value
Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period

# concept[].designation[].value
Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

# concept[].designation[].value
Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

# concept[].designation[].value
Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment

# concept[].designation[].value
Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

# concept[].designation[].value
Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

# concept[].designation[].value
Suicide risk based on their clinician's evaluation or a clinician-rated tool

# concept[].designation[].value
Patients who died during the measurement period

# concept[].designation[].value
Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

# concept[].designation[].value
Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

# concept[].designation[].value
Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained

# concept[].designation[].value
Suicidal ideation and/or behavior symptoms based on the c-ssrs

# concept[].designation[].value
Suicide risk based on their clinician's evaluation or a clinician-rated tool

# concept[].designation[].value
Patients who died during the measurement period

# concept[].designation[].value
Patients who did not have a follow-up assessment within 120 days of the index assessment

# concept[].designation[].value
Calculated 10-year ascvd risk score of >= 20 percent during the performance period

# concept[].designation[].value
Patient encounter during the performance period with hospice and palliative care specialty code 17

# concept[].designation[].value
Focusing on women's health mips value pathway

# concept[].designation[].value
Quality care for the treatment of ear, nose, and throat disorders mips value pathway

# concept[].designation[].value
Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway

# concept[].designation[].value
Quality care in mental health and substance use disorders mips value pathway

# concept[].designation[].value
Rehabilitative support for musculoskeletal care mips value pathway

# concept[].designation[].value
Most recent glycemic status assessment (hba1c or gmi) level < 7.0%

# concept[].designation[].value
Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%

# concept[].designation[].value
Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%

# concept[].designation[].value
An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

# concept[].designation[].value
An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

# concept[].designation[].value
An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

# concept[].designation[].value
Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient

# concept[].designation[].value
Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)

# concept[].designation[].value
A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified

# concept[].designation[].value
Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under "denominator note" or the long-acting injectable antipsychotic medications listed under "denominator note"

# concept[].designation[].value
Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure

# concept[].designation[].value
Patient encounter during the performance period with place of service code 11

# concept[].designation[].value
Patients who died during the performance period

# concept[].designation[].value
Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up

# concept[].designation[].value
Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period

# concept[].designation[].value
Patients who died during the performance period

# concept[].designation[].value
Patients with documentation of an exam performed for recurrence of melanoma

# concept[].designation[].value
Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period

# concept[].designation[].value
All patients who were diagnosed with recurrent melanoma during the current performance period

# concept[].designation[].value
Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)

# concept[].designation[].value
Patients who were not diagnosed with recurrent melanoma during the current performance period

# concept[].designation[].value
Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group

# concept[].designation[].value
Patients on a therapeutic clinical trial

# concept[].designation[].value
Patients with baseline and follow-up promis surveys documented in the medical record

# concept[].designation[].value
Patients who leave the practice during the follow-up period

# concept[].designation[].value
Patients who died during the follow-up period

# concept[].designation[].value
Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group

# concept[].designation[].value
Patients with baseline and follow-up promis surveys documented in the medical record

# concept[].designation[].value
Patients on a therapeutic clinical trial

# concept[].designation[].value
Patients who leave the practice during the follow-up period

# concept[].designation[].value
Patients who died during the follow-up period

# concept[].designation[].value
Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer

# concept[].designation[].value
Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis

# concept[].designation[].value
Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis

# concept[].designation[].value
Currently on first-line immune checkpoint inhibitors without chemotherapy

# concept[].designation[].value
Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement

# concept[].designation[].value
Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy

# concept[].designation[].value
Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)

# concept[].designation[].value
Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy

# concept[].designation[].value
Patient received hospice services any time during the performance period

# concept[].designation[].value
Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination

# concept[].designation[].value
Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician

# concept[].designation[].value
Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination

# concept[].designation[].value
Complete ophthalmologic care mips value pathway

# concept[].designation[].value
Gastroenterology care mips value pathway

# concept[].designation[].value
Optimal care for patients with urologic conditions mips value pathway

# concept[].designation[].value
Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision

# concept[].designation[].value
Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician

# concept[].designation[].value
Culture, bacterial, urine; quantitative, sensitivity study

# concept[].designation[].value
Blood (whole), for transfusion, per unit

# concept[].designation[].value
Red blood cells, leukocytes reduced, each unit

# concept[].designation[].value
Fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit

# concept[].designation[].value
Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit

# concept[].designation[].value
Plasma, cryoprecipitate reduced, pathogen reduced, each unit

# concept[].designation[].value
Cryoprecipitated fibrinogen complex, pathogen reduced, each unit

# concept[].designation[].value
Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit

# concept[].designation[].value
Platelets, leukocytes reduced, each unit

# concept[].designation[].value
Platelets, leukocytes reduced, irradiated, each unit

# concept[].designation[].value
Platelets, pheresis, leukocytes reduced, each unit

# concept[].designation[].value
Platelets, pheresis, irradiated, each unit

# concept[].designation[].value
Platelets, pheresis, leukocytes reduced, irradiated, each unit

# concept[].designation[].value
Red blood cells, deglycerolized, each unit

# concept[].designation[].value
Red blood cells, leukocytes reduced, irradiated, each unit

# concept[].designation[].value
Infusion, plasma protein fraction (human), 5%, 50 ml

# concept[].designation[].value
Plasma, cryoprecipitate reduced, each unit

# concept[].designation[].value
Infusion, plasma protein fraction (human), 5%, 250 ml

# concept[].designation[].value
Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit

# concept[].designation[].value
Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit

# concept[].designation[].value
Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit

# concept[].designation[].value
Whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed, each unit

# concept[].designation[].value
Whole blood, leukocytes reduced, irradiated, each unit

# concept[].designation[].value
Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit

# concept[].designation[].value
Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit

# concept[].designation[].value
Fresh frozen plasma between 8-24 hours of collection, each unit

# concept[].designation[].value
Fresh frozen plasma, donor retested, each unit

# concept[].designation[].value
Plasma, pooled multiple donor, pathogen reduced, frozen, each unit

# concept[].designation[].value
Plasma (single donor), pathogen reduced, frozen, each unit

# concept[].designation[].value
Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit

# concept[].designation[].value
Platelets, pheresis, pathogen-reduced, each unit

# concept[].designation[].value
Blood component or product not otherwise classified

# concept[].designation[].value
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled

# concept[].designation[].value
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge

# concept[].designation[].value
Catheterization for collection of specimen, single patient, all places of service

# concept[].designation[].value
Catheterization for collection of specimen(s) (multiple patients)

# concept[].designation[].value
Infusion therapy, using other than chemotherapeutic drugs, per visit

# concept[].designation[].value
Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit

# concept[].designation[].value
Chemotherapy administration by infusion technique only, per visit

# concept[].designation[].value
Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit

# concept[].designation[].value
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory

# concept[].designation[].value
Wet mounts, including preparations of vaginal, cervical or skin specimens

# concept[].designation[].value
All potassium hydroxide (koh) preparations

# concept[].designation[].value
Post-coital direct, qualitative examinations of vaginal or cervical mucous

# concept[].designation[].value
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)

# concept[].designation[].value
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)

# concept[].designation[].value
Azithromycin dihydrate, oral, capsules/powder, 1 gram

# concept[].designation[].value
Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen

# concept[].designation[].value
Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen

# concept[].designation[].value
Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

# concept[].designation[].value
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg

# concept[].designation[].value
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg

# concept[].designation[].value
Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg

# concept[].designation[].value
Injection, casirivimab and imdevimab, 600 mg

# concept[].designation[].value
Injection, casirivimab and imdevimab, 2400 mg

# concept[].designation[].value
Injection, casirivimab and imdevimab, 1200 mg

# concept[].designation[].value
Injection, bamlanivimab and etesevimab, 2100 mg

# concept[].designation[].value
Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

# concept[].designation[].value
Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type

# concept[].designation[].value
Power module for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Driver for use with pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Microprocessor control unit for use with electric ventricular assist device, replacement only

# concept[].designation[].value
Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only

# concept[].designation[].value
Monitor/display module for use with electric ventricular assist device, replacement only

# concept[].designation[].value
Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Monitor control cable for use with electric ventricular assist device, replacement only

# concept[].designation[].value
Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Power pack base for use with electric ventricular assist device, replacement only

# concept[].designation[].value
Power pack base for use with electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Emergency power source for use with electric ventricular assist device, replacement only

# concept[].designation[].value
Emergency power source for use with electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Emergency power supply cable for use with electric ventricular assist device, replacement only

# concept[].designation[].value
Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Holster for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only

# concept[].designation[].value
Filters for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Mobility cart for pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Battery for pneumatic ventricular assist device, replacement only, each

# concept[].designation[].value
Power adapter for pneumatic ventricular assist device, replacement only, vehicle type

# concept[].designation[].value
Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only

# concept[].designation[].value
Miscellaneous supply or accessory for use with an external ventricular assist device

# concept[].designation[].value
Miscellaneous supply or accessory for use with an implanted ventricular assist device

# concept[].designation[].value
Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a

# concept[].designation[].value
Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant

# concept[].designation[].value
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period

# concept[].designation[].value
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period

# concept[].designation[].value
Pharmacy dispensing fee for inhalation drug(s); per 30 days

# concept[].designation[].value
Pharmacy dispensing fee for inhalation drug(s); per 90 days

# concept[].designation[].value
Injection, sermorelin acetate, 1 microgram

# concept[].designation[].value
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days

# concept[].designation[].value
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days

# concept[].designation[].value
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days

# concept[].designation[].value
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

# concept[].designation[].value
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days

# concept[].designation[].value
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription

# concept[].designation[].value
New technology intraocular lens category 4 as defined in federal register notice

# concept[].designation[].value
New technology intraocular lens category 5 as defined in federal register notice

# concept[].designation[].value
Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml

# concept[].designation[].value
Injection, fosphenytoin, 50 mg phenytoin equivalent

# concept[].designation[].value
Influenza virus vaccine, split virus, for intramuscular use (agriflu)

# concept[].designation[].value
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)

# concept[].designation[].value
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)

# concept[].designation[].value
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)

# concept[].designation[].value
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)

# concept[].designation[].value
Influenza virus vaccine, not otherwise specified

# concept[].designation[].value
Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion

# concept[].designation[].value
Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion

# concept[].designation[].value
Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg

# concept[].designation[].value
Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg

# concept[].designation[].value
Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)

# concept[].designation[].value
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

# concept[].designation[].value
Radioelements for brachytherapy, any type, each

# concept[].designation[].value
Telehealth originating site facility fee

# concept[].designation[].value
Injection, interferon beta-1a, 1 mcg for intramuscular use

# concept[].designation[].value
Injection, interferon beta-1a, 1 mcg for subcutaneous use

# concept[].designation[].value
Casting supplies, body cast adult, with or without head, plaster

# concept[].designation[].value
Cast supplies, body cast adult, with or without head, fiberglass

# concept[].designation[].value
Cast supplies, shoulder cast, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, shoulder cast, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, long arm cast, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, long arm cast, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, long arm cast, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, long arm cast, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, short arm cast, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, short arm cast, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, short arm cast, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, short arm cast, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, long arm splint, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, long arm splint, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, long arm splint, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, long arm splint, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, short arm splint, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, short arm splint, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, short arm splint, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, short arm splint, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, hip spica (one or both legs), adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, long leg cast, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, long leg cast, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, long leg cast, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, long leg cast, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, long leg cylinder cast, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, short leg cast, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, short leg cast, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, short leg cast, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, short leg cast, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, long leg splint, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, long leg splint, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, long leg splint, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, long leg splint, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, short leg splint, adult (11 years +), plaster

# concept[].designation[].value
Cast supplies, short leg splint, adult (11 years +), fiberglass

# concept[].designation[].value
Cast supplies, short leg splint, pediatric (0-10 years), plaster

# concept[].designation[].value
Cast supplies, short leg splint, pediatric (0-10 years), fiberglass

# concept[].designation[].value
Cast supplies, for unlisted types and materials of casts

# concept[].designation[].value
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)

# concept[].designation[].value
Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms

# concept[].designation[].value
Injection, epoetin alfa, 100 units (for esrd on dialysis)

# concept[].designation[].value
Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)

# concept[].designation[].value
Skin substitute, not otherwise specified

# concept[].designation[].value
Oasis wound matrix, per square centimeter

# concept[].designation[].value
Oasis burn matrix, per square centimeter

# concept[].designation[].value
Integra bilayer matrix wound dressing (bmwd), per square centimeter

# concept[].designation[].value
Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter

# concept[].designation[].value
Integra flowable wound matrix, injectable, 1 cc

# concept[].designation[].value
Matristem wound matrix, per square centimeter

# concept[].designation[].value
Matristem burn matrix, per square centimeter

# concept[].designation[].value
Dermacell, dermacell awm or dermacell awm porous, per square centimeter

# concept[].designation[].value
Oasis ultra tri-layer wound matrix, per square centimeter

# concept[].designation[].value
Memoderm, dermaspan, tranzgraft or integuply, per square centimeter

# concept[].designation[].value
Flex hd, or allopatch hd, per square centimeter

# concept[].designation[].value
Epifix or epicord, per square centimeter

# concept[].designation[].value
Grafix core and grafixpl core, per square centimeter

# concept[].designation[].value
Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter

# concept[].designation[].value
Amnioexcel, amnioexcel plus or biodexcel, per square centimeter

# concept[].designation[].value
Biodfence dryflex, per square centimeter

# concept[].designation[].value
Amniomatrix or biodmatrix, injectable, 1 cc

# concept[].designation[].value
Xcm biologic tissue matrix, per square centimeter

# concept[].designation[].value
Architect, architect px, or architect fx, extracellular matrix, per square centimeter

# concept[].designation[].value
Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter

# concept[].designation[].value
Allowrap ds or dry, per square centimeter

# concept[].designation[].value
Amnioband or guardian, per square centimeter

# concept[].designation[].value
Dermavest and plurivest, per square centimeter

# concept[].designation[].value
Neox 100 or clarix 100, per square centimeter

# concept[].designation[].value
Bio-connekt wound matrix, per square centimeter

# concept[].designation[].value
Keramatrix or kerasorb, per square centimeter

# concept[].designation[].value
Puraply or puraply am, per square centimeter

# concept[].designation[].value
Palingen or palingen xplus, per square centimeter

# concept[].designation[].value
Palingen or promatrx, 0.36 mg per 0.25 cc

# concept[].designation[].value
Neopatch or therion, per square centimeter

# concept[].designation[].value
Cellesta or cellesta duo, per square centimeter

# concept[].designation[].value
Cellesta flowable amnion (25 mg per cc); per 0.5 cc

# concept[].designation[].value
Genesis amniotic membrane, per square centimeter

# concept[].designation[].value
Membrane graft or membrane wrap, per square centimeter

# concept[].designation[].value
Axolotl graft or axolotl dualgraft, per square centimeter

# concept[].designation[].value
Amnion bio or axobiomembrane, per square centimeter

# concept[].designation[].value
Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter

# concept[].designation[].value
Bellacell hd or surederm, per square centimeter

# concept[].designation[].value
Human health factor 10 amniotic patch (hhf10-p), per square centimeter

# concept[].designation[].value
Amniobind or dermabind tl, per square centimeter

# concept[].designation[].value
Myown skin, includes harvesting and preparation procedures, per square centimeter

# concept[].designation[].value
Cogenex amniotic membrane, per square centimeter

# concept[].designation[].value
Amniorepair or altiply, per square centimeter

# concept[].designation[].value
Amnio-maxx or amnio-maxx lite, per square centimeter

# concept[].designation[].value
Corecyte, for topical use only, per 0.5 cc

# concept[].designation[].value
Polycyte, for topical use only, per 0.5 cc

# concept[].designation[].value
Dermacyte amniotic membrane allograft, per square centimeter

# concept[].designation[].value
Amniply, for topical use only, per square centimeter

# concept[].designation[].value
Zenith amniotic membrane, per square centimeter

# concept[].designation[].value
Reguard, for topical use only, per square centimeter

# concept[].designation[].value
Celera dual layer or celera dual membrane, per square centimeter

# concept[].designation[].value
Dual layer impax membrane, per square centimeter

# concept[].designation[].value
Woundplus membrane or e-graft, per square centimeter

# concept[].designation[].value
Xcell amnio matrix, per square centimeter

# concept[].designation[].value
Barrera sl or barrera dl, per square centimeter

# concept[].designation[].value
Biovance tri-layer or biovance 3l, per square centimeter

# concept[].designation[].value
Nudyn dl or nudyn dl mesh, per square centimeter

# concept[].designation[].value
Nudyn sl or nudyn slw, per square centimeter

# concept[].designation[].value
Revoshield + amniotic barrier, per square centimeter

# concept[].designation[].value
Membrane wrap-hydro, per square centimeter

# concept[].designation[].value
Amnio tri-core amniotic, per square centimeter

# concept[].designation[].value
American amnion ac tri-layer, per square centimeter

# concept[].designation[].value
American amnion ac, per square centimeter

# concept[].designation[].value
Regenelink amniotic membrane allograft, per square centimeter

# concept[].designation[].value
Axolotl dualgraft, per square centimeter

# concept[].designation[].value
Artacent vericlen, per square centimeter

# concept[].designation[].value
Dermacyte ac matrix amniotic membrane allograft, per square centimeter

# concept[].designation[].value
Tri-membrane wrap, per square centimeter

# concept[].designation[].value
Matrix hd allograft dermis, per square centimeter

# concept[].designation[].value
Shelter dm matrix, per square centimeter

# concept[].designation[].value
Rampart dl matrix, per square centimeter

# concept[].designation[].value
Palisade dm matrix, per square centimeter

# concept[].designation[].value
Enclose tl matrix, per square centimeter

# concept[].designation[].value
Overlay sl matrix, per square centimeter

# concept[].designation[].value
Hospice or home health care provided in patient's home/residence

# concept[].designation[].value
Hospice or home health care provided in assisted living facility

# concept[].designation[].value
Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)

# concept[].designation[].value
Hospice care provided in skilled nursing facility (snf)

# concept[].designation[].value
Hospice care provided in inpatient hospital

# concept[].designation[].value
Hospice care provided in inpatient hospice facility

# concept[].designation[].value
Hospice care provided in long term care facility

# concept[].designation[].value
Hospice care provided in inpatient psychiatric facility

# concept[].designation[].value
Hospice or home health care provided in place not otherwise specified (nos)

# concept[].designation[].value
Hospice home care provided in a hospice facility

# concept[].designation[].value
Injection, infliximab, biosimilar, 10 mg

# concept[].designation[].value
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg

# concept[].designation[].value
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

# concept[].designation[].value
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units

# concept[].designation[].value
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

# concept[].designation[].value
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

# concept[].designation[].value
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg

# concept[].designation[].value
Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg

# concept[].designation[].value
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg

# concept[].designation[].value
Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg

# concept[].designation[].value
Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg

# concept[].designation[].value
Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg

# concept[].designation[].value
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg

# concept[].designation[].value
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg

# concept[].designation[].value
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg

# concept[].designation[].value
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

# concept[].designation[].value
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

# concept[].designation[].value
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg

# concept[].designation[].value
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg

# concept[].designation[].value
Injection, rituximab-arrx, biosimilar, (riabni), 10 mg

# concept[].designation[].value
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg

# concept[].designation[].value
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

# concept[].designation[].value
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

# concept[].designation[].value
Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg

# concept[].designation[].value
Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg

# concept[].designation[].value
Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

# concept[].designation[].value
Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg

# concept[].designation[].value
Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg

# concept[].designation[].value
Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

# concept[].designation[].value
Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg

# concept[].designation[].value
Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg

# concept[].designation[].value
Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg

# concept[].designation[].value
Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg

# concept[].designation[].value
Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg

# concept[].designation[].value
Injection, adalimumab-fkjp, biosimilar, 1 mg

# concept[].designation[].value
Injection, adalimumab-aaty, biosimilar, 1 mg

# concept[].designation[].value
Injection, adalimumab-ryvk biosimilar, 1 mg

# concept[].designation[].value
Injection, adalimumab-adbm, biosimilar, 1 mg

# concept[].designation[].value
Injection, adalimumab-aacf (idacio), biosimilar, 1 mg

# concept[].designation[].value
Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg

# concept[].designation[].value
Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg

# concept[].designation[].value
Counseling, individual, by chaplain services

# concept[].designation[].value
Department of veterans affairs whole health partner services

# concept[].designation[].value
Injection, sulfur hexafluoride lipid microspheres, per ml

# concept[].designation[].value
Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml

# concept[].designation[].value
Injection, iron-based magnetic resonance contrast agent, per ml

# concept[].designation[].value
Oral magnetic resonance contrast agent, per 100 ml

# concept[].designation[].value
Injection, perflexane lipid microspheres, per ml

# concept[].designation[].value
Injection, perflutren lipid microspheres, per ml

# concept[].designation[].value
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml

# concept[].designation[].value
High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml

# concept[].designation[].value
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml

# concept[].designation[].value
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml

# concept[].designation[].value
High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml

# concept[].designation[].value
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml

# concept[].designation[].value
High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml

# concept[].designation[].value
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml

# concept[].designation[].value
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml

# concept[].designation[].value
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml

# concept[].designation[].value
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg

# concept[].designation[].value
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose

# concept[].designation[].value
Injection, epoetin beta, 1 microgram, (for esrd on dialysis)

# concept[].designation[].value
Injection, epoetin beta, 1 microgram, (non-esrd use)

# concept[].designation[].value
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg

# concept[].designation[].value
Injection, factor viii fc fusion protein (recombinant), per iu

# concept[].designation[].value
Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron

# concept[].designation[].value
Compounded drug, not otherwise classified

# concept[].designation[].value
Netupitant 300 mg and palonosetron 0.5 mg

# concept[].designation[].value
Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg

# concept[].designation[].value
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries

# concept[].designation[].value
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

# concept[].designation[].value
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg

# concept[].designation[].value
Injection, hydroxyprogesterone caproate, (makena), 10 mg

# concept[].designation[].value
Platelets, pheresis, pathogen-reduced, each unit

# concept[].designation[].value
Ustekinumab, for intravenous injection, 1 mg

# concept[].designation[].value
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg

# concept[].designation[].value
Injection, buprenorphine extended-release (sublocade), greater than 100 mg

# concept[].designation[].value
In-line cartridge containing digestive enzyme(s) for enteral feeding, each

# concept[].designation[].value
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg

# concept[].designation[].value
Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg

# concept[].designation[].value
Injection, ustekinumab-aekn (selarsdi), 1 mg

# concept[].designation[].value
Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen

# concept[].designation[].value
Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen

# concept[].designation[].value
Transportation of portable ekg to facility or location, per patient

# concept[].designation[].value
Butorphanol tartrate, nasal spray, 25 mg

# concept[].designation[].value
Injection, bupivicaine hydrochloride, 30 ml

# concept[].designation[].value
Injection, cimetidine hydrochloride, 300 mg

# concept[].designation[].value
Injection, sulfamethoxazole and trimethoprim, 10 ml

# concept[].designation[].value
Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams

# concept[].designation[].value
Injection, clindamycin phosphate, 300 mg

# concept[].designation[].value
Injection, pentamidine isethionate, 300 mg

# concept[].designation[].value
Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)

# concept[].designation[].value
Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)

# concept[].designation[].value
Injection, morphine sulfate, 500 mg (loading dose for infusion pump)

# concept[].designation[].value
Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets

# concept[].designation[].value
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)

# concept[].designation[].value
Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg

# concept[].designation[].value
Injection, pegylated interferon alfa-2a, 180 mcg per ml

# concept[].designation[].value
Injection, pegylated interferon alfa-2b, 10 mcg

# concept[].designation[].value
Sterile dilutant for epoprostenol, 50 ml

# concept[].designation[].value
Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)

# concept[].designation[].value
Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)

# concept[].designation[].value
Dialysis/stress vitamin supplement, oral, 100 capsules

# concept[].designation[].value
Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine

# concept[].designation[].value
Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs

# concept[].designation[].value
Partial hospitalization services, less than 24 hours, per diem

# concept[].designation[].value
Non-emergency transportation; mileage, per mile

# concept[].designation[].value
Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes

# concept[].designation[].value
Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes

# concept[].designation[].value
Comprehensive geriatric assessment and treatment planning performed by assessment team

# concept[].designation[].value
Hospice referral visit (advising patient and family of care options) performed by nurse, social worker, or other designated staff

# concept[].designation[].value
Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service)

# concept[].designation[].value
History and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service)

# concept[].designation[].value
Genetic counseling, under physician supervision, each 15 minutes

# concept[].designation[].value
Physician management of patient home care, standard monthly case rate (per 30 days)

# concept[].designation[].value
Physician management of patient home care, hospice monthly case rate (per 30 days)

# concept[].designation[].value
Physician management of patient home care, episodic care monthly case rate (per 30 days)

# concept[].designation[].value
Physician visit at member's home, outside of a capitation arrangement

# concept[].designation[].value
Nurse practitioner visit at member's home, outside of a capitation arrangement

# concept[].designation[].value
Medical home program, comprehensive care coordination and planning, initial plan

# concept[].designation[].value
Medical home program, comprehensive care coordination and planning, maintenance of plan

# concept[].designation[].value
Colonoscopy consultation performed prior to a screening colonoscopy procedure

# concept[].designation[].value
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)

# concept[].designation[].value
Hospitalist services (list separately in addition to code for appropriate evaluation and management service)

# concept[].designation[].value
Comprehensive management and care coordination for advanced illness, per calendar month

# concept[].designation[].value
Disease management program; initial assessment and initiation of the program

# concept[].designation[].value
Telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month

# concept[].designation[].value
Lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage

# concept[].designation[].value
Lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage

# concept[].designation[].value
Lifestyle modification program for management of coronary artery disease, including all supportive services; fourth quarter / stage

# concept[].designation[].value
Treatment planning and care coordination management for cancer, initial treatment

# concept[].designation[].value
Treatment planning and care coordination management for cancer, established patient with a change of regimen

# concept[].designation[].value
Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit

# concept[].designation[].value
Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic

# concept[].designation[].value
Global fee for extracorporeal shock wave lithotripsy treatment of kidney stone(s)

# concept[].designation[].value
Single vision prescription lens (safety, athletic, or sunglass), per lens

# concept[].designation[].value
Bifocal vision prescription lens (safety, athletic, or sunglass), per lens

# concept[].designation[].value
Trifocal vision prescription lens (safety, athletic, or sunglass), per lens

# concept[].designation[].value
Non-prescription lens (safety, athletic, or sunglass), per lens

# concept[].designation[].value
Daily wear specialty contact lens, per lens

# concept[].designation[].value
Scleral lens, liquid bandage device, per lens

# concept[].designation[].value
Polycarbonate lens (list this code in addition to the basic code for the lens)

# concept[].designation[].value
Nonstandard lens (list this code in addition to the basic code for the lens)

# concept[].designation[].value
Integral lens service, miscellaneous services reported separately

# concept[].designation[].value
Dispensing new spectacle lenses for patient supplied frame

# concept[].designation[].value
Phakic intraocular lens for correction of refractive error

# concept[].designation[].value
Annual gynecological examination, new patient

# concept[].designation[].value
Annual gynecological examination; clinical breast examination without pelvic evaluation

# concept[].designation[].value
Audiometry for hearing aid evaluation to determine the level and degree of hearing loss

# concept[].designation[].value
Routine ophthalmological examination including refraction; new patient

# concept[].designation[].value
Physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)

# concept[].designation[].value
Removal of sutures; by a physician other than the physician who originally closed the wound

# concept[].designation[].value
Deluxe item, patient aware (list in addition to code for basic item)

# concept[].designation[].value
Customized item (list in addition to code for basic item)

# concept[].designation[].value
Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel

# concept[].designation[].value
Continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)

# concept[].designation[].value
Continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)

# concept[].designation[].value
Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices

# concept[].designation[].value
Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system

# concept[].designation[].value
Transmitter; external, for use with artificial pancreas device system

# concept[].designation[].value
Receiver (monitor); external, for use with artificial pancreas device system

# concept[].designation[].value
Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)

# concept[].designation[].value
Mometasone furoate sinus implant, 370 micrograms

# concept[].designation[].value
Stent, non-coronary, temporary, with delivery system (propel)

# concept[].designation[].value
Transplantation of small intestine and liver allografts

# concept[].designation[].value
Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor

# concept[].designation[].value
Donor lobectomy (lung) for transplantation, living donor

# concept[].designation[].value
Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral

# concept[].designation[].value
Breast reconstruction of a single breast with "stacked" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral

# concept[].designation[].value
Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral

# concept[].designation[].value
Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)

# concept[].designation[].value
Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline

# concept[].designation[].value
Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres

# concept[].designation[].value
Islet cell tissue transplant from pancreas; allogeneic

# concept[].designation[].value
Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment

# concept[].designation[].value
Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)

# concept[].designation[].value
Metal-on-metal total hip resurfacing, including acetabular and femoral components

# concept[].designation[].value
Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation

# concept[].designation[].value
Cord blood harvesting for transplantation, allogeneic

# concept[].designation[].value
Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; marrow ablative therapy; drugs, supplies, hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition

# concept[].designation[].value
Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition

# concept[].designation[].value
Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft

# concept[].designation[].value
Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts

# concept[].designation[].value
Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft

# concept[].designation[].value
Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft

# concept[].designation[].value
Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft

# concept[].designation[].value
Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear

# concept[].designation[].value
Implantation of auditory brain stem implant

# concept[].designation[].value
Chemodenervation of abductor muscle(s) of vocal cord

# concept[].designation[].value
Chemodenervation of adductor muscle(s) of vocal cord

# concept[].designation[].value
Nasal endoscopy for post-operative debridement following functional endoscopic sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral

# concept[].designation[].value
Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar

# concept[].designation[].value
Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace

# concept[].designation[].value
Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)

# concept[].designation[].value
Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervical

# concept[].designation[].value
Each additional cervical vertebral body (list separately in addition to code for primary procedure)

# concept[].designation[].value
Repair, congenital diaphragmatic hernia in the fetus using temporary tracheal occlusion, procedure performed in utero

# concept[].designation[].value
Repair, urinary tract obstruction in the fetus, procedure performed in utero

# concept[].designation[].value
Repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero

# concept[].designation[].value
Repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero

# concept[].designation[].value
Repair, myelomeningocele in the fetus, procedure performed in utero

# concept[].designation[].value
Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero

# concept[].designation[].value
Repair, congenital malformation of fetus, procedure performed in utero, not otherwise classified

# concept[].designation[].value
Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome

# concept[].designation[].value
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)

# concept[].designation[].value
Diabetic indicator; retinal eye exam, dilated, bilateral

# concept[].designation[].value
Performance measurement, evaluation of patient self assessment, depression

# concept[].designation[].value
Stat laboratory request (situations other than s3601)

# concept[].designation[].value
Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility

# concept[].designation[].value
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis;  hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)

# concept[].designation[].value
Hiv-1 antibody testing of oral mucosal transudate

# concept[].designation[].value
Saliva test, hormone level; during menopause

# concept[].designation[].value
Saliva test, hormone level; to assess preterm labor risk

# concept[].designation[].value
Prostate cancer antigen 3 (pca3) testing

# concept[].designation[].value
Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil

# concept[].designation[].value
Genetic testing for amyotrophic lateral sclerosis (als)

# concept[].designation[].value
Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2

# concept[].designation[].value
Genetic testing for von hippel-lindau disease

# concept[].designation[].value
Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness

# concept[].designation[].value
Genetic testing for hemoglobin e beta-thalassemia

# concept[].designation[].value
Genetic testing for niemann-pick disease

# concept[].designation[].value
Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease

# concept[].designation[].value
Genetic testing for myotonic muscular dystrophy

# concept[].designation[].value
Gene expression profiling panel for use in the management of breast cancer treatment

# concept[].designation[].value
Genetic testing for detection of mutations in the presenilin - 1 gene

# concept[].designation[].value
Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome

# concept[].designation[].value
Comprehensive gene sequence analysis for hypertrophic cardiomyopathy

# concept[].designation[].value
Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family

# concept[].designation[].value
Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability

# concept[].designation[].value
Dna analysis, fecal, for colorectal cancer screening

# concept[].designation[].value
Interim labor facility global (labor occurring but not resulting in delivery)

# concept[].designation[].value
In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development

# concept[].designation[].value
Complete cycle, gamete intrafallopian transfer (gift), case rate

# concept[].designation[].value
Complete cycle, zygote intrafallopian transfer (zift), case rate

# concept[].designation[].value
Complete in vitro fertilization cycle, not otherwise specified, case rate

# concept[].designation[].value
Frozen in vitro fertilization cycle, case rate

# concept[].designation[].value
Incomplete cycle, treatment cancelled prior to stimulation, case rate

# concept[].designation[].value
Frozen embryo transfer procedure cancelled before transfer, case rate

# concept[].designation[].value
In vitro fertilization procedure cancelled before aspiration, case rate

# concept[].designation[].value
In vitro fertilization procedure cancelled after aspiration, case rate

# concept[].designation[].value
Assisted oocyte fertilization, case rate

# concept[].designation[].value
Donor services for in vitro fertilization (sperm or embryo), case rate

# concept[].designation[].value
Procurement of donor sperm from sperm bank

# concept[].designation[].value
Microsurgical epididymal sperm aspiration (mesa)

# concept[].designation[].value
Sperm procurement and cryopreservation services; initial visit

# concept[].designation[].value
Sperm procurement and cryopreservation services; subsequent visit

# concept[].designation[].value
Stimulated intrauterine insemination (iui), case rate

# concept[].designation[].value
Cryopreserved embryo transfer, case rate

# concept[].designation[].value
Monitoring and storage of cryopreserved embryos, per 30 days

# concept[].designation[].value
Management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle

# concept[].designation[].value
Penile contracture device, manual, greater than 3 lbs traction force

# concept[].designation[].value
Contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies

# concept[].designation[].value
5% dextrose and 0.45% normal saline, 1000 ml

# concept[].designation[].value
5% dextrose in lactated ringer's, 1000 ml

# concept[].designation[].value
5% dextrose with potassium chloride, 1000 ml

# concept[].designation[].value
5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1000 ml

# concept[].designation[].value
5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml

# concept[].designation[].value
Home infusion therapy, routine service of infusion device (e.g., pump maintenance)

# concept[].designation[].value
Home infusion therapy, repair of infusion device (e.g., pump repair)

# concept[].designation[].value
Day care services, adult; per 15 minutes

# concept[].designation[].value
Day care services, center-based; services not included in program fee, per diem

# concept[].designation[].value
Home care training to home care client, per 15 minutes

# concept[].designation[].value
Home care training to home care client, per session

# concept[].designation[].value
Home care training, family; per 15 minutes

# concept[].designation[].value
Home care training, non-family; per 15 minutes

# concept[].designation[].value
Home care training, non-family; per session

# concept[].designation[].value
Companion care, adult (e.g., iadl/adl); per 15 minutes

# concept[].designation[].value
Companion care, adult (e.g., iadl/adl); per diem

# concept[].designation[].value
Foster care, therapeutic, child; per diem

# concept[].designation[].value
Foster care, therapeutic, child; per month

# concept[].designation[].value
Unskilled respite care, not hospice; per 15 minutes

# concept[].designation[].value
Unskilled respite care, not hospice; per diem

# concept[].designation[].value
Emergency response system; installation and testing

# concept[].designation[].value
Emergency response system; service fee, per month (excludes installation and testing)

# concept[].designation[].value
Emergency response system; purchase only

# concept[].designation[].value
Home delivered meals, including preparation; per meal

# concept[].designation[].value
Laundry service, external, professional; per order

# concept[].designation[].value
Home health respiratory therapy, initial evaluation

# concept[].designation[].value
Home health respiratory therapy, nos, per diem

# concept[].designation[].value
Medication reminder service, non-face-to-face; per month

# concept[].designation[].value
Wellness assessment, performed by non-physician

# concept[].designation[].value
Home infusion therapy, catheter care / maintenance, not otherwise classified; includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, catheter care / maintenance, simple (single lumen), includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, catheter care / maintenance, complex (more than one lumen), includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, catheter care / maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (use this code for interim maintenance of vascular access not currently in use)

# concept[].designation[].value
Home infusion therapy, all supplies necessary for restoration of catheter patency or declotting

# concept[].designation[].value
Home infusion therapy, all supplies necessary for catheter repair

# concept[].designation[].value
Home infusion therapy, all supplies (including catheter) necessary for a peripherally inserted central venous catheter (picc) line insertion

# concept[].designation[].value
Home infusion therapy, all supplies (including catheter) necessary for a midline catheter insertion

# concept[].designation[].value
Home infusion therapy, insertion of peripherally inserted central venous catheter (picc), nursing services only (no supplies or catheter included)

# concept[].designation[].value
Home infusion therapy, insertion of midline venous catheter, nursing services only (no supplies or catheter included)

# concept[].designation[].value
Insulin, most rapid onset (lispro or aspart); 5 units

# concept[].designation[].value
Insulin, intermediate acting (nph or lente); 5 units

# concept[].designation[].value
Insulin delivery device, reusable pen; 1.5 ml size

# concept[].designation[].value
Insulin delivery device, reusable pen; 3 ml size

# concept[].designation[].value
Insulin cartridge for use in insulin delivery device other than pump; 150 units

# concept[].designation[].value
Insulin cartridge for use in insulin delivery device other than pump; 300 units

# concept[].designation[].value
Insulin delivery device, disposable pen (including insulin); 1.5 ml size

# concept[].designation[].value
Insulin delivery device, disposable pen (including insulin); 3 ml size

# concept[].designation[].value
Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy

# concept[].designation[].value
Low-dose computed tomography for lung cancer screening

# concept[].designation[].value
Magnetic resonance imaging (mri), low-field

# concept[].designation[].value
Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)

# concept[].designation[].value
Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)

# concept[].designation[].value
Electron beam computed tomography (also known as ultrafast ct, cine ct)

# concept[].designation[].value
Asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer)

# concept[].designation[].value
Holding chamber or spacer for use with an inhaler or nebulizer; without mask

# concept[].designation[].value
Holding chamber or spacer for use with an inhaler or nebulizer; with mask

# concept[].designation[].value
Peak expiratory flow rate (physician services)

# concept[].designation[].value
Oxygen contents, gaseous, 1 unit equals 1 cubic foot

# concept[].designation[].value
Oxygen contents, liquid, 1 unit equals 1 pound

# concept[].designation[].value
Interferential current stimulator, 2 channel

# concept[].designation[].value
Interferential current stimulator, 4 channel

# concept[].designation[].value
Tracheostomy supply, not otherwise classified

# concept[].designation[].value
Mandibular orthopedic repositioning device, each

# concept[].designation[].value
Enuresis alarm, using auditory buzzer and/or vibration device

# concept[].designation[].value
Infection control supplies, not otherwise specified

# concept[].designation[].value
Gradient pressure aid (sleeve and glove combination), custom made

# concept[].designation[].value
Gradient pressure aid (sleeve and glove combination), ready made

# concept[].designation[].value
Gradient pressure aid (sleeve), custom made, medium weight

# concept[].designation[].value
Gradient pressure aid (sleeve), custom made, heavy weight

# concept[].designation[].value
Gradient pressure aid (sleeve), ready made

# concept[].designation[].value
Gradient pressure aid (glove), custom made, medium weight

# concept[].designation[].value
Gradient pressure aid (glove), custom made, heavy weight

# concept[].designation[].value
Gradient pressure aid (glove), ready made

# concept[].designation[].value
Gradient pressure aid (gauntlet), ready made

# concept[].designation[].value
Splint, prefabricated, digit (specify digit by use of modifier)

# concept[].designation[].value
Insulin syringes (100 syringes, any size)

# concept[].designation[].value
Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient

# concept[].designation[].value
Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes

# concept[].designation[].value
Complex lymphedema therapy, each 15 minutes

# concept[].designation[].value
Physical or manipulative therapy performed for maintenance rather than restoration

# concept[].designation[].value
Resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event)

# concept[].designation[].value
Home uterine monitor with or without associated nursing services

# concept[].designation[].value
Intra-vaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device

# concept[].designation[].value
Extracorporeal shockwave lithotripsy for gall stones (if performed with ercp, use 43265)

# concept[].designation[].value
Procuren or other growth factor preparation to promote wound healing

# concept[].designation[].value
Home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Services provided in an urgent care center (list in addition to code for service)

# concept[].designation[].value
Vertebral axial decompression, per session

# concept[].designation[].value
Home visit, phototherapy services (e.g., bili-lite), including equipment rental, nursing services, blood draw, supplies, and other services, per diem

# concept[].designation[].value
Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month

# concept[].designation[].value
Home health aide or certified nurse assistant, providing care in the home; per hour

# concept[].designation[].value
Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)

# concept[].designation[].value
Nursing care, in the home; by licensed practical nurse, per hour

# concept[].designation[].value
Social work visit, in the home, per diem

# concept[].designation[].value
Occupational therapy, in the home, per diem

# concept[].designation[].value
Diabetic management program, follow-up visit to non-md provider

# concept[].designation[].value
Diabetic management program, follow-up visit to md provider

# concept[].designation[].value
Insulin pump initiation, instruction in initial use of pump (pump not included)

# concept[].designation[].value
Home management of preterm labor, including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)

# concept[].designation[].value
Home management of preterm premature rupture of membranes (pprom), including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)

# concept[].designation[].value
Home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)

# concept[].designation[].value
Home management of postpartum hypertension, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)

# concept[].designation[].value
Home management of preeclampsia, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately); per diem (do not use this code with any home infusion per diem code)

# concept[].designation[].value
Home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)

# concept[].designation[].value
Home infusion therapy, pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (do not use this code with s9326, s9327 or s9328)

# concept[].designation[].value
Home infusion therapy, continuous (twenty-four hours or more) pain management infusion; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, intermittent (less than twenty-four hours) pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)

# concept[].designation[].value
Home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy, hemodialysis; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately), per diem

# concept[].designation[].value
Home infusion therapy, continuous anticoagulant infusion therapy (e.g., heparin), administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; enteral nutrition via gravity; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; enteral nutrition via bolus; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor viii); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, chelation therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, diuretic intravenous therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, anti-spasmotic therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, total parenteral nutrition (tpn); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem (do not use with home infusion codes s9365-s9368 using daily volume scales)

# concept[].designation[].value
Home infusion therapy, total parenteral nutrition (tpn); one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, total parenteral nutrition (tpn); more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, total parenteral nutrition (tpn); more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, total parenteral nutrition (tpn); more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; intermittent anticoagulant injection therapy (e.g., heparin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code for flushing of infusion devices with heparin to maintain patency)

# concept[].designation[].value
Home infusion therapy, hydration therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use with hydration therapy codes s9374-s9377 using daily volume scales)

# concept[].designation[].value
Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, hydration therapy; more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, hydration therapy; more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, hydration therapy; more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Delivery or service to high risk areas requiring escort or extra protection, per visit

# concept[].designation[].value
Anticoagulation clinic, inclusive of all services except laboratory tests, per session

# concept[].designation[].value
Pharmacy compounding and dispensing services

# concept[].designation[].value
Medical foods for non-inborn errors of metabolism

# concept[].designation[].value
Medical food nutritionally complete, administered orally, providing 100% of nutritional intake

# concept[].designation[].value
Modified solid food supplements for inborn errors of metabolism

# concept[].designation[].value
Medical foods for inborn errors of metabolism

# concept[].designation[].value
Childbirth refresher classes, non-physician provider, per session

# concept[].designation[].value
Cesarean birth classes, non-physician provider, per session

# concept[].designation[].value
Vbac (vaginal birth after cesarean) classes, non-physician provider, per session

# concept[].designation[].value
Asthma education, non-physician provider, per session

# concept[].designation[].value
Birthing classes, non-physician provider, per session

# concept[].designation[].value
Lactation classes, non-physician provider, per session

# concept[].designation[].value
Parenting classes, non-physician provider, per session

# concept[].designation[].value
Patient education, not otherwise classified, non-physician provider, individual, per session

# concept[].designation[].value
Patient education, not otherwise classified, non-physician provider, group, per session

# concept[].designation[].value
Infant safety (including cpr) classes, non-physician provider, per session

# concept[].designation[].value
Weight management classes, non-physician provider, per session

# concept[].designation[].value
Exercise classes, non-physician provider, per session

# concept[].designation[].value
Nutrition classes, non-physician provider, per session

# concept[].designation[].value
Smoking cessation classes, non-physician provider, per session

# concept[].designation[].value
Stress management classes, non-physician provider, per session

# concept[].designation[].value
Diabetic management program, group session

# concept[].designation[].value
Diabetic management program, nurse visit

# concept[].designation[].value
Diabetic management program, dietitian visit

# concept[].designation[].value
Cardiac rehabilitation program, non-physician provider, per diem

# concept[].designation[].value
Pulmonary rehabilitation program, non-physician provider, per diem

# concept[].designation[].value
Enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem

# concept[].designation[].value
Ambulatory setting substance abuse treatment or detoxification services, per diem

# concept[].designation[].value
Vestibular rehabilitation program, non-physician provider, per diem

# concept[].designation[].value
Intensive outpatient psychiatric services, per diem

# concept[].designation[].value
Family stabilization services, per 15 minutes

# concept[].designation[].value
Crisis intervention mental health services, per hour

# concept[].designation[].value
Crisis intervention mental health services, per diem

# concept[].designation[].value
Home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504)

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 3 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal; once every 6 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home infusion therapy, antibiotic, antiviral, or antifungal; once every 4 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient

# concept[].designation[].value
Home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin, g-csf, gm-csf); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem

# concept[].designation[].value
Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy, irrigation therapy (e.g., sterile irrigation of an organ or anatomical cavity); including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

# concept[].designation[].value
Home therapy; professional pharmacy services for provision of infusion, specialty drug administration, and/or disease state management, not otherwise classified, per hour (do not use this code with any per diem code)

# concept[].designation[].value
Services by a journal-listed christian science practitioner for the purpose of healing, per diem

# concept[].designation[].value
Services by a journal-listed christian science nurse, per hour

# concept[].designation[].value
Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)

# concept[].designation[].value
Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)

# concept[].designation[].value
Transplant related lodging, meals and transportation, per diem

# concept[].designation[].value
Lodging, per diem, not otherwise classified

# concept[].designation[].value
Meals, per diem, not otherwise specified

# concept[].designation[].value
Medical records copying fee, administrative

# concept[].designation[].value
Not medically necessary service (patient is aware that service not medically necessary)

# concept[].designation[].value
Services provided as part of a phase i clinical trial

# concept[].designation[].value
Services provided outside of the united states of america (list in addition to code(s) for service(s))

# concept[].designation[].value
Services provided as part of a phase ii clinical trial

# concept[].designation[].value
Services provided as part of a phase iii clinical trial

# concept[].designation[].value
Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion

# concept[].designation[].value
Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion

# concept[].designation[].value
Meals for clinical trial participant and one caregiver/companion

# concept[].designation[].value
Private duty / independent nursing service(s) - licensed, up to 15 minutes

# concept[].designation[].value
Services of a qualified nursing aide, up to 15 minutes

# concept[].designation[].value
Alcohol and/or substance abuse services, family/couple counseling

# concept[].designation[].value
Alcohol and/or substance abuse services, treatment plan development and/or modification

# concept[].designation[].value
Child sitting services for children of the individual receiving alcohol and/or substance abuse services

# concept[].designation[].value
Meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program)

# concept[].designation[].value
Alcohol and/or substance abuse services, skills development

# concept[].designation[].value
Sign language or oral interpretive services, per 15 minutes

# concept[].designation[].value
Telehealth transmission, per minute, professional services bill separately

# concept[].designation[].value
Targeted case management, each 15 minutes

# concept[].designation[].value
School-based individualized education program (iep) services, bundled

# concept[].designation[].value
Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)

# concept[].designation[].value
Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)

# concept[].designation[].value
Home health aide or certified nurse assistant, per visit

# concept[].designation[].value
Contracted home health agency services, all services provided under contract, per day

# concept[].designation[].value
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter

# concept[].designation[].value
Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter

# concept[].designation[].value
Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per diem

# concept[].designation[].value
Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per hour

# concept[].designation[].value
Family training and counseling for child development, per 15 minutes

# concept[].designation[].value
Assessment of home, physical and family environment, to determine suitability to meet patient's medical needs

# concept[].designation[].value
Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling

# concept[].designation[].value
Nursing care, in the home, by registered nurse, per diem

# concept[].designation[].value
Nursing care, in the home, by licensed practical nurse, per diem

# concept[].designation[].value
Services performed by a doula birth worker, per 15 minutes

# concept[].designation[].value
Services performed by a doula birth worker, per diem

# concept[].designation[].value
Medicaid certified community behavioral health clinic services, per diem

# concept[].designation[].value
Medicaid certified community behavioral health clinic services, per month

# concept[].designation[].value
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit

# concept[].designation[].value
Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit

# concept[].designation[].value
Electronic medication compliance management device, includes all components and accessories, not otherwise classified

# concept[].designation[].value
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks"

# concept[].designation[].value
Transportation waiting time, air ambulance and non-emergency vehicle, one-half (1/2) hour increments

# concept[].designation[].value
Preadmission screening and resident review (pasrr) level i identification screening, per screen

# concept[].designation[].value
Preadmission screening and resident review (pasrr) level ii evaluation, per evaluation

# concept[].designation[].value
Habilitation, educational; waiver, per diem

# concept[].designation[].value
Habilitation, educational, waiver; per hour

# concept[].designation[].value
Habilitation, prevocational, waiver; per diem

# concept[].designation[].value
Habilitation, prevocational, waiver; per hour

# concept[].designation[].value
Habilitation, residential, waiver; per diem

# concept[].designation[].value
Habilitation, residential, waiver; 15 minutes

# concept[].designation[].value
Habilitation, supported employment, waiver; per diem

# concept[].designation[].value
Habilitation, supported employment, waiver; per 15 minutes

# concept[].designation[].value
Day habilitation, waiver; per 15 minutes

# concept[].designation[].value
Service assessment/plan of care development, waiver

# concept[].designation[].value
Waiver services; not otherwise specified (nos)

# concept[].designation[].value
Specialized childcare, waiver; per 15 minutes

# concept[].designation[].value
Specialized supply, not otherwise specified, waiver

# concept[].designation[].value
Specialized medical equipment, not otherwise specified, waiver

# concept[].designation[].value
Residential care, not otherwise specified (nos), waiver; per month

# concept[].designation[].value
Residential care, not otherwise specified (nos), waiver; per diem

# concept[].designation[].value
Utility services to support medical equipment and assistive technology/devices, waiver

# concept[].designation[].value
Therapeutic camping, overnight, waiver; each session

# concept[].designation[].value
Therapeutic camping, day, waiver; each session

# concept[].designation[].value
Community transition, waiver; per service

# concept[].designation[].value
Vehicle modifications, waiver; per service

# concept[].designation[].value
Financial management, self-directed, waiver; per 15 minutes

# concept[].designation[].value
Supports brokerage, self-directed, waiver; per 15 minutes

# concept[].designation[].value
Hospice inpatient respite care; per diem

# concept[].designation[].value
Hospice general inpatient care; per diem

# concept[].designation[].value
Hospice long term care, room and board only; per diem

# concept[].designation[].value
Habilitation, prevocational, waiver; per 15 minutes

# concept[].designation[].value
Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem

# concept[].designation[].value
Non-emergency transportation; stretcher van, mileage; per mile

# concept[].designation[].value
Financial management, self-directed, waiver; per diem

# concept[].designation[].value
Supports brokerage, self-directed, waiver; per diem

# concept[].designation[].value
Human breast milk processing, storage and distribution only

# concept[].designation[].value
Adult sized disposable incontinence product, brief/diaper, small, each

# concept[].designation[].value
Adult sized disposable incontinence product, brief/diaper, medium, each

# concept[].designation[].value
Adult sized disposable incontinence product, brief/diaper, large, each

# concept[].designation[].value
Adult sized disposable incontinence product, brief/diaper, extra large, each

# concept[].designation[].value
Adult sized disposable incontinence product, protective underwear/pull-on, small size, each

# concept[].designation[].value
Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each

# concept[].designation[].value
Adult sized disposable incontinence product, protective underwear/pull-on, large size, each

# concept[].designation[].value
Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each

# concept[].designation[].value
Pediatric sized disposable incontinence product, brief/diaper, small/medium size, each

# concept[].designation[].value
Pediatric sized disposable incontinence product, brief/diaper, large size, each

# concept[].designation[].value
Pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each

# concept[].designation[].value
Pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each

# concept[].designation[].value
Youth sized disposable incontinence product, brief/diaper, each

# concept[].designation[].value
Youth sized disposable incontinence product, protective underwear/pull-on, each

# concept[].designation[].value
Incontinence product, protective underwear/pull-on, reusable, any size, each

# concept[].designation[].value
Incontinence product, protective underpad, reusable, bed size, each

# concept[].designation[].value
Diaper service, reusable diaper, each diaper

# concept[].designation[].value
Incontinence product, diaper/brief, reusable, any size, each

# concept[].designation[].value
Incontinence product, protective underpad, reusable, chair size, each

# concept[].designation[].value
Incontinence product, disposable underpad, large, each

# concept[].designation[].value
Incontinence product, disposable underpad, small size, each

# concept[].designation[].value
Adult sized disposable incontinence product, protective brief/diaper, above extra large, each

# concept[].designation[].value
Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each

# concept[].designation[].value
Incontinence product, disposable, penile wrap, each

# concept[].designation[].value
Positioning seat for persons with special orthopedic needs

# concept[].designation[].value
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel

# concept[].designation[].value
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc

# concept[].designation[].value
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by  cms-2020-01-r

# concept[].designation[].value
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r

# concept[].designation[].value
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2

# concept[].designation[].value
Sphere, single vision, plano to plus or minus 4.00, per lens

# concept[].designation[].value
Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens

# concept[].designation[].value
Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens

# concept[].designation[].value
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens

# concept[].designation[].value
Lenticular, (myodisc), per lens, single vision

# concept[].designation[].value
Not otherwise classified, single vision lens

# concept[].designation[].value
Sphere, bifocal, plano to plus or minus 4.00d, per lens

# concept[].designation[].value
Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens

# concept[].designation[].value
Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens

# concept[].designation[].value
Sphere, trifocal, plano to plus or minus 4.00d, per lens

# concept[].designation[].value
Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens

# concept[].designation[].value
Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00 cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12 to 2.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens

# concept[].designation[].value
Spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens

# concept[].designation[].value
Lenticular, (myodisc), per lens, trifocal

# concept[].designation[].value
Variable asphericity lens, single vision, full field, glass or plastic, per lens

# concept[].designation[].value
Variable asphericity lens, bifocal, full field, glass or plastic, per lens

# concept[].designation[].value
Contact lens, pmma, toric or prism ballast, per lens

# concept[].designation[].value
Contact lens, pmma, color vision deficiency, per lens

# concept[].designation[].value
Contact lens, gas permeable, spherical, per lens

# concept[].designation[].value
Contact lens, gas permeable, toric, prism ballast, per lens

# concept[].designation[].value
Contact lens, gas permeable, bifocal, per lens

# concept[].designation[].value
Contact lens, gas permeable, extended wear, per lens

# concept[].designation[].value
Contact lens, hydrophilic, spherical, per lens

# concept[].designation[].value
Contact lens, hydrophilic, toric, or prism ballast, per lens

# concept[].designation[].value
Contact lens, hydrophilic, bifocal, per lens

# concept[].designation[].value
Contact lens, hydrophilic, extended wear, per lens

# concept[].designation[].value
Contact lens, hydrophilic, spherical, photochromic additive, per lens

# concept[].designation[].value
Contact lens, hydrophilic, dual focus, per lens

# concept[].designation[].value
Contact lens, hydrophilic, with blue-violet filter, per lens

# concept[].designation[].value
Contact lens, scleral, gas impermeable, per lens (for contact lens modification, see 92325)

# concept[].designation[].value
Contact lens, scleral, gas permeable, per lens (for contact lens modification, see 92325)

# concept[].designation[].value
Hand held low vision aids and other nonspectacle mounted aids

# concept[].designation[].value
Single lens spectacle mounted low vision aids

# concept[].designation[].value
Telescopic and other compound lens system, including distance vision telescopic, near vision telescopes and compound microscopic lens system

# concept[].designation[].value
Fabrication and fitting of ocular conformer

# concept[].designation[].value
Slab off prism, glass or plastic, per lens

# concept[].designation[].value
Special base curve, glass or plastic, per lens

# concept[].designation[].value
Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens

# concept[].designation[].value
Mirror coating, any type, solid, gradient or equal, any lens material, per lens

# concept[].designation[].value
Polarization, any lens material, per lens

# concept[].designation[].value
Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens

# concept[].designation[].value
Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens

# concept[].designation[].value
Lens, polycarbonate or equal, any index, per lens

# concept[].designation[].value
Processing, preserving and transporting corneal tissue

# concept[].designation[].value
Specialty occupational multifocal lens, per lens

# concept[].designation[].value
Astigmatism correcting function of intraocular lens

# concept[].designation[].value
Presbyopia correcting function of intraocular lens

# concept[].designation[].value
Amniotic membrane for surgical reconstruction, per procedure

# concept[].designation[].value
Vision supply, accessory and/or service component of another hcpcs vision code

# concept[].designation[].value
Hearing aid, monaural, body worn, air conduction

# concept[].designation[].value
Hearing aid, monaural, body worn, bone conduction

# concept[].designation[].value
Semi-implantable middle ear hearing prosthesis

# concept[].designation[].value
Hearing aid, contralateral routing device, monaural, in the ear (ite)

# concept[].designation[].value
Hearing aid, contralateral routing device, monaural, in the canal (itc)

# concept[].designation[].value
Hearing aid, contralateral routing device, monaural, behind the ear (bte)

# concept[].designation[].value
Hearing aid, contralateral routing, monaural, glasses

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, ite/ite

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, ite/itc

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, ite/bte

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, itc/itc

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, itc/bte

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, bte/bte

# concept[].designation[].value
Hearing aid, contralateral routing system, binaural, glasses

# concept[].designation[].value
Dispensing fee, contralateral routing system, binaural

# concept[].designation[].value
Dispensing fee, monaural hearing aid, any type

# concept[].designation[].value
Hearing aid, analog, monaural, cic (completely in the ear canal)

# concept[].designation[].value
Hearing aid, analog, monaural, itc (in the canal)

# concept[].designation[].value
Hearing aid, digitally programmable analog, monaural, cic

# concept[].designation[].value
Hearing aid, digitally programmable, analog, monaural, itc

# concept[].designation[].value
Hearing aid, digitally programmable analog, monaural, ite (in the ear)

# concept[].designation[].value
Hearing aid, digitally programmable analog, monaural, bte (behind the ear)

# concept[].designation[].value
Hearing aid, digitally programmable analog, binaural, cic

# concept[].designation[].value
Hearing aid, digitally programmable analog, binaural, itc

# concept[].designation[].value
Hearing aid, digitally programmable, binaural, ite

# concept[].designation[].value
Hearing aid, digitally programmable, binaural, bte

# concept[].designation[].value
Hearing aid, disposable, any type, monaural

# concept[].designation[].value
Hearing aid, disposable, any type, binaural

# concept[].designation[].value
Ear mold/insert, not disposable, any type

# concept[].designation[].value
Hearing aid or assistive listening device/supplies/accessories, not otherwise specified

# concept[].designation[].value
Assistive listening device, telephone amplifier, any type

# concept[].designation[].value
Assistive listening device, alerting, any type

# concept[].designation[].value
Assistive listening device, television amplifier, any type

# concept[].designation[].value
Assistive listening device, television caption decoder

# concept[].designation[].value
Assistive listening device, for use with cochlear implant

# concept[].designation[].value
Assistive listening device, not otherwise specified

# concept[].designation[].value
Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type

# concept[].designation[].value
Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type

# concept[].designation[].value
Assistive listening device, personal fm/dm neck, loop induction receiver

# concept[].designation[].value
Assistive listening device, personal fm/dm, ear level receiver

# concept[].designation[].value
Assistive listening device, personal fm/dm, direct audio input receiver

# concept[].designation[].value
Assistive listening device, personal blue tooth fm/dm receiver

# concept[].designation[].value
Assistive listening device, personal fm/dm receiver, not otherwise specified

# concept[].designation[].value
Assistive listening device, personal fm/dm transmitter assistive listening device

# concept[].designation[].value
Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type

# concept[].designation[].value
Assistive listening device, transmitter microphone, any type

# concept[].designation[].value
Repair/modification of augmentative communicative system or device (excludes adaptive hearing aid)